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ABSTRACT
FOSTERING COMPASSIONATE CARE FOR PERSONS WITH ALZHEIMER’S
DISEASE LIVING IN NURSING FACILITIES
Sam Gilbert Cotton
November 12, 2018
The aim of this dissertation study was to examine the impact of the
implementation of a new Compassionate Care (CC) curriculum on the quality of care
provided by Certified Nursing Assistants (CNAs) to residents with Alzheimer’s disease
(AD). More specifically, this dissertation used Kirkpatrick’s model of evaluation to
assess the reactions, learning, and behavior change of the CNAs exposed to the
curriculum, and ultimately the impact of the curriculum on the stress levels of residents
with AD. To accomplish this, we had two studies that aligned with the Kirkpatrick model
of evaluation.
For Study #1, the evaluation of the compassionate care curriculum (Kirkpatrick
Levels One, Two, and Three), the following hypotheses guided the study: Hypothesis 1:
After completion of the compassionate care curriculum by the CNA experimental group,
CNAs will show a significantly higher increase in knowledge, caregiving self-efficacy,
caregiving satisfaction and a significantly higher reduction in feelings of affiliate stigma
than the CNAs who completed the current standard curriculum (control group).
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For Study #2, Evaluation of the Compassionate Care Curriculum (Kirkpatrick
Level Four), the following hypotheses were used to guide the study: Hypothesis 1a:
Residents with AD from the experimental nursing facility will have a different 12-week
agitation change trajectory from the residents with AD from the control nursing facility.
Hypothesis 1b: Residents with AD from the experimental nursing facility will have a
different 12-week salivary cortisol change trajectory from the residents with AD from the
control nursing facility. Hypothesis 2a: Differences in change in CNAs knowledge,
confidence, satisfaction and affiliate stigma will have a differential effect on the 12-week
agitation trajectories of residents with AD in the experimental and control nursing
facilities. Hypothesis 2b: Differences in change in CNAs knowledge, confidence,
satisfaction and stigma and differences in residents with AD agitation will have a
differential effect on the 12-week salivary cortisol trajectories of residents with AD in the
experimental and control nursing facilities.
Methods: The study included an experimental and control nursing facility. The
sample of residents with AD from the two facilities, including a convenient sample of 25
residents from the experimental group and 27 from the control group. All the CNAs who
took care of the residents with AD that took part in the study were also included in the
study for a total of 99 CNAs, 48 in the experimental group and 51 in the control group.
At baseline, prior to the implementation of the curriculum, data were collected on
the demographics of the CNAs along with their pre-test on AD knowledge, self-efficacy,
caregiving satisfaction, and affiliate stigma for both the experimental and control groups.
At the 12-week period, after the curriculum and care groups were implemented, data on
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AD knowledge, self-efficacy, caregiving satisfaction, and affiliate stigma were collected
again for both groups.
After equivalency between the two groups was tested, a two-way mixed method
MANOVA was utilized to examine how scores changed for all of the dependent
variables. For this study, the focus of the analysis was to examine whether there was a
significant difference over time (within-subjects), whether there were differences
between the control and experimental groups (between-subjects), and whether there was
an interaction effect between time and group, indicating if the groups change differently
over time.
The second study examined the final element of the Kirkpatrick model, namely
stress levels of residents with AD. This study was conducted by testing a hybrid
multilevel growth model.
Results: CNAs changes in terms of their knowledge of AD, self-efficacy,
caregiving satisfaction and affiliate stigma were analyzed to understand the impact the
compassionate care curriculum had on the CNAs, using levels 1, 2 and 3 of the
Kirkpatrick Evaluation Model. For AD knowledge, we saw a significant increase in
scores from baseline to 12 weeks for the experimental group while the control group
remained the same over the 12-week period. Self-efficacy for the experimental group
improved between baseline and 12-weeks but deteriorated slightly for the control group.
Caregiver satisfaction showed a slight improvement at 12-weeks for both groups, yet the
experimental group showed a trend of greater improvement than the control group. For
the experimental group, feelings of affiliate stigma declined between baseline and 12weeks, while the control group remained similar at the 12-week period.
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From the Kirkpatrick model, level 4 examined outcomes. This study focused on
the stress outcomes of the residents with AD, specifically agitation and salivary cortisol
levels. All models built showed that the experimental group performed better in reducing
agitation and reducing salivary cortisol levels. The final models were able to show how
the changes in the CNAs specifically affected these positive outcomes. CNA knowledge
and self-efficacy had the most impact on changing agitation levels, and CNA knowledge
and agitation levels had the most impact on salivary cortisol levels.
Conclusions: The results of this study showed that integrating a compassionate
care curriculum into the work that CNAs perform with persons with AD can lead to
positive outcomes on CNAs knowledge, self-efficacy, caregiving satisfaction, affiliate
stigma and a reduction of agitation and cortisol levels in persons with AD. This has
implications for the way we conceptualize the type of care that is provided by CNAs to
persons with AD in nursing facilities. Currently, CNAs are trained to only provide
traditional basic nursing care focuses primarily on the basic needs of the person such as
attending to activities of daily living. While traditional basic nursing care is important, it
should be supplemented with compassionate care for persons with AD. Compassionate
care (CC) emphasizes the bond between the caregiver (the CNA) and the care receiver
(the person with AD) and their journey together. CC can also provide CNAs with skills to
respond to the changes that the person with AD experiences as they decline.
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CHAPTER I: PROBLEM STATEMENT
Alzheimer’s Disease (AD) is a progressive neurodegenerative disorder that affects
cognition and daily functioning (Liang et al., 2016). It is characterized by what it strips
from persons suffering in its grasp. It progressively destroys the ability to eat, walk, bathe
and dress. It slowly erodes memories and perceptions of time, along the way, taking
pieces of one’s identity. The changes experienced by persons with AD contributes to an
inability to recall the context of what is occurring, which in turn, invites delusions,
anxiety, and at times agitation. As the brain undergoes changes, persons with AD slowly
retreat from the realities of this world and into a world of their own. In some instances
persons with AD are labeled the “living dead” and their last years are referred to as “the
funeral that never ends” (Behuniak, 2011).
As the sixth leading cause of death in the United States (Centers for Disease
Control and Prevention, 2017 ), AD kills more persons each year than prostate and breast
cancer combined (Alzheimer’s Association, 2018). It is the only disease in the top
contributors of death for which we have no prevention or cure and no means of slowing
its progression (Alzheimer’s Association, 2018). The average time lapse between an
individual exhibiting any symptoms of the disease and receiving the diagnosis is 2.8
years (Brookmeyer, Corrada, Curriero, & Kawas, 2002). Currently, one in 10 persons
aged 65 and older have a diagnosis of AD-type dementia (Alzheimer’s Association,
2018). Between 2000 and 2014, there was an 89% increase in deaths attributed to the
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disease. During this time frame, deaths from AD nearly doubled while reported deaths of
the number one killer, cardiovascular disease, declined (Alzheimer’s Association, 2018).
The disease affects 5.5 million persons in the United States and every 66 seconds a
person is diagnosed with AD (Centers for Disease Control and Prevention, 2017 ). In
Kentucky, home to just over 4 million people, the story is similarly dire. Kentucky is
ranked 18th in the nation for AD mortality (United States Department of Health and
Human Services Centers for Disease Control, 2018). There are 71,000 persons or 1.6 %
of the population diagnosed with AD in Kentucky, and this number is projected to
increase by 21.1% to 86,000 persons by 2025 or 1.9% of the population (Alzheimer’s
Association, 2018).
As Alzheimer’s disease progresses cognition, including language, thought, memory,
executive function, judgment, attention, perception, and the ability to live a purposeful
life changes and it becomes difficult for persons with AD to live a normal life (National
Research Council, 2000). Behavior changes and daily living concerns caused by the
disease creates problems for caregivers to provide care and engagement in a meaningful
way (Beck, Ortigara, Mercer, & Shue, 1999). Estimates suggest that aggression occurs in
roughly 40% to 60% of persons living in facilities such as nursing homes (Corbett,
Smith, Creese, & Ballard, 2012). These behaviors are related to greater overall
impairment in functioning and short survival time (Weiner, Hynan, Bret, & White, 2005).
The focus of care shifts to keeping persons with AD safe and managing activities of daily
living.
As a result, more persons with AD and other forms of dementia are receiving care
from formal care providers in nursing home facilities (Gaugler, Fang, Davila, & Shippee,
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2014). According to a study by the Centers for Disease Control and Prevention, in 2014
there were 1,369,700 current residents in nursing homes with more than half having AD
or related dementia (Harris-Kojetin et al., 2016). Having an AD diagnosis increases the
chance that an individual will be admitted to a nursing home. It is predicted that an
estimated 4% of the general population will be admitted into a nursing home by age 80
compared to 75% of persons with AD at the same age (Alzheimer’s Association, 2018).
Within nursing homes in the United States, Certified Nursing Assistants (CNAs)
are predominately charged with providing care to persons with AD. It is estimated that
more than 600,000 CNAs provide direct care that includes personal and activities of daily
living (ADL) support for the 1.4 million persons with AD that live in nursing facilities in
the United States (U.S. Census Bureau, 2015). The work performed by CNAs is arduous
and challenging due to the complexities of providing care to persons with AD. The
profession experiences high levels of turnover and issues with recruitment from burnout
and job dissatisfaction (Sengupta, Ejaz, & Harris-Kojetin, 2012).
The bulk of the care provided by CNAs in nursing facilities is described as basic
nursing care (Pennington, Scott, & Magilvy, 2003; Reinhard, Young, Kane, & Quinn,
2003; Stombaugh & Judd, 2014; U.S. Department of Health and Human Services, 2002;
Wiener, Squillace, Anderson, & Khatutsky, 2009). Basic nursing care is task-oriented and
designed to meet the essential needs of the person (U.S. Department of Health and
Human Services, 2002). It is defined as basic infection control, bathing, bed-making, safe
patient handling, elimination assistance, nutrition and fluids, personal hygiene and
grooming, and vital signs (Stombaugh & Judd, 2014; U.S. Department of Health and
Human Services, 2002; Wiener et al., 2009). Certification for CNAs is federally
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mandated and includes 75-hours of basic nursing care that will be explained in more
detail later in this chapter. (Reinhard et al., 2003; Wiener et al., 2009).
Compassionate Care
CNAs receive limited dementia training, and therefore, are often ill-prepared to
provide care to persons with AD (Chu, Wodchis, & McGilton, 2014; Pennington et al.,
2003). In Kentucky, CNAs who are employed at nursing homes only receive 10 hours of
specific dementia training, as part of their license certification (Kentucky Adminstrative
Regulations, 2006; Patient Protection and Affordable Care Act, 2010). The content of this
training is primarily focused on the process of providing basic nursing care specifically to
persons with AD (Kentucky Adminstrative Regulations, 2006; Patient Protection and
Affordable Care Act, 2010). Additionally, a portion of the training focuses on how to
understand and communicate with persons with AD (Kentucky Adminstrative
Regulations, 2006; Patient Protection and Affordable Care Act, 2010). The training
CNAs receive in dementia care is insufficient to provide the care persons with AD
require as the disease progresses (Sengupta, Harris-Kojetin, & Ejaz, 2010).
Due to the complexities of the disease, persons with AD needs more than just
basic nursing care. They need care that will allow them to flourish. Flourishing refers to
the experience of a life going well and represents a combination of feeling good and
functioning effectively (Huppert & So, 2013), with high levels of emotional,
psychological, and social well-being (Keyes, 2005). For persons with AD this may not
look like it would in a highly functioning individual, but it represents living within an
optimal range of human functioning (Fredrickson & Losada, 2005). It is a state of
existence where disease or impairment co-exists with dignity and quality of life. The
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conceptualization of flourishing differs in part from many definitions of health in that the
expectation of freedom from disease, disability, high cognitive and physical functioning
and active engagement with life (Rowe & Kahn, 1998) are not required in order to
flourish.
In order to train CNAs to provide care that allows persons with AD to flourish
and improve patient outcomes it is recommended that CNA training hours be increased
(Trinkoff, Storr, Lerner, Yang, & Han, 2017). This curriculum should supplement the
existing mandated training CNAs receive and provide a deeper understanding of the
journey that persons with AD experience as they progress through the disease. CNAs
have expressed that they felt inadequately prepared for real-life resident care and
requested additional training (Sengupta et al., 2010).
Compassionate Care (CC) refers to care that promotes and allows persons with
AD to flourish by improving the dyadic relationship between the CNA and persons with
AD. It is achieved by focusing on the physical and mental health of persons with AD
including neurological, cognitive, general health and psychosocial factors, and also
factors that are more dynamic, such as the physical and social environment and the
changing needs and states within persons with AD (Norton, Allen, Snow, Hardin, &
Burgio, 2010). Improving the dyadic relationship between persons with AD and their
caregiver contributes greatly to improved physical and mental health outcomes
(Pickering, Nurenberg, & Schiamberg, 2017). CC is a response to suffering, distress or
discomfort that is associated with disease or decline in mental and physical functioning
(Tierney, Seers, Tutton, & Reeve, 2017). CC respects the dignity of persons with AD by
providing the task-oriented care needed to ensure safety and physical functioning as well
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as the care needed to support mental health, as the disease progresses. CC is deliberate
and intentional in its focus to alleviate pain and suffering while also promoting that
persons with AD can flourish throughout their lifespan. This is achieved through the
implementation of enhanced responses to behaviors and situations that persons with AD
exhibit. It includes deeper caregiver and care-receiver relationships where the caregiver
has the ability to communicate in a manner that promotes positive energy within and
between persons with AD and their families (D. Cohen, 2000).
While definitions for CC vary (Dewar, Adamson, Smith, Surfleet, & King, 2014;
Schantz, 2007; von Dietze & Orbb, 2000) most include the relief of suffering as a key
concept. The concept of relieving suffering is distinguishable from related concepts such
as kindness, empathy, sympathy, and pity. In order to provide CC, caregivers must have
the ability to be open, alert, and sensitive to suffering, and also take action to alleviate or
prevent suffering from continuing (Gilbert & Choden, 2013). While CNAs are trained to
alleviate suffering following task-oriented procedures, the standard protocol focused on
basic nursing care fails to highlight compassionate caregiving that promotes human
flourishing. This model requires that the CNA not only changes personal attitudes,
beliefs and actions in working with persons with AD but also have a desire to infuse CC
in the larger organization or health care system. Current CNA training programs do not
spend enough time to allow CNAs to understand the complexities of providing CC.
The goal of this study is to develop a CC curriculum for CNAs in nursing
facilities and evaluate how the delivery of such a curriculum will improve care to
persons with AD in nursing facilities. In order to understand the complexity of the
disease, including its origin, treatment, and care, this chapter outlines the history of AD,
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the development of pharmaceuticals, and the history of care provisions to older adults
from home care to the growth of institutional care.
The History of Alzheimer’s Disease
To fully understand the lack of compassionate care for persons with AD, one must
first examine the characterizations of the disease throughout history. Since the origins of
the disease, persons with AD have often been stigmatized and portrayed as less than
human for the way that the disease contributes to their decline both mentally and
physically. To begin unraveling the story of dementia and understand how the disease
came to be misunderstood and stigmatized, one must start with the development of the
ancient medical structure.
Dementia in Antiquity (approximately 476 BC- 1453 AD)
During antiquity, everyday life was met with natural disasters, fatal disease and a
never-ending series of warfare. Medical practice, during this time, was heavily predicated
on the use of magic and sacred ritual. According to the Greeks, the healing god
Aesculapius was considered the highest authority of medicine (Stanton, 1999; Zilboorg &
Henry, 1941). Mythological writings dating back to around 1500 BC suggest that
Aesculapius was the son of Apollo and his mortal mistress Coronis. According to the
narrative, in a fit of rage Apollo killed Coronis upon learning she was pregnant. He took
the baby after her death and gave him to a centaur to learn the ancient art of healing
(Stanton, 1999). Subsequently, temples were erected in Aesculapius’s name, and a high
order of priests carried out a series of rituals to heal the ill. Until Hippocrates’ time,
laymen were not permitted to administer any treatment. Only specialized clergy was
allowed to administer medical treatment (Roman, 2003; Zilboorg & Henry, 1941).
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Treatment at the temple included a combination of acts on the part of both the
patient and the priests. In most cases, the patient would be required to sleep near the
temple and dream of the God appearing to them. Based on the interpretation of this
dream, there were various remedies of fermented mixtures that were used to cure the
ailment and rites that included ceremonies involving both music and dance (Roman,
2003). As early as the Neolithic period, humans understood the utility of plants and other
substances found in the wild that could be mixed to alleviate pain, nausea, and other
maladies (Hillman, 2014).
Within the confines of the medical temples and Greek society, physical ailments
were the only diseases that were treated. Little consideration was given to mental
disorders, and no treatment was provided if an individual suffered from mental illnesses
or the symptoms associated with cognitive decline that we know today (Cilliers & Retief,
2009). Interestingly, some persons with various forms of mental illness were granted a
higher status within society and viewed as having special powers. They were often used
to interpret dreams and assist clergy in providing treatment to those with physical
ailments within the temples of Aesculapius (Zilboorg & Henry, 1941). Around the same
period that the Greeks were receiving treatment delivered in the name of Aesculapius, the
ancient Egyptians developed a precise art to the care and preparation of the dead, known
as mummification, which was believed to assist the person in their journey to the afterlife. Little thought was given to the brain during this process of mummification. In fact,
this vital organ was deemed so insignificant that it was extracted through the nose using a
hook and discarded immediately after death (Wickens, 2015). Other writings from the
time also suggest that the brain was viewed simply as a vessel for moving mucus from
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the body to the nose (Wickens, 2015).This was in contrast to views on the heart, which
was viewed as the center of all things good (Wickens, 2015). As different historical
scholars began to articulate theories about cognitive decline and aging, the location of
mental capacities would change dependent on the popular theory of the time (Boller &
Forbes, 1998). While ancient Egyptians were not concerned with the brain, hieroglyphics
from around 2000 BC suggest that they were aware of cognitive decline and associated
this decline with one’s age. However, this theory was predicated on the notion that the
heart and diaphragm were the seats of mental capacities (Boller & Forbes, 1998).
The first formal descriptions of dementia are commonly attributed to Pythagoras (ca.
570-490 BC). He was an often-controversial figure within Greek history and primarily
known as a philosopher and mathematician. Pythagoras is primarily known as the
inventor of a theorem bearing his name that states that the square of a hypotenuse is equal
to the sum of the squares of the other two sides (Ingram, 2014). While Pythagoras
produced no formal writings, reports from his contemporaries provide insight into his
work (Huffman, 2014). The long history of formalizing clinical descriptions of dementia
begins with Pythagoras’ construction of a delineation of the human lifespan into five
distinct phases corresponding with ages 7, 21, 49, 63, and 81 (Halpert, 1983). Each phase
is marked by defining characteristics. The last two phases Pythagoras termed senium,
referred to the increasing mental decline that occurred in this phase for most humans.
This was also a time when the body began to enter into a state of decline and decay
(Halpert, 1983). Pythagoras equated senium as similar to the period of infancy and
childhood (Berchtold & Cotman, 1998; Halpert, 1983). Pythagoras, furthermore,
commented on the fact that it was rare during this time to live to old age with the average
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life expectancy during this time frame being only 30 years (Roman, 2003). In other
writings detailing Pythagoras’ work, the word imbecility is attributed to the process of
cognitive decline (Halpert, 1983). By the 19th century, this term would evolve to become
used as a derogatory term for persons with intellectual disabilities (Trent, 1995).
During the Greco-Roman era (ca. 332-395 BC), mental health was studied from both
the medical perspective and detailed in the literature. Scholars have noted that there is a
difference in these conceptualizations of mental health with medical writings focusing
primarily on the biological mechanisms involved while contemporary literature from this
time period focused primarily on the supernatural or divine origins of the disease (Cilliers
& Retief, 2009). Homer’s epic poem The Odyssey, written near the end of the 8th
century, describes the theory regarding the connection between age and cognitive ability.
In The Odyssey, readers are introduced to King Laertes of Ithaca, the father of the titular
character Odysseus. Homer writes of Laertes prestigious role as a physically vigorous
war hero (Homer, 1996). When Odysseus returns to his home in Ithaca twenty years after
first leaving to fight in the Trojan war, he finds his father in a much different state
(Homer, 1996). To distinguish Laertes condition from other psychological diseases,
Homer places emphases on his memory, particularly his long-term memories (Homer,
1996). For example, Laertes is described as an individual that despite his wealth and
prestige, decides to spend his days in the gardens of the city and sleeping in barns since
this is where his fondest childhood experiences occurred. Laertes seems unaware of any
short-term memory that he has gained in the twenty years since Odysseus first left, and
this is reiterated in a passage where Odysseus identifies himself to his father by pointing
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to a scar that he obtained during childhood as well as reciting the number of trees that the
duo planted together in the gardens decades ago (Homer, 1996).
Descriptions of dementia are equally present in Greek mythology suggesting that the
disease was considered an aspect of life. Mythology was commonly used to explain any
phenomenon that was not understood at the time. In one myth, Tithonus is described as
handsome but mortal, and he is married to the goddess of dawn Eos. As a gift to her
husband, Eos pleads with Zeus to make her husband immortal. Her wish is granted.
However, she failed to ask that he keep his youth. Thus, Tithonus continued to age,
despite his immortality and began showing features of dementia including incessant talk
that was unintelligible to his wife. When Eos could no longer stand watching her
husband’s decline, she turned him into a grasshopper (Bulfinch, 2014). While the
mythology does not offer a formal name for dementia, only a description, it can be
ascertained from the moral of the story, that as Tithonus aged, despite his newfound
immortality, his behaviors and mannerisms were similar to an “aging mind” that we now
refer to as cognitive decline (J. Jones & Jones, 2010).
Legal writings further reveal social commentary on the perceived nature of cognitive
decline during antiquity. While only fragments of his writings still exist today, Solon
(630-530 BC) is known for generating reforms in Athens by developing revisions to
codified laws. Solon is credited with foraging a reform to end political and moral decline.
In regards to dementia, Solon determined that old age was one factor that could
contribute to impaired judgment and thus, persons might not have a sound mind to make
decisions (Boller & Forbes, 1998).
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While a trend towards describing the symptoms of dementia was apparent in
literature, scholars, and philosophers after Pythagoras continued to posit theories about
the nature of the brain and cognitive decline. Nearly two centuries after Pythagoras
detailed the life stages previously described, Hippocrates (ca. 460-370 BC) demarcated
his own medical classification. Hippocrates is known as one of the most influential
medical doctors of all times. Hippocrates work is still utilized within the medical field
(Breitenfeld, Jurasic, & Breitenfeld, 2014). There are 60 known works that are credited to
Hippocrates. However, it is commonly believed that much of his writing was written by
his students (Porter, 2004). Hippocrates does not provide an exact characterization of
dementia; however, many scholars often equate the use of the term paranoia to the same
definition that Pythagoras provides for imbecility (Berchtold & Cotman, 1998; Halpert,
1983). It has been suggested that the absence of the terms cognitive decline or dementia
is due to the common perception that it was intertwined with old age (Roman, 2003).
Since Hippocrates did not provide direct commentary for mental decline, it is difficult to
determine whether paranoia was an accurate description of dementia. However, it should
be noted that the Hippocratic cannon postulated that all illnesses could be attributed to an
imbalance in the four cardinal body fluids. During this time, ancient Greeks held that
there were four cardinal body fluids, often referred to as humours, and four primary and
opposite fundamental qualities known as hot, cold, wet and dry. This theory posited that
each humour was connected to a mental state and thus, an imbalance would contribute to
certain declines or behaviors (Boller & Forbes, 1998; Jouanna, Eijk, & Allies, 2012;
Porter, 2004).
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Hippocrates’ work was central to the development of medicine. Until his work, the
field of medicine was not organized, and treatment of conditions was largely performed
by religious leaders or clergy. Furthermore, given the emphasis on religion, there was not
an emphasis on scientific inquiry (Porter, 2004). Thus, Hippocrates work with identifying
humours is important since this led to the prevention and treatment of physical
conditions. For example, if the imbalance occurred within the individual’s blood system,
such as a buildup of toxins, then bloodletting was recommended as a suitable treatment
for this ailment (Porter, 2004).
Despite Hippocrates work in medicine, the debate about the nature of the mind
persisted within philosophy. Plato (ca. 429-347 BC) and his student, Aristotle (ca. 384322 BC) wrote about the correlation between age and cognitive decline. Aristotle’s most
notable work in the field of psychology is De Anima, which provides a broad overview of
his theories on the nature of living things (Shields, 2016). In particular, it is clear from
Aristotle’s writings that there is a perception that cognitive decline as one ages is an
inevitable condition. Furthermore, Aristotle disagreed with Hippocrates theory that the
brain (or head) was the center of mental functioning. Instead, Aristotle arrived at the
conclusion that the heart was the source of mental faculties and life.
Contribution to the debate about the nature of mental capacity and old age was also
provided by Cicero (ca. 106-43 BC). Cicero was a Roman philosopher, known as a great
orator who primarily studied the law. By the time that Cicero was writing, the connection
between old age and cognitive decline was generally accepted. However, Cicero
disagreed with the prevailing notion that cognitive decline, which he referred to as senile
debility, was an inherent nature of old age. Instead, Cicero argued that only those that
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were of weak constitution suffered from senility, thus adding an element directly
correlated to one’s morality (Boller & Forbes, 1998). Furthermore, Cicero believed that
cognitive decline could be prevented, primarily by one staying active and keeping an
active mind (Boller, Bick, & Duyckaerts, 2007). This, Cicero believed, was the key to
avoiding the disease.
Roman physician Celsus (ca. AD 14-37), who translated significant medical works
from Greek to Latin, is thought to have been the first to employ the terms dementia and
insanity as medical terms in De Medicina (Berrios, 1990; Roman, 2003). Celsus,
influenced by the work of Hippocrates, divided insanity into three different categories
that included melancholia, phrenitis, and dementia. Each was determined by a different
cause (Roman, 2003). Prior to the work of Celsus, many mental disorders were
characterized under the same phenomenon given the overarching symptomology. From
the work of Celsus, we know that he was continuously on a search for the most effective
drugs for his patients (Hillman, 2014).
Galen (ca. AD 129 -200), the Greek physician is known as a prolific writer, having
completed 21 volumes of work of an estimated 1,000 pages each. His writings are heavily
influenced by the work of Hippocrates (P. N. Singer, 2016; Wickens, 2015). More of
Galen’s writings have survived by comparison to those physicians and philosophers
writing prior to this time (Hillman, 2014). In one of his voluminous encyclopedias, the
physician listed morosis, his word for dementia, as a mental disease linked to the brain
(Berchtold & Cotman, 1998; Schäfer, 2005). In his description of morosis, he
characterized that disease by stating, “some who in the knowledge of letters and other
arts are totally obliterated; indeed they can’t even remember their own names” (Berchtold
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& Cotman, 1998). Given that he was heavily influenced by the work of Hippocrates,
Galen’s writings posit that old age itself was considered a disease given the process that
persons experience (Berchtold & Cotman, 1998; Halpert, 1983; Schäfer, 2005).
Furthermore, Galen conjectured that disorders, such as cognitive impairment, could be
related to diseases or processes in other organs in the body, a theory that was first posited
by Hippocrates (Boller & Forbes, 1998). While most of Galen’s work was a continuation
of previous scholars, Galen distinguished himself from others in that he went a step
further to prove the theories that he wrote about. Despite the fact that these were rare
practices during this time, writings show that Galen performed scientific experiments and
dissection which provided more concrete knowledge about the human body (Wickens,
2015).
Galen’s work comes at the end of the Greco-Roman period. By the time he was
writing and producing scientific evidence, the decline of the empire had already started.
From the works of this period, it can be ascertained that dementia was established as a
normal process of aging. Epidemics, disease, and death due to lack of resources were a
part of life.However, it was viewed that if one survived to old age cognitive decline
would inevitably occur.
By the 5th century (AD), due to a shifting political landscape and a decline in
power, the Western Roman Empire was largely considered a failed state (Philippides,
1980). Despite these major losses, the Eastern Roman Empire, known primarily today as
the Byzantine Empire, continued on and lasted from approximately 330 AD to 1453 AD
(Philippides, 1980). Much of the research and scholarly work during this time was an
extension on the work that had been developed during the Greco-Roman period.
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The roots of gerontology begin to take shape during the Byzantine Empire
(Lascaratos & Poulakou-Rebelakou, 2000). We know through the work of Aetius of
Amida, that by the 6th century (AD) , there were physicians that treated the aging
population, simply referred to as the “aged” (Poulakou-Rebelakou, Kalantzis, Tsiamis, &
Ploumpidis, 2012). The emphasis on providing specialty care to older adults is
particularly interesting given that during the Byzantine Empire there is the first known
movement towards a desire to appear more youthful. In particular, Empress Zoe is
credited with starting this trend, as she continued to search for elixirs and remedies to
appear much younger during her 60s (Panas, Poulakou-Rebelakou, Kalfakis, &
Vassilopoulos, 2012). The detailed accounts of Zoe’s quest for youth are noteworthy in
that it provides insight into Byzantine pharmacology. Medicinal practices during this time
grew to be heavily predicated on the use of plants. Unlike their predecessors, the
Byzantine’s began to cultivate plants that were known more for their medicinal properties
(Scarborough, 2002).
Aging was not the only concern during this period as the significant medical
discourse during this time period was focused on the Justinian Plague (around 542 AD ),
the cause of which we now know to be yersinia pestis, the same bacteria responsible for
the Bubonic plague (Drancourt et al., 2004). This pandemic was devastating to the
population, and an estimated 13% of the world population succumbed to death from the
outbreak (W. Rosen, 2007). Detailed descriptions and theories about the plague were
postulated by Paul of Aegina and provided the foundation for understanding more about
dementia and memory loss. Paul recorded a number of persons that were struck by the
plague also exhibited memory loss as the disease progressed. Building upon the work of

16

Hippocrates, Paul suggested that this memory loss, or as modern descriptions term it,
dementia, was due to the buildup of certain fluids in the humours (Poulakou-Rebelakou et
al., 2012).
While dementia was viewed as only a symptom of the plague, other historians
began to take notice of cognitive decline through their observations of the Emperors.
Surviving historical texts from the Byzantine Empire suggests that dementia was not
uncommon among Emperors that lived into older age. There was a number of persons
that lived to be 70 years or older (Poulakou-Rebelakou et al., 2012). Records from this
period are extremely detailed, and it was not unusual for historians to document an
Emperor across their lifespan. These detailed, longitudinal texts provide accounts that
suggest symptoms that are hallmarks of the different forms of dementia. From Justine I
(518-527 AD) all the way to Andronicus II Palaeologus (1282-1328 AD), there are
accounts of dementia, or at the very least some mention of cognitive decline. For
example, analysis of documents pertaining to Justin I (518-527) notes the leader’s
remarkable decision-making skill in governing and military matters while later texts
suggests that his cognitive abilities deteriorated to the point where his nephew Justinian
carried out many of his obligations (Poulakou-Rebelakou et al., 2012). Sadly, Justinian
would later suffer a similar fate, as historians described the onset of mental decline that
forced his wife, Theodora to carry out his duties (Poulakou-Rebelakou et al., 2012). Even
famed Empress Zoe, known for her incessant need to appear young and exuberant, was
described in later years as suffering from many of the symptoms that we now know are
characteristics of dementia (Poulakou-Rebelakou et al., 2012).
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This period provides us with commentary about specific historical persons that
suffered from the disease. We know their names, their work, and what their lives were
like before and after the disease. This is important because it is the first surviving
chronicle of cognitive disease. This period is also particularly important due to the
development of more standardized pharmacological interventions that were developed to
treat physical ailments, but there is no mention of treating cognitive decline.
In tracing the origins of characterizations of dementia in the writings of scholars of
antiquity in this section provides an understanding of how misunderstanding and stigma
became attached to the disease. The earliest surviving documents illustrate that the brain
was secondary to the heart, which was considered the soul and primary hub for all
thought. Little was known about the functions of the brain. Although medicines for
physical ailments such as pain and nausea were being developed in antiquity, the lack of
understanding of dementia and cognitive decline delayed a search for treating or curative
medicine for cognitive decline. Examination of this period also provides an
understanding of how the field of medicine developed. From the origins of the temples
devoted to Aesculapius, whereby persons presented with ailments and were provided
with treatment the focus was on physical ailments, not mental ailments, firmly
establishing medicine as a separate field.
Medieval era (approximately 5th century to the 16th century)
Commentary on what is now known as AD and other forms of dementia
continued intermittently until the Middle Ages. However, any progress that was made
stalled during the Medieval period. The lack of writings and depictions of the disease
during this period can be attributed to two primary causes: the rise of the Church and the
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rapid spread of the Black Plague. The Catholic church became a formidable force during
the Middle Ages, and its stances on scientific research contributed to a decline in research
(Carruthers, 2008).
During this time, the Church rose as a powerful force and ultimately contributed
to the decline in the status of medicine, science and the work of scholars from these fields
(Logan, 2002). The clergy was the ultimate authority over knowledge and reasons leaving
little room for those that disagreed, such as physicians and scientists. The Black Plague
spread quickly throughout much of Europe and was the foremost cause for any public
health concerns (J. Kelly, 2005). Given this, the only known existing essay on the disease
during this time was written by Franciscan Friar Roger Bacon. During his life, Bacon was
known for his use of empirical methods and his push towards scientific reason. He was
subsequently imprisoned for his views (Brophy, 1963). While in solitary confinement just
before his death, he wrote ‘Methods of Preventing The Appearance of Senility,’ in which
he describes old age and links the loss of memory and cognition to the posterior part of
the brain (Brophy, 1963). Furthermore, Bacon described persons as being without reason,
and essentially without the capacity for thought. While Bacon does not provide
justification for his argument, this is the first publication that linked memory and
cognition to a specific portion of the brain.
Despite the lack of literature on dementia from the Medieval period, what is
noteworthy is the prominence that was placed on memory, particularly by the church. For
the medieval period, great emphasis was placed on collective memory (Brenner, Cohen,
& Franklin-Brown, 2013). Works of art and writings, particularly those rooted in
Christian ideology are filled with allegories and metaphors (Carruthers, 2008). Take for
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example, ‘Hypnerotomachia Poliphili,’ which in English translates to Poliphilo’s Strife
of Love in a Dream, which comes at the end of the Medieval period. The book has been
attributed to many authors and is written in a rather bizarre mix of Latinate Italian. It
remains an important work because of its overuse of imagery and is an example of
Medieval allegory of the moral perils of love (Trippe, 2002). The original versions of the
books were adorned with large wood etchings that depicted scenes from the story. The
same feelings are conjured through the work of Medieval artist Giotto. His scene of the
Nativity or the Crucifixion of Rimini utilizes similar themes and approaches ("Giotto Di
Bondone," 2017).
These works are important because the use of imagery allows people to form
memories of the images depicted. By and large, during the Medieval period, persons were
illiterate, so it would stand to reason that building memory based on these images was
important. Scholars argued that building a collective memory during this period was not
merely a byproduct of the lack of education for most persons. Instead, it could be viewed
under the auspices of the goals of the Church (S. Katz, 2013). Use of collective memory
assisted in developing a moral and just population. Ethics were built through the
development of these memories. Even the clergy was taught the importance of memory
and trained to eat and drink while reading scripture in hopes of retaining the properties of
the text they were studying (S. Katz, 2013).
The maintenance of memory was so desired that it was often lauded through the
descriptions of influential persons by noting their ability to remember. For example,
Thomas Aquinas, the priest, who was respected and renowned during the Medieval
period, is still often described as both excellent at recalling information and morally
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superb (Carruthers, 1990). The implications in these statements are that one’s moral
identity is inherently connected to their ability to remember.
For our discussion of dementia, this emphasis on building memory created a
lasting impact. First, it was predicated on this concept that everyone should have the
capacity to build memory. Regardless of one’s educational status, there was an
expectation that if you heard a sermon or any number of stories that were contained with
religious text, you would be able to recount it orally to others. Memory was not directed
through intellect or physiology. The inability to complete such tasks was viewed as a
moral deficit. While the Medieval period is often known as the dark era for the lack of
philosophical and scientific inquiry, for characterizations of dementia it would prove to
have damning effects in that the stigmatization of not being able to remember was a
moral defect.
Dementia During the Enlightenment Period (17th -18th Century)
As the Enlightenment period began paving the way for modern developments,
public health began receiving more attention. In the Medieval era, record keeping became
an accepted way of providing information about the population at large. Major cities such
as London kept records on vital statistics, such as prevalent diseases that physicians
reported treating and the causes of death of its citizens. In smaller towns, records were
often less detailed with brief descriptions of ailments. As the Medieval period ended, and
the world shifted towards increasing discovery and innovation, more emphasis was
placed on naming diseases and providing an overview of the symptoms commonly
associated with specific diseases. With increasing longevity, scholars were taking note of
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concerns about public health in part through an analysis of the existing records (Pagden,
2013) .
This renewed interest in science paved the way for many important discoveries
within the medical field. Surgical procedures, while still rudimentary by modern
standards, were implemented as medical interventions by the mid-1600’s (Gay, 1966).
During this time frame, the practice of bloodletting and similar procedures was still used.
By 1661, the development of the microscope allowed physicians and scholars to view
microscopic structures that were previously not accessible. The discovery of blood
circulation led to the use of blood transfusion for many diseases. By the mid-1700’s,
inoculation for diseases such as smallpox were in use. It was indeed a time of rapid
development for many diseases and interventions.
Classification of medical terminology also developed through the course of the
17th to 18th centuries. Dementia was now characterized by a grouping of diverse terms
such as imbecility, amentia, phrenesis, and most commonly, senility. This would change
with the publication of a classification of mental disorders entitled ‘Nosographie
philosophique ou méthode de l'analyse appliquée à la medicine’ by physician Phillippe
Pinel (Wallace & Gach, 2010). Originally written in 1798 and widely embraced, Pinel
coined the term dementia to define the broad characteristics of cognitive decline. Pinel
differentiated between delusion and manic behaviors, which were previously associated
solely with cognitive decline. Pinel argued that persons with dementia were without the
capacity for logic and decision-making. While much of the depictions are dated and used
antiquated terminology, Pinel was the first to provide a lengthy analysis of the loss of
memory, cognitive function, and the notion that dementia was a progressive disease
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(Wallace & Gach, 2010). Hence, prior to Alzheimer’s presentation, Pinel was
predominately credited with providing an overview of cognitive decline.
By the 17th and 18th centuries, characterizations of the disease would permeate
cultural works as well. Whether in comedy or tragedy the disease was portrayed as a
representation of the curse of getting old. This period marked a shift towards the
Enlightenment period. Thus, literature during this time reflected the movements towards
social commentary and often included satirical works. The depictions of dementia varied
from serious soliloquies to the use of ironic humor to portray the failures of the mind that
are associated with the disease (Boller & Forbes, 1998).
Renowned playwright William Shakespeare provided several allusions to the
devastation caused by dementia in his plays. Shakespeare’s works ‘As You Like It,’
‘Hamlet,’ and ‘King Lear’ all contain soliloquies that explore a character’s thoughts
relating to the aging process. In ‘As You Like It,’ Shakespeare introduces the concept of
dementia in direct correlation to becoming old in the following passage from Scene 2,
Act 7 (W. Shakespeare, 1623), as follows:
“With spectacles on nose and pouch on side
His youthful hose, well saved, a world too wide
For his shrunk shank; and his big manly voice,
Turning again towards childish treble, pipes
And whistles in his sound. Last scene of all
That ends this strange eventful history
Is second childishness and mere oblivion
Sans teeth, sans eyes, sans teeth, sans everything.”
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Unlike medical scholars of the time, Shakespeare also made clear distinctions
between senility as portrayed in ‘King Lear,’ and the differing accounts of delirium
associated with madness as exhibited by Lady Macbeth in ‘Macbeth.’ This was unusual
for this time period because most physicians believed that these forms of cognitive
decline were the same. In ‘King Lear’ Act IV, Scene 7, the featured character explores
his memory loss (W. Shakespeare, 1606), as follows:
“I am a very foolish fond old man,
Fourscore and upward, not an hour more nor less;
And, to deal plainly,
I fear that I am no in my perfect mind.
Methinks I should know you, and know this man;
Yet I am doubtful for I am mainly ignorant
What place this is; and all the skill I have
Remembers not these garments; not I know not
Where I did lodge last night… (…) Am I in France?”
Dementia is also mentioned within the fictional world of ‘Gulliver’s Travels.’
First published in 1726, Jonathan Swift’s book is a satirical work that targeted nearly
everyone of prominence from the Church to the Monarchy and quickly became a
bestselling novel (Ingram, 2014). At the time, Swift’s hard-hitting satire was widely
controversial prompting the author to publish the book under the moniker given to the
titular character, Gulliver.
On his third journey, toward the end of the book, Gulliver travels to the colony of
Luggnagg. Upon arriving, Gulliver observes, “The Luggnaggians are polite and generous
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people,” yet it is the Struldbrugs, a group of persons living in the colony that really
capture his attention, for the Struldbrugs are said to be immortal (Swift, 1726). Initially,
Gulliver is enamored by this concept stating “I freely own myself to have been struck
with inexpressible delight, upon hearing this account”; the idea that anyone would have
the opportunity to live forever without fear of death was an extraordinary idea (Swift,
1726). His initial thrill regarding the ability to live forever is quickly deflated after
meeting several Struldbrugs, for it seems that immortality, in this case, was marred by the
problems with which it is associated (Swift, 1726).
As the story progresses, Gulliver soon learns that the Struldbrugs are profoundly
disabled by their lack of memory as they age through observations of these immortal
persons. It is remarked that those that lose their memories entirely fair the best since this
loss comes without feelings of sorrow. These encounters left Gulliver shaken, and he
concluded that the Struldbrugs were a mortifying sight, one that no longer evokes envy
regarding their immortality (Swift, 1726).
In a horrific twist of fate, nearly a decade after Swift penned these descriptions of
dementia; he wrote a letter to a friend stating “I have entirely lost my memory… I can
hardly understand one word I write” (Ingram, 2014). Correspondence such as this letter
along with writings of his friends and colleagues have left many scholars to suggest that
Swift suffered from AD or another form of dementia (Bewley, 1998; Ingram, 2014).
However, this has been largely debated in recent decades, as some scholars argue that
Swift’s symptoms as described were more in alignment with Pick’s disease, a rare form
of progressive dementia, that affects the frontal lobes of the brain (Bewley, 1998;
Crichton, 1993; Lorch, 2006). By 1742, Swift was declared incompetent, and
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subsequently, all of his affairs were handled by caregivers. He passed away from the
disease two years later (Bewley, 1998; Ingram, 2014).
The incorporation of dementia into the themes of these cultural works illustrated
key concepts in the discourse about the historical conceptions of dementia even though
these were fictional accounts. The way in which dementia was depicted as being
intrinsically related to old age demonstrated that by this time, the correlation between the
two was solidified. These depictions presented a dark side of dementia that further
contributed to the stigmatization of the disease.
Modern Descriptions of Alzheimer’s disease (the 1900’s- Present)
On November 4th, 1906, Dr. Alois Alzheimer stood before attendees of the 37th
meeting of the South West Germany Society of Psychiatry in Tubingen, Germany and
delivered an extraordinary address regarding the disease that would eventually bear his
name (Cipriani, Dolciotti, Picchi, & Bonuccelli, 2011; Goedert & Ghetti, 2007; Maurer &
Maurer, 2003). As he took the stage, Alzheimer began his address, entitled ‘On a
Peculiar, Severe Disease Process of the Cerebral Cortex’, by thanking his former
employer, Professor Emil Sioli, for allowing him to present the accumulation of clinical
notes and tissue collections from the autopsy on his former patient, known only as
Auguste D (Alzheimer, 1907; Maurer & Maurer, 2003; Maurer, Volk, & Gerbaldo,
1997).
The room was quiet as Alzheimer began his speech with the following, “From a
clinical perspective my Auguste D. case already offered such a distinctive clinical picture
that it would not be classified among any of the known illnesses. I will describe it to you
in what follows” (Maurer & Maurer, 2003).

26

Alzheimer first encountered Auguste nearly five years earlier as a patient who had
presented at the Asylum for the Insane and Epileptic, a psychiatric facility in Frankfurt
(Cipriani et al., 2011; Maurer & Maurer, 2003; Maurer et al., 1997). Alzheimer served as
an assistant physician and had worked under the mentorship of Sioli to improve the
conditions at the facility. On his first day, Alzheimer was appalled by the horrid
conditions and wrote, “Some patients appeared with pockets filled with all sorts of waste,
others had masses of paper and writing materials hidden all over the place and in big
packets under their arms.” By the time Auguste D. was admitted to the facility,
Alzheimer, Sioli, and their colleague Dr. Franz Nissel had initiated policies to ensure all
patients were fed, bathed, rooms were cleaned and not used as isolation rooms when
possible, and duration baths were established to calm and reduce the agitation of patients
(Maurer & Maurer, 2003). In 1901, these approaches were considered progressive in the
treatment of persons with mental illness. Traditionally, psychiatric institutions had been
separated from medical hospitals. Classical treatment included bloodletting and
cathartics. However, these methods were slowly being replaced with non-restraints and
moral therapy which had first been introduced by Philippe Pinel in the mid-1800’s. Pinel
was well respected in the psychiatric community, known for his nosological classification
of all diseases including senile dementia (Bynum, 2008).
For Auguste, the facility would become home for the final five years of her life. At
51 years of age, Auguste exhibited a rapid decline in functioning that was
uncharacteristic given her family history and with no known cause. Eight months prior to
admission, Auguste exhibited no symptoms (Cipriani et al., 2011). Her husband, a
railway clerk, could no longer provide for her care forcing him to admit her. A review of
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her medical records indicated that at the time of admittance she suffered from paranoia,
delusions and hallucinations, along with progressively declining cognitive impairment
(Cipriani et al., 2011; Goedert & Spillantini, 2006; Hippius & Neundorfer, 2003). During
one of his first assessments, Alzheimer sat with her while she ate her midday meal and
recorded the following interaction:
“At midday Auguste D. had cauliflower and pork for lunch.
Alzheimer- What are you eating?
Auguste D.- Spinach!
She chewed the meat.
Alzheimer- What are you eating now?
Auguste D.- First I eat the potatoes and then the horseradish.” (Maurer & Maurer,
2003)
On this first encounter, he continued his observations by showing her several objects.
After a short span of time, Auguste no longer knew what the objects were that she had
been shown (Maurer & Maurer, 2003). Her short-term memory seemed completely
erased. When Alzheimer offered her a pencil to write her name on a sheet of paper, she
could barely scribble out the A in Auguste before stopping and entering into a confused
state (Maurer & Maurer, 2003). While Auguste was initially not at ease with Alzheimer’s
presence, this changed overtime, and they were able to form a bond that was based on
their mutual experiences growing up in the same town in Germany (Maurer et al., 1997).
The disease that had no name would continue to haunt Auguste as her condition
worsened. Clinical notes by Alzheimer and other physicians provided a first-hand
account of the horrors that Auguste was suffering. Whatever this disease was, its onset
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had been quick, and its symptoms were intense. Often, Auguste would shout in agony
succumbing to her fear that someone was attempting to kill her while other times she
would sit quietly, alone and stare blankly into space (Maurer & Maurer, 2003; Maurer et
al., 1997). She would pace and speak unintelligibly often directed to her husband and her
child, despite their absence. Her memories seemed distorted as if someone was slowly
chipping away at their contents. Sleep was disrupted as she would often pace or sit up in
her bed in lieu of resting. On occasion, she was known to go into the main room of the
facility, where other patients congregated, grab their faces and strike them violently with
her hands (Cipriani et al., 2011; Maurer & Maurer, 2003).
In his experience as a physician, Alzheimer had encountered similar cases in other
patients, yet, he was intrigued due to the manifestation of these symptoms in someone
much younger. At the time, such behaviors were exhibited by persons much older than
Auguste’s 51 years (Maurer et al., 1997). Given the age of his previous patients,
Alzheimer had hypothesized that this form of mental decline was associated with the
thickening of the blood vessels of the brain, known as atherosclerosis (Maurer & Maurer,
2003).
As was customary for the time, Alzheimer’s primary course of treatment included an
approach to reduce the patient’s agitation. Assessments were completed through talking
with patients and records indicated that Alzheimer did this frequently. Alzheimer did
extensive research on the therapeutic effects of warm and mild baths that extended over
several hours, and in some cases, days, to soothe and calm extremely agitated patients
(Maurer & Maurer, 2003). Alcohol was to be administered in mild doses for its calming
properties. Not unlike modern facilities, for Auguste, and other patients at the asylum,
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pharmaceuticals were used and considered to be useful in working with agitated patients.
It was common practice to use 2 to 3 grams of Chloral Hydrate, a sedative, to manage
behavior. With this treatment, no injection was needed, and therefore, patients in
Auguste’s condition would not need to be confined to receive treatment (López-Muñoz,
Ucha-Udabe, & Alamo, 2005).
On at least one occasion, Alzheimer had to fight to keep Auguste at the asylum. Her
husband could no longer pay the fees to keep her at the facility, and a plan was put in
place to transfer her to another asylum. Knowing her importance to his work, Alzheimer
was able to negotiate for her to stay (Maurer & Maurer, 2003). By 1903, Alzheimer had
accepted a new position working as head of the anatomy lab at the Royal Psychiatric
Clinic. However, he had not forgotten his patient and continued to track her progress
(Hippius & Neundorfer, 2003). On April 9th, 1906, Alzheimer received a call that
Auguste had passed away, he immediately requested her brain be sent him for further
research so that he could complete a histological analysis (Hippius & Neundorfer, 2003;
Maurer & Hoyer, 2006). Using silver staining, developed by his colleague, Max
Bielschowsky, Alzheimer was able to clearly describe the senile plaques and
neurofibrillary tangles in the patient’s brain (J. Jones & Jones, 2010). His analysis
revealed what is now considered pathological hallmarks of the disease (D. H. Small &
Cappai, 2006). It should be noted that by the time that Alzheimer made his discovery,
dementia, as a general term to describe the loss of memory as one ages, was utilized
within the medical lexicon, and both Phillipe Pinel and Jean-Etienne Esquirol had
provided characterizations of the disease (Cipriani et al., 2011). Furthermore, the
presence of plaques and tangles were also noted in the literature, however, neither had
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been connected as a marker of cognitive decline (Cipriani et al., 2011). Thus, when
Alzheimer made the connection between these two elements and posited that Auguste’s
decline was due to the plaques and tangles that formed in her brain, his theory changed
the dominant view regarding senile dementia.
On that day in November 1906, as Alzheimer finished presenting his slides that
included the histological analysis, he posited not only the connection between the plaques
and tangles and the memory loss and bizarre behaviors of his patient but also shattered
the notion that dementia was only related to old age. When he was finished with his
presentation, he anticipated a lively discussion. Yet was met with unexpected silence. He
had, after all, just explained, in his professional opinion, the details of a potentially rare
disease for the very first time. It was customary for the chair of the meeting to bring forth
any questions from the audience, however, on this occasion, the audience seemed
preoccupied (Cipriani et al., 2011; Dahm, 2006; Hippius & Neundorfer, 2003). The
facilitator inquired about questions and comments, and the audience remained silent.
Alzheimer left the podium feeling perplexed by the lack of response (Maurer & Maurer,
2003).
Today the story of a seemingly rare disease, to use Alzheimer’s words, would make
the front pages of all the major news outlets. However, coverage of Alzheimer’s
presentation was limited, with the Tubinger Chronicle only noting the following, “Dr.
Alzheimer from Munich gave an account of a peculiarly severe disease process, which
caused significant shrinkage of the nerve cells within four and a half years” (Maurer &
Maurer, 2003). Alzheimer’s presentation had been overshadowed by a formidable foe
namely, the psychoanalytic movement. By 1906, names like Freud, Adler, and Jung were
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making waves, and the psychiatric community was, in effect, seduced with the idea of
psychosexual development and talk therapy. Sitting in the audience at the conference was
C.G. Jung, a collaborator of Sigmund Freud, and a proponent of psychoanalytic theory.
His presence contributed to the shift in focus to the psychological aspect in the often
tense debates that ignited during the conference (Maurer & Maurer, 2003). The debate
erupted into the equivalent of an academic shouting match centered around a lecture
presented the previous May by Professor Gustav Aschaffenburg from Cologne. This
lecture was a provocative criticism of Freudian theory that centered on compulsive
masturbation. This was followed by a presentation on a proposed modification that the
author termed psychosynthesis. The presenting opinions of these scholars ignited a lively
debate among the crowd including a heated exchange between members of the audience
and Jung regarding the principles of psychoanalytics (Maurer & Maurer, 2003).
While the audience contributed to the increasing debate surrounding Freudian theory,
the disease that Alzheimer described seemed to be lost, much like the memory of his
patient. Despite the initial setback incurred at the conference, Alzheimer was undeterred
and published an article based on his findings in 1907 entitled, “A Characteristic Serious
Disease of the Cerebral Cortex” (Alzheimer, 1907; Strassing & Ganguli, 2005). In the
years that followed, a number of other publications noted the histological symptoms of
patients discovered post-mortem with descriptions of behaviors similar to Auguste D.
when they were alive. A year after Alzheimer’s publication, his Italian co-worker
Francesco Bonfiglio described a second patient with similar symptoms and presenting
behaviors (Cipriani et al., 2011). In In 1909, the case of Auguste D. was once again
presented along with three other cases of similar origin, at the Psychiatric Clinic of the
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German University of Prague, focusing on a detailed description of histopathological
changes in dementia (Cipriani et al., 2011).
In the end, it was German psychiatrist Emil Kraepelin that introduced the eponym
‘Alzheimer’s disease’ in the eighth edition of the Handbook of Psychiatry published in
1910 (Hippius & Müller, 2008). Kraepelin was an esteemed, well-respected psychiatrist,
that spent most of his career developing a classification of psychiatric disorders (Bynum,
2008). In his text, Kraepelin separated AD from presenile dementia, citing it as a separate
disease, a theory that contemporary research has since overturned (Cipriani et al., 2011).
Despite Kraepelin’s contention that this was a separate, potentially new disease, it
should be noted that it is unclear what, if any, discussions that Alzheimer and Kraepelin
had about the nature of the disease and its classification. Since Kraepelin’s publication in
1910, scholars have speculated his motivation for naming the disease after Alois
Alzheimer (Hippius & Neundorfer, 2003). Kraepelin would have been aware of the other
scholars working in the field to define the disease. It could be that Kraepelin did in
earnest believe that Alzheimer had discovered a new disease, one that needed to be, for
clinical purposes, separated from presenile dementia (Beach, 1987; Goedert & Ghetti,
2007). It is also worth noting that Alzheimer worked in Kraepelin’s lab in Munich and
closely collaborated with him during his time in Munich (Maurer et al., 1997).
Furthermore, it was Kraepelin who encouraged Alzheimer to present his findings at a
scientific meeting in Tubingen (Hippius & Neundorfer, 2003). Thus, his motivation may
have been the rivalry between his lab and that of Pick in Prague, where Fischer worked
(Goedert & Ghetti, 2007). This has led many scholars to suggest that the eponym
Alzheimer’s disease is not accurate (Boller & Forbes, 1998).
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Regardless of Kraepelin’s motivations, giving this disease a name did little to bring it
to the collective consciousness in terms of a matter pertinent to public health. Even with
Kraepelin’s stature in the psychiatric community, senile dementia continued to be
considered a byproduct of aging, and little attention was given to cases of early-onset
dementia (Lock, 2014). Furthermore, after his death in 1915, Alzheimer was remembered
more for his histological acumen and his intensive work ethic than for the disease that
carried his name (Ballenger, 2006). Thus, in the intervening years, after Kraepelin
introduced the term Alzheimer’s disease, there was little research occurring regarding the
disease (Hippius & Neundorfer, 2003). Alzheimer’s research culminated in other
researchers replicating Alzheimer’s observations and initial histological analysis of the
patient’s brain specimen’s post-mortem.
Paradoxically, Alzheimer’s discovery is situated during a time of increasing medical
innovation and insight. Prior to the advances in medicine made during the late 19th and
early 20th centuries, the lifespan of persons with many chronic conditions was short and
debilitating. By 1897 Felix Hoffman, a German chemist, synthesized Aspirin, a drug that
now has implications in the daily lives of persons worldwide (Van Dulken, 2001). In
1907, Alfred Bertheim and Paul Ehrlich began the era of antibiotic chemotherapy, by
developing arsphenamine to be used to treat the infection associated with syphilis
(Parascandola, 2009). This paved the way for the development of penicillin in 1928 by
Alexander Fleming (Ligon, 2004). These innovations produced significant improvements
for the quality of life and the human condition. Furthermore, these discoveries and others
contributed to the extension of the human lifespan. However, a tension between the
progressive medical techniques being developed and the mental health system at the time
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created notable tension due to the historical mistreatment of persons with mental illness
and cognitive impairment. By the early 19th century, older adults with AD were often
grouped together with adults of all ages that had cognitive impairments such as
intellectual disabilities and Down syndrome (Trent, 1995). Persons with any form of
cognitive impairment were known as imbeciles, idiots, or feeble-minded and their
condition was often thought to be connected to moral decay or impurity (Trent, 1995).
This led to many individuals, including those with AD to be institutionalized in, often,
deplorable conditions much like the one that Alzheimer encountered when he first arrived
to work at the Asylum for the Insane and Epileptic.
AD remained in the dark, both metaphorically and quite literally, due to the
cascading effect of several, significant factors. First, senile dementia has primarily been
viewed as a byproduct of aging. If one survived the array of maladies and diseases that
killed most persons before the prevalence of modern medicine, they would surely
succumb to the afflictions associated with old age (Bishop, 1904). Second, as previously
stated, although AD was noted in the literature it was not until the mid-20th century that
scholars refocused their attention to the disease as falling under the umbrella of dementia
rather than senile dementia. Dementia was viewed as a product of aging, one that was
largely associated with old age given that a distinction between the decline in acuity that
accompanies normal aging and the decline seen in persons with dementia was not clearly
formulated. Hence, early scholars and researchers arrived at the conclusion that this was
an inevitable condition. The fact that this was a circumstance of living to old age meant
that this disease could not possibly be cured and thus, preventative medical interventions
were not explored.
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This characterization of cognitive decline permeated scientific inquiry through time,
even today, nearly 116 years later. AD and other forms of dementia are inherently tied to
the process of aging which has an impact on the disease in terms of funding, research,
and stigma. AD research is far behind that of other diseases of public health concern,
particularly if one examines the funding that is allocated each year through the National
Institute of Health.
Current Characterizations of Alzheimer’s Type Dementia. Alzheimer’s Disease
is now classified as a neurocognitive disorder (NCD) with major or mild subtypes. The
term “dementia,” is still used in settings due to custom, familiarity with the term, and
continuity of medical data (American Psychological Association, 2013). The term
dementia is used as an umbrella term to describe a decline in cognitive ability that is
severe enough to impede activities of daily living. Currently, there exist several known
neurobiological causes of dementia. Furthermore, each type of dementia has different
patterns of symptoms and brain abnormalities, with some similarities between specific
forms of dementia. AD is by far the most commonly diagnosed form of dementia, which
accounts for an estimated 60% to 80% of all cases (Alzheimer’s Association, 2018;
Centers for Disease Control and Prevention, 2017 ). This is followed by vascular
dementia, dementia with Lewy bodies (DLB), Parkinson’s disease dementia and mixed
dementia, which is the presence of abnormalities of more than one cause of dementia
(Alzheimer’s Association, 2018). Rarer cases of dementia include frontotemporal lobar
degeneration (FTLD), Creutzfeldt-Jakob disease, and normal pressure hydrocephalus
(Alzheimer’s Association, 2018).

36

AD is defined by a distinct pathology that includes the presence of senile plaques
(SPs) composed of beta amyloid (Aβ) and neurofibrillary tangles (NFTs) consisting of
tau (Esiri, 2007; Harrington, 2012). The human brain contains tens of billions of neurons.
These are cells that control and transmit information through a series of electrical and
chemical signals (Whalley, 2001). Neurons are critical in providing information to
different parts of the human body to maintain and function properly. Amyloid plaques
within the brain are found within spaces between neurons. The plaque consists primary of
abnormal deposits of a brain protein fragment known as beta-amyloid (Aβ) (DeKosky,
2003). It is not currently known whether these plaque buildups are the cause of AD or a
result of the disease’s progression. Inside neurons, neurofibrillary tangles (NFTs) are also
a hallmark sign of the presence of AD (Serrano-Pozo, Frosch, Masliah, & Hyman, 2011).
NFTs are clumps of the protein tau, and when an individual suffers from Alzheimer’s
disease, tau undergoes an abnormal transformation that causes it to detach from
microtubules and stick to tau molecules (DeKosky, 2003; Serrano-Pozo et al., 2011). This
results in the formation of clumps of tangles. Finally, there is a loss of neural connections
when the synaptic connections between certain groups of neurons stop working and thus,
begin to degenerate, causing cell death (Whalley, 2001). Unlike cells in other parts of the
human body, neurons do not divide, and when they die, they are not replaced by new
ones. While the loss of neural connections is present within the disease, it is simply
unknown if the loss of neural connections is related to the buildup of amyloid plaques
and tau. Furthermore, researchers are currently examining if there are other abnormalities
in the brain that could provide new insights into the disease (DeKosky, 2003).
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Under a microscope, the presence of beta amyloid plaques is detected as
extracellular deposits while the accumulation of the tau protein occurs at the intracellular
level (Harrington, 2012). The current prevailing theory, of which most medical research
and development is predicated, is that Aβ deposition is the primary lesion that contributes
to Alzheimer’s disease and that neurofibrillary tangles are secondary, perhaps caused by
the presence of Aβ. (Penke, Bogar, & Fulop, 2017; Sajjad, Arif, Shah, Manzoor, &
Mustafa, 2018).
The presence of the two compounds are not the only changes that appear within
the brain. Typically, the weight of the brain decreases anywhere from 100-200 grams as
the disease takes over, with atrophy showing in the temporal, parietal, and frontal lobes
along with the hippocampus (Poirier & Gauthier, 2014). As these sections of the brain
begin to atrophy, the ventricular system becomes enlarged (Budson & Solomon, 2016).
Furthermore, the neurochemistry of the brain is altered and a deficit of acetylcholine, a
neurotransmitter, is consistently found in persons with AD (Budson & Solomon, 2016).
Despite the understanding of these changes occurring within the brain, there are
conflicting accounts of what produces the pathology of the disease. There are many
questions that are the focal point of active research, such as: Does the presence of plaques
and tangles represent the essence of the disease? Or: Are plaques and tangles merely
byproducts of the disease process? Furthermore, even if the answer to either one of these
questions is affirmative, this does not establish what causes this pathology in the brain to
occur (Poirier & Gauthier, 2014).
Current research within the AD field is focused on pinpointing the trajectory of
the disease as this could lead to potential pharmaceutical interventions. As to what causes
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these changes in the brain to occur, there have been a plethora of studies that have
pointed to everything from excessive air pollution (Moulton & Wei, 2012) to sleep
disorders (Cipriani, Danti, Vedovello, Nuti, & Lucetti, 2014), and even, aluminum
(Kawahara, 2005) as being the culprits in causing AD while social engagement (Krueger
et al., 2009), diet (Gu, Luchsinger, Stern, & Scarmeas, 2010; Luchsinger, Noble, &
Scarmeas, 2007), and exercise (Coelho et al., 2013; Yaffe, 2010), have all been touted as
preventative measures for decreasing cognitive decline. The results of these studies and
others similar in content are often sensationalized in the popular media, which often leads
to stereotypes (Kirkman, 2006) all the while, there is still so much that is unknown
regarding the disease.
Symptoms and Behaviors Associated with AD. As previously noted, AD has
profound effects on the brain and its’ ability to function and communicate with the rest of
the body. This results in decline in activities of daily living to behaviors that are both
disruptive and, often, harmful. Persons with mild AD experience profound memory loss
that affects many of the activities of daily living. Person with AD may wander and
become lost in environments that should be familiar. Social interactions may become
difficult as persons with mild AD can become lost in conversation and ask the same
questions repeatedly. Routine activities may take longer than usual to complete.
Furthermore, persons may have difficulty with familiar tasks related to money
management such as paying bills or receiving change back from a cashier. Family
members and friends may notice increased changes in the individual’s demeanor and
behaviors. As the disease progresses, the presence of behavioral symptoms, such as
agitation and aggression, are commonly associated with moderate AD. These behaviors
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are related to greater overall impairment in functioning and short survival time (Weiner et
al., 2005).
As time progresses, persons with moderate AD may experience more profound
effects. The memory loss experienced in the mild impairment stage may worsen, and
persons may lose the functional capacity to communicate, to reason, and participate in
abstract thought. As memory loss worsens, persons with moderate AD may not be able to
recognize family members, friends or care providers. They may have issues with
completing multi-step tasks such as putting on clothes or preparing meals. Moreover, as
confusion sets in the individual may develop paranoia, delusional thoughts, and in some
instances, act in an agitated or aggressive manner. Estimates suggest that aggression
occurs in roughly 40% to 60% of persons living in facilities such as nursing homes
(Corbett et al., 2012).
In the final stages of the disease, persons with severe AD are increasingly
dependent on others for care and require increased sleep. Furthermore, as their body
begins to shut down from the effects of the disease, they may experience weight loss
from the lack of appetite or difficulty swallowing. The person with AD may suffer
seizures; this can be attributed to gliosis and neuronal injury in the brain as a result of the
dementia process. If they are confined to bed, they may experience skin infections from
decreased mobility.
While each individual’s journey with AD is different, the aforementioned stages
provide a brief overview of the progression of the disease and how it affects the
individual’s ability to function. For some individuals, the process is swift, while others
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must endure a long and painful journey. In some cases, persons with AD pass within 3
years of diagnosis, while others suffer for as long as 20 years (Brookmeyer et al., 2002).
The Development of Pharmaceuticals
For as long as humans have been aware of illness and disease, they have tried to
develop treatments and cures. Today, after decades of scientific discovery, most
medications are chemically synthesized compounds that are created and tested in labs,
and then approved for mass production by federal regulating bodies (Liebenau, 1987).
However, the origins of medicines are rooted in the use of simple solutions that were
historically readily available such as plants and, in some cases, animal compounds. Many
cultures maintained records of medications that were most effective for treating common
ailments. China was by far the most sophisticated in their approach. By 1100 BCE, China
developed and documented at least one dozen treatments for common ailments (Leung,
2006). By the 16th century, this significantly increased to more than 1,900 different
remedies (Leung, 2006).The first pharmacopeia, known as the De Material Medica, is
estimated to have been written in the first century CE and is attributed to Dioscorides.
Little is known about the scholar except that he was thought to be from Greece, and a
botanist (Eadie, 2004). In India, Ayurveda is a medical system that was developed around
5000 years ago. Within its structure remedies included herbs and other substances found
in nature. The first medicinal documentation in English that is known is The English
Physician, published in 1652 by Nicholas Culpeper (Culpeper, 2016). It is noteworthy for
its comprehensive categorization of medicinal herbs and their usages.
The late 1800’s and early 1900’s was a time of increased medical innovation and
discovery. In the case of tetanus, a series of discoveries led to the understanding of
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tetanus bacillus, the development of antitoxin, and the use of a vaccine to ward off this
infectious disease (Porter, 1999). The case of tetanus is only one case study that
represents the overarching development of pharmaceuticals.
The movement toward increased research marks a shift in thought about medical
practices. The field of medicine, and physicians were less equated with the mysticism
than in previous centuries. This shift can also be attributed to the development in the
understanding of modern organic chemistry. Before the 1800’s, chemists posited that
compounds that were obtained from humans and other living organisms were gifted with
what they termed a vital force; this was in part to distinguish from inorganic compounds.
The underlying theory was that these compounds could only be produced within living
organisms, thus making them unique. This changed in 1828 when Fredrich Wöhler made
a profound discovery in which he could produce the organic chemical urea, a constituent
of urine, from the entirely inorganic compound, ammonium cyanate (Porter, 1999).
From Small Apothecaries to Big Pharma
The current pharmaceutical industry can be traced from two primary sources, all
of which emerged during the late 1800’s through the early 1900’s. Today,
pharmaceutical companies such as Pfizer, Johnson & Johnson, GlaxcoSmith Kline, and
Merck are international, Fortune 500 companies (Malerba & Orsenigo, 2015). Yet,
during the 1800’s, their origins were far humbler, as each of these companies started as a
family-owned apothecary (Liebenau, 1987). As medications during this time
predominately consisted of herbs and other plant compounds, an apothecary was
managed by persons skilled in the trade of mixing combinations of herbs, minerals, and
other commonly found items to produce solutions or pastes in the treatment of a variety
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of ailments (Malerba & Orsenigo, 2015). Other remedies that were used included
morphine and quinine. Eventually, these smaller apothecaries were replaced as it became
easier to manufacture drugs in mass. Thus, many of these apothecaries transitioned from
natural products to developing and manufacturing medications on a larger scale (Malerba
& Orsenigo, 2015).
While there are many companies today that started as apothecaries and eventually
developed into medication manufacturing, many companies such as Bayer and Pfizer
started as dyestuff and chemical companies. With the pharmaceutical market showing
steady growth these companies established research labs and applied for patents for drugs
(DiMasi, Hansen, & Grabowski, 2003). By the 1930’s, these companies were established
drug developers, yet they developed slowly. In 1930, most medications were still
procured without a prescription. People suffering from a malady could go into a
pharmacy, explain their symptoms, and receive a compounded drug. During this period
physicians were also dispensing medications directly to their patients (Freeman & Louçã,
2002).
In the 1920s and 1930s both penicillin and insulin were discovered and
manufactured, albeit at a modest scale. The Second World War provided a major
stimulus to the developing pharmaceutical industry, with requirements for the large-scale
manufacture of analgesics and antibiotics and increasing demands from governments to
undertake research to identify treatments for a wide range of conditions. The post-war
period from the 1950s to the 1990s saw major advances in drug development with the
introduction of new antibiotics, new analgesics, such as acetaminophen and ibuprofen,
and completely new classes of pharmaceuticals such as oral contraceptives, beta-

43

blockers, benzodiazepines and a wide range of novel anti-cancer medicines (Chandler Jr.,
2005; Liebenau, 1987).
Commercializing Medication
As the decades passed, pharmaceutical companies such as Pfizer and Eli Lilly
became more prominent. It was during this time that pharmaceutical sales began to be
heavily promoted. Drugs were marketed to doctors with the intent to spur more
prescriptions and sales. Doctors were financially rewarded by the pharmaceutical
companies for promoting their products (Chandler Jr., 2005).
The rise of big pharmaceutical companies was also bolstered through marketing
directly focused on potential consumers. Until the mid-1980’s print and digital marketing
to consumers were not common. When print marketing, in magazines and newspapers
began, there were federal regulations that stated that drugs could not be touted as a
miracle cure for ailments, and all of the side effects of the medication had to be listed at
the bottom of the advertisement to safeguard the public. Furthermore, the Food and Drug
Administration enacted a provision in 1969 requiring that all advertising had to be both
fair and balanced (Chandler Jr., 2005). In 1986, the first commercial advertisement for
medication was filmed that directly targeted consumers. This opened the door for more
medications to be marketed directly to consumers without the need to market to
physicians (J. Li, 2014)
The following is an example of consumer pharmaceutical advertising that
highlights the problem with direct marketing to consumers. Seldane (generic:
terfenadine) was first approved for use in 1985. The drug was an antihistamine used to
treat allergies, hives, and other allergic inflammatory conditions without causing
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drowsiness. In the first commercial that aired in 1986 for Seldane, the name of the drug
could not be used, but the marketing campaign urged consumers to ask their doctor about
a new drug that could help them if they were suffering from allergies. This was a way of
getting around the FDA regulation. By all accounts, the campaign was successful. It was
estimated the drug sales for Seldane were roughly $34 million, and several years after the
advertisement first aired, sales were estimated at $800 million. However, by 1998,
Seldane was completely removed from the market (Geier, 1998). Throughout the 12
years that it was on the market, the FDA received numerous complaints and inquires
because, as it would later be revealed, the drug interacted with several antifungal drugs
(generics: ketoconazole and itraconazole), several antibiotics (generics: E.E.S, E-Mycin,
Ery-Tab; clarithromycin; azithromycin) and a popular ulcer medication (cimetidine)
(Geier, 1998). This interaction included serious heart abnormalities and contributed to 8
known deaths. Citing this, the FDA finally pulled the drug from the market (Geier, 1998).
The 1980’s and 1990’s saw more leniency in pharmaceutical advertising regulations that
allowed the name and proposed benefits of drugs to appear in advertisements (J. Li,
2014).
Medications and Alzheimer’s Disease
Living with AD in a nursing facility often proves difficult for the person with AD,
their family, and for those providing care to them. Feeling disconnected from family and
in a foreign setting can lead to unrest. Confused by the unfamiliar faces of the everchanging stream of staff providing direct care, agitation may ensue. Agitation has been
defined as “inappropriate verbal, vocal, or motor activity that is not judged by an outside
observer to be an obvious outcome of the needs or confusion of the individual” (Cohen-
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Mansfield, 2001). Given the nature and severity of the behaviors of persons with AD,
psychotropic medications are often the first line intervention for those living in nursing
facilities, even though it has been recommended that they should be avoided in patients
with dementia (Borda, 2006; Gentile, 2010).
Often known by their generic names, drugs such as Seroquel, Abilify, and
Risperidone are commonly used to treat aggression, agitation, and delusions.
Furthermore, these medications can be prescribed to persons with AD in nursing facilities
to combat the behaviors often associated with the disease (Borda, 2006). While
administering dosages of one or more of these medications can prove helpful in calming
down an agitated or aggressive resident in a nursing facility, these medications are not
without side effects. Antipsychotic medication use in older adults with AD can contribute
to an increase in cognitive decline, increase in falls, metabolic changes such as
hyperglycemia and diabetes, and dysphasia (Garrard, Chen, & Dowd, 1995). The most
alarming side effect from the use of antipsychotic medications is the increase in mortality
of those who take them. This evidence is based on 17 placebo-controlled trials over a 6 to
12-week time frames. While significant changes were shown in participant’s levels of
agitation and aggression, there was a 1.6-1.7 increased risk for mortality in the groups
that received antipsychotic medications (C. G. Ballard, Gauthier, Cummings, & Lyketsos,
2009). Causes of death in these studies varied, however, most were attributed to
cardiovascular or infectious events. This evidence has led the Food and Drug
Administration (FDA) to issue black box warnings to several anti-psychotic medications,
including Risperidone, indicating that these medications have severe or life-threatening
adverse effects (Lenzer, 2005). Currently, there are no FDA approved antipsychotic
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medications for use with persons with dementia, including AD (C. G. Ballard, Waite, &
Birks, 2006).
The big problem is that many of the published articles promoting drugs are written
by researchers working on behalf of pharmaceutical companies. One example of this is
Janssen Pharmaceutica’s research and marketing of Risperidone (Lenzer, 2005) which
was shown effective and safe by their researchers. Janssen Pharmaceuticals is a
subsidiary of the Johnson & Johnson company, considered an American institution.
Although primarily known as the manufacture of staple household products, such as baby
oil, baby powder, and shampoos Johnson & Johnson actually makes 91% of it’s profit
from medical devices and drugs, not from consumer products. Production of Risperidone
began in 1994 and was intended to replace Haldol, which came off-patent in 1986
(Colpaert, 2003). Part of the marketing strategy for Risperidone was to make it the “top
choice” of medications for Medicaid run programs for older adults in state nursing
facilities. By 2005, the FDA issued black box warnings on several anti-psychotic
medications, including Risperidone. The company continued to promote Risperidone for
unapproved usages, including for older adults with dementia, to physicians prescribing
medications in nursing home settings as a safe and efficient drug but unfortunately, that
was not the case. In 2012, Johnson & Johnson reached a $181 million consumer fraud
settlement that included 36 states along with the District of Columbia (Thomas, 2012).
The company was also accused of minimizing and concealing the risks associated with
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the medication’s use. These events were purported to occur after the FDA issued their
black box warning on the medication (El Haj et al., 2016).
In addition to the black box warnings, and the fines imposed on companies, there are
other provisions established to prevent the misuse of antipsychotic medications in nursing
homes. Primarily known as OBRA-87, the Omnibus Budget Reconciliation Act of 1987
requires that new long-term care residents be assessed for mental illness and
nonpharmacological treatments be used to manage behaviors (M. Kelly, 1989). This law
was added after repeated concerns were expressed in the media and among leaders in the
geriatric field that medication management was dangerous in most long-term care
facilities. OBRA-87 took effect in October 1990 and provided guidelines for state
surveyors to determine nursing home compliance with federal regulations (Anderson &
Bjorklund, 2009). Persons transitioning into nursing facilities for long-term care must
undergo the Pre-admission Screening and Resident Review (PASRR) to ensure that they
are not inappropriately placed in long-term care (Madhusoodanan, Nwedo, Brenner, &
Mirza, 2014). PASRR as a federal mandate brings states in accordance with the Supreme
Court decision, Olmsted vs. L.C., which held that all persons have the right to live in the
least restrictive setting possible (United States Reports, 1999) . PASRR requires that 1)
all applicants to a Medicaid-certified nursing facility be evaluated for mental illness
and/or intellectual disability; 2) be offered the most appropriate setting for their needs (in
the community, a nursing facility, or acute care settings); and 3) receive the services they
need in those settings. While the PASSR provisions exist at the federal level, many states
including Kentucky, include exemptions to these rules. Residents being admitted directly
from hospitals are exempt from screening and furthermore, persons that have a diagnosis
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of dementia or intellectual disability are exempt from PASSR (Madhusoodanan et al.,
2014).
In Kentucky, in most long-term care facilities, antipsychotic medications are still
prescribed on a regular basis. Between the end of 2011 and the end of the first quarter of
2017 roughly 19.1% of persons living in Kentucky long-term care facilities received
antipsychotic medications compared to the national average of 15.7% (Monroe &
Ceballos, 2017). The use of antipsychotic medications in nursing facilities in Kentucky
poses another overarching concern about the state of older adults with AD and other
forms of dementia. CNAs are also primarily responsible for the care and behavior
management of these individuals. Therefore, appropriate training of CNAs is warranted
(Molinari et al., 2017).
The first medication brought to the market for AD was Cognex (generic: tacrine).
It was developed by neuroscientist William Summers. Early reports of the medication
were marked by Summers unconventional approaches to development and research
(Kolata, 1992; Leary, 1991). From his research, Summers felt that AD needed to be
targeted with a medication that could block or reduce the production of
acetylcholinesterase. Without any funders or backing, Summers invested $90,000 of his
own money into the production of a tacrine pill that could be brought to market. In 1981,
in an experiment to test the drug, Summers administered the medication to 12 of his
patients that had AD (Jebelli, 2017). As he did not know what dose would be of benefit to
the patients, they received varying dosages intravenously (Jebelli, 2017). Hours after
administering the drug, Summers noted a marked difference in his patient’s cognitive
abilities (Jebelli, 2017). Despite these findings which were published in 1986, the FDA
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was initially reluctant to approve the medication, citing its potential for causing liver
disease (Leary, 1991). Later reports suggested that Summers findings could not be
replicated (Kolata, 1992).
Even today, the available options that exist for AD are only for managing the
effects of the disease, including behaviors, if the patient is in the mild to moderate stages
of the disease. Medications including Cognex (generic: tacrine), Razadyne (generic:
galantamine), Exelon (generic: rivastigmine), and Aricept (generic: donepezil) are
commonly used to treat mild to moderate stage AD. These medications are known as
cholinesterase inhibitors and work by preventing the breakdown of a specific brain
chemical, acetylcholine (G. Small & Bullock, 2011). Acetylcholine is critical for the
processes of memory and thinking. These medications work because they augment
acetylcholine and act as neurotransmitter augmentation therapy (G. Small & Bullock,
2011; Wattmo, Minthon, & Wallin, 2016). However, as the disease progresses, it is not as
affected by these medications.
For persons progressing to the moderate to severe stages of the disease, there is
another medication known as Namenda (generic: memantine) that are commonly
prescribed. Both Namenda and Aricept are used for the severe stages of the disease
(Plosker & Lyseng-Williamson, 2005). Namenda is an N-methyl D-aspartate (NMDA)
antagonist. The basis of Namenda is that it contributes to the regulation of glutamate, a
brain chemical allowing for better cognition and global functioning (Zhou & Danbold,
2014). Another pharmaceutical approach to this disease is Namzaric, which is a
combination of Namenda and Aricept.
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To summarize, as of 2018, we have 5 medications on the market that are
available, and this is the extent to which pharmaceutical treatments are available for a
disease that is the 6th overall leading cause of death in the United States. The medications
do not stop the disease itself nor do these medications aggressively slow the disease. The
medications can only show some effects on mitigating the behaviors associated with the
disease.
Providing Care to Older Adults: From Home Care to Growth of Institutions
To fully conceptualize the current status of care for persons with AD in the United
States, we must understand the origins of caregiving. Care for older adults during much
of the history has been provided in the home. Families were expected to provide the daily
care for their older family members. In return, any property or financial means of the
individual was bequeathed to the family (Gawande, 2014). Often, it was customary for
generations of one family to live together, or at the very least, within close proximity and
often, this reflected customs that were derived from the family’s country of origin
(Benjamin, 1993). Given this arrangement, nearly all care was delivered in the home, and
in many situations by either family members or other natural caregivers. If persons found
themselves without family support or care, there were accommodations that could be
made to assist the aging individual. For example, in some instances, the town would
supplement another family to provide care. Alternatively, if the individual had their own
home, they might barter goods for someone to come and provide them with support
(Lacey, 1999). However, by the mid-19th century, this began to shift due to the
development of the medical model of care and changes in familial structures (Gawande,
2014).
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This shift first began in larger cities in the United States, as the colonial model of
providing care in-home and development of a barter system were not always possible.
Moving to a city, however, often required leaving family, and therefore, a support
system. Furthermore, by the late 1800’s, persons were having fewer children, and
therefore, less reliable sources of support as they aged (L. E. Jones & Tertilt, 2006). The
lack of support, particularly as persons aged, would make way for the development of
almshouses. Almshouses originated in England in the 10th century and were designed to
be used by the indigent that could not afford other accommodations. For many centuries
almshouses were available only for the deserving poor or persons in the community who
were deemed in good moral standing (Goose, Caffrey, & Langley, 2016). Known for
being crowded and unsanitary, and with abusive support staff, the almshouse was often
the last resort for many (S. Katz, 2013). The widely referenced, Quincy Report of 1821,
offers a description of the care provided to these persons who were often considered the
lowest of society for they had nowhere else to turn (M. B. Katz, 1984; S. Katz, 2013).
Furthermore, a review of the 1865 almshouse census records indicates that the average
age of the institutionalized in the almshouse was just under 50 years of age (Lacey,
1999).
By the late 19th century, there were other options for care in addition to the
almshouses. Private, charitable homes began to be developed to provide services in
many cities across the United States. Furthermore, the rise of mental institutions and
hospitals were also developing during this time (Trent, 1995). Many of the charitable
houses of the time that accepted older adults were limited to white persons of the
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Protestant faith with little or no impairments. There were long waiting lists for rooms at
these facilities with many persons waiting years to receive support (Lacey, 1999).
In the United States, home care began to diminish particularly after World War I.
This period reflected a number of interrelated factors that would change the fabric of care
provided to older adults, including those with AD. The end of the war brought new
challenges to public health as returning soldiers presented with disabilities, as a result of
their service, that needed to be addressed (Linker, 2011; Murphy, 2014). Due to the
technological advances that resulted from the Industrialization Revolution, persons began
to live longer. Between1900 and 1920 the older adult population grew dramatically. The
estimates suggest that this population grew from about 3 million persons to about 5
million persons (Hobbs & Stoops, 2002). Furthermore, the number of persons aged 85
years and older increased from 100,000 to 300,000 persons (Hobbs & Stoops, 2002).
During this time, public health became an increasing concern due to the rapid
urbanization that occurred at the beginning of the century. Persons were living in cities in
increasing numbers, and the concern regarding the spread of infectious disease led to this
newfound concern (Armstrong, Conn, & Pinner, 1999). Also, the rapid increase in the
older adult population created a systematic breakdown of the provision of care for this
population. The increase of older adults coupled with the turbulent financial years of the
Great Depression created a need for external sources of care as it became increasingly
difficult for families to provide the support to aging family members as they had once
done (Haber, 1993).
The deplorable conditions witnessed in almshouses and mental facilities were also
a cause for concern. There were limited regulations regarding specific care for older
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adults, and those with cognitive impairments such as AD. The Social Security Act of
1932 was developed to pave the way for a better structure for institutionalizing care for
older adults. Initially, the act was designed to provide independence to the aging
population of American citizens (Haber, 1993). The Social Security Act of 1932
contributed to the decline and subsequent closures of almshouses across the United States
(Haber, 1993; M. B. Katz, 1984).
In response to the closure of almshouses privately owned boarding houses began
to develop in each state due to federal funding provisions. While some of these houses
provided excellent care, this was not always the case with some providing care on par
with the almshouses that they replaced. Further, the regulations for these care providers
during this time were limited. In the end, care was inconsistent, and furthermore, there
was simply not enough privately-owned houses for this to be a sustainable safety net for
older adults (Lacey, 1999).
By the 1950’s, this led to housing older adults and those with AD in state mental
hospitals across the nation even though the initial purpose of these hospitals was to
provide acute care to persons with psychiatric illness. These facilities were never
designed to provide long-term care, and therefore, this form of care was ultimately not
sustainable (Haber, 1993; Haber & Gratton, 1993). This led to the development of
nursing facilities or skilled nursing facilities, to provide care specifically to older adults
and those with cognitive impairments such as AD. The need for more sustainable, longterm care coupled with the growing interest in developing an aging-related industry led to
a surge in nursing home facilities. Between 1963 and 1980, it is estimated that more than
one million new nursing home beds were added to provide care to this population (Doty,
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Liu, & Wiener, 1985; Vladeck, 1980). The original nursing home model was based on the
institutional care model (E. Goffman, 1968). In this model, emotional and cognitive
experiences and autonomy were disregarded (Doll, Cornelison, Heath, & Syme, 2017).
This model promoted uniformity in all aspects of life, was directed by a single authority
and was conducted in the same place. Staff carried out daily duties that were regimented
under a single plan that sought to fulfill the official aim of the institution (Wiersma &
Dupuis, 2010).
The changes that led to the increases in long-term care facilities did not ensure the
quality of care. Furthermore, many of these facilities were subsidized with government
funding. By 1975, Medicaid paid over $5 billion dollars for nursing home care each year
(Lacey, 1999). During the 1970’s and early 1980’s, there were various published
accounts that called into question the care that was provided to persons in nursing
facilities. Stories of nursing home fires, of residents dying from bedsores, and food
poisoning were widely described in reports given to government officials and in the
media (Hawes, 2003). Despite the nature of these concerns and the amount of
government funding allotted to nursing facilities, these facilities remained largely
unregulated until the late-1980 were when the Nursing Home Reform Provisions of 1987
were passed in Congress (Zhang & Grabowski, 2004).
Currently, long-term care for persons with AD has come a long way from the
unsafe and often-deplorable conditions mentioned in this section. However, this is not to
suggest that more improvements are not needed. Behaviors such as delusions, outbursts,
and aggression are symptomatic of AD. Chemical and physical restraints have many
times been utilized in these situations to make the individual more manageable (Fossey et
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al., 2006). Furthermore, a large portion of persons with dementia living in nursing
facilities receives substantial doses of tranquilizers for behavioral symptoms. This was
instituted despite the literature suggesting only modest results along with high placebo
effects and, in some scenarios, adverse side effects for those persons (Fossey et al.,
2006).
The Development of the Nurse Aide Profession
The care provided to persons with AD is often characterized as either delivered by
informal or formal providers. In 2014 alone, nearly 16 million family members and other
caregivers provided an estimated 18 billion hours of unpaid caregiving to persons with
AD and other forms of dementia. Although, more persons with AD and other forms of
dementia are receiving care from formal care providers in nursing home facilities
(Gaugler et al., 2014). CNAs make up an estimated 60% of the employees in an average
nursing home in the United States (Trinkoff et al., 2013).
In nursing homes, CNAs provide functional assistance to residents in all aspects
of their daily care. CNAs are charged with completing tasks to support residents with
activities of daily living. These tasks range from personal care support to administering
medication. CNAs receive minimal training and low pay for a stressful job many times
managing problematic symptoms and behaviors. As a result, burnout and turnover are
common for these front-line workers (J. Rosen, Stiehl, Mittal, & Leana, 2011). Many of
the issues that are faced by CNAs today are a direct result of their history of volunteer
service and marginalization within the nurse field which will be discussed next.
A Volunteer Reserve Is Formed. The need for nurse's aides, the precursor to
CNAs, developed during the United States entry into World War I in April of 1917. The
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use of heavy artillery and machine guns posed new challenges as the carnage left soldiers
with debilitating wounds, fractures, and infection. The American Red Cross, tasked with
filling positions to take care of the soldiers on the front lines, recruited nurses from across
the United States (M. M. Jones, 2012). However, the need far exceeded the nursing
professionals that were available. In Britain, the Voluntary Aid Detachment (VAD was
developed in 1909 by the Red Cross to fill these gaps in the workforce (While, 2014). It
would subsequently serve as a model for the volunteers that would be needed in the
United States. While nurses and other trained medical professionals were actively
recruited for the war effort, the Red Cross also began to seek volunteers in the form of
nurse's aides. These volunteers had little or no medical background and were often
women recruited from middle to upper-class backgrounds (While, 2014).
The initial criteria for volunteer nurse aides were for practical purposes. All
applicants had to be between the ages of 25 and 35, unmarried, in good health and
capable of hard physical labor. Applicants could not have German or Austrian
relationships by birth or marriage. Furthermore, applicants could not be daughters,
mothers, or wives of anyone serving in the United States Army, Navy, states or abroad.
Vaccinations against smallpox along with inoculations against typhoid and paratyphoid
were required. Prospective nurse aides were also required to have graduated from or be
willing to take a specific course in elementary hygiene and home care of the sick. These
were the only required preparation for the role (While, 2014).
World War I depleted the number of nurses in the United States that were
necessary to provide care within hospitals. The drain on human resources required the
Red Cross to continue to recruit actively and train nurse's aides to fill the roles once
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occupied by graduate level nurses. Training courses for hospital care for nurse's aides
were implemented in Red Cross sites across the nation to help prepare nurse aides. Many
of the requirements that were previously mandated were removed to accommodate those
persons that might be interested but did not meet the established care criteria (Hallett,
2014; Yen, 2012).
From the onset, the utilization of a voluntary force of workers presented unique
challenges to the American Nursing Association and the Red Cross. The field of nursing
had established standardization and professional training. Highly regarded institutions of
education offered nursing degree programs. Yet, many of the volunteer nurse aides had
little experience in healthcare or any field for that matter. Training for volunteer nurse
aides was limited during this time. This, in part, can be attributed to the tension between
wanting to deploy professional, experience nurse aides as opposed to volunteer nurse
aides. This tension played out between the Red Cross and the Federal government
throughout the war, and the role of the nurse aide was never clear. The President of the
American Red Cross, Jane Delano, at the time, was adamant in her opposition to the use
of volunteer nurse aides from the beginning of the War. However, by the War's end,
Delano along with key organizations such as the American Hospital Association (AHA)
understood that the need for nurse aides outweighed the risks of using volunteers. Federal
provisions were put in place to activate the reserve of volunteer nurse aides that had been
recruited. These reserves were never used as the War ended after the provisions were
enacted. Nurse aides, after the War, remained a volunteer position that fell within the
purview of the Red Cross. After WWI, many of the training programs enacted by the Red
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Cross throughout the United States remained inactive until there was cause for their need
during the beginning of WWII (Hallett, 2014; Irwin, 2013).
Current Training and Workforce Development for Nurse Aides. Due to their
status as volunteer workers, nurse aides did not emerge as a profession with rules or
formal training until the mid-20th century. The profession was formalized by the Nursing
Home Reform Provisions of the Omnibus Budget Reconciliation Act of 1987 (known as
OBRA-87) (Code of Federal Regulations, 2012). OBRA-87 established the requirement
for a 75-hour nurse aide training that included at least 12 hours of continuing education
and competency evaluation program for those persons employed as nurse aides in longterm care facilities (Han, Trinkoff, Storr, & Lerner, 2014; Klauber & Wright, 2001). Each
state was tasked with creating and implementing its own curriculum and testing system
(Klauber & Wright, 2001). In Kentucky, this has been implemented as a 75-hour course
along with 16 hours of hands-on clinical training. Currently, only 4 of the 75 mandatory
hours focus on dementia care.
With the introduction of the Affordable Care Act of 2010, more mandated
education was required. Specifically, section 6121 requires six 1-hour modules, known as
Hand in Hand, covering 7 areas including: 1) understanding the world of dementia; 2)
the person and the disease; 3) what is abuse; 4) listening and speaking; 5) being a person
with dementia, actions and reactions; 6) preventing abuse; and 7) being with a person
with dementia making a difference (Patient Protection and Affordable Care Act, 2010).
Table 1 delineates an overview of the current curriculum mandates in each state and
how they are implemented. This table does not include the Hand in Hand training that is
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a requirement in all long-term care facilities that receive federal funding and review.
Only additional dementia training to Hand in Hand is included in the table.
Table 1
CNA Training by State
CNA Training by State (Patient Protection and Affordable Care Act, 2010)
State

Statute or Regulations Related to Nurse
Aide Training Citations

Hours Required for Nurse
Aide Certification

Dementia Training Required?

Alabama

1. Federal Code of Regulations: CFR Title Total Instruction: 75
42, Vol. 3, 483.
hours
Includes: 16 hours of clinical
experience

N/A

Alaska

1. Alaska Administrative Code, Title 12,
44.835.

Total Instruction: 140
hours

N/A

Arizona

1. Arizona Admin Code § R4-19-802
(2014)

Total Instruction: 120 hours
Includes: 40 hours of classroom
instruction, 20 hours of instructorsupervised skills practice and 40
hours of instructor-supervised
clinical experience

N/A

Arkansas

1. Ark. Code Ann. § 20-10- 705
(2005)
2. Ark. Code R. 016.06.07-IV (2012)

Total instruction: minimum of 90
hours

15 hours of training related to
Alzheimer’ disease and dementia if
working in a long-term care
facility.

California

1. Cal. Health. & Safety Code. 1263
(2002)
2. Cal. Health. & Safety Code. 1337.1
(2013)
3. Cal. Health. & Safety Code. 1337.3
(2013)
4. Cal. Code. Regs. tit. 22
§ 71835 (2013)
5. Cal. Code Regs. tit. 22
§ 71847 (1992)

Total instruction: 150
hours
Includes: 100 hours of clinical
hours

2 hours initial dementia training for
nurse aides working in skilled or
intermediate care facilities and five
hours annually after the initial
training.

Colorado

1. 3 Colo. Code Regs. § 716- 1:11-5
(2014)

Total Instruction: 75
hours
Includes: 16 hours of clinical
experience

N/A

Connecticut

1. Connecticut Department of Public
Health Regulations, Public Health Code,
Chapter IV, Title 19-13-D8t.

Total Instruction: 100
hours
Includes: 50 hours of clinical
experience

N/A

Delaware

1. 16-3000-3220 Del. Admin. Code § 2.0
(2013)

Total Instruction: 150
hours
Includes: 75 hours of clinical
experience

6 hours of dementia-specific training
during each 24-month certification
period.

District of
Columbia

1. D.C. Mun. Regs. tit. 29, § 3204 (2014)

Total Instruction: 120
hours
Includes: 75 hours of clinical
experience

16 hours of nurse aide training must
include topics related to Dementia
care as part of standard certified
nurse aide training.
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CNA Training by State (Patient Protection and Affordable Care Act, 2010)
Florida

1. Florida Administrative Code, Rule
Chapter: 64B9-15.

Total Instruction: 120
hours
Includes: 40 hours of clinical
experience

N/A

Georgia

1. Alliant GMCF, Nurse Aide Program
Overview.

Total Instruction: 85
hours
Includes: 24 hours of clinical
experience

N/A

Hawaii

1. Hawaii Administrative Rules, Title 16, Total Instruction: 100
Chapter 89A
2. hours
Includes: 70 hours of clinical
Med-QUEST Division, Certification
experience
Programs, “State Certified Nurse Aide
Training Program” (May 2004)

N/A

Idaho

1. Health Professions Program, Idaho
Division of Professional-Technical
Education, “How to Start a Nursing
Assistant Course.”

Total Instruction: 120
hours
Includes: 32 hours of clinical
experience

N/A

Illinois

1. Ill. Admin. Code tit. 77, § 395.150
(2013)
2. Ill. Admin. Code tit. 77, § 395.300
(2013)

Total Instruction: 120
hours
Includes: 40 hours of clinical
experience

12 hours of nurse aide training must
include topics related to Dementia
care as part of standard certified
nurse aide training.

Indiana

1. 410 Ind. Admin. Code 16.2-3.1- 14
(2013)

Total Instruction: 105
hours
Includes: 75 hours of clinical
experience

Staff in nursing facilities who have
regular contact with residents must
have a minimum of 5 hours of
dementia-specific training within the
first 6 months of employment or
within 30 days for those assigned to
the Alzheimer’s and dementia
special care unit. All nurse aides are
to do three-hours annual dementia
specific continuing education for
recertification.

1. 441 Iowa Ad- min. Code r. 81.16
(2014)

Total Instruction: 75
hours
Includes: 30 hours of clinical
experience

16 hours of nurse aide training must
include topics related to Dementia
care as part of standard certified
nurse aide training.

Kansas

1. Kansas Administrative Regulations 2839-165.

Total Instruction: 90
hours
Includes: 45 hours of clinical
experience

N/A

Kentucky

1. Kentucky Administrative Regulations,
Title 907, Chapter 1, Section 450.

Total Instruction: 75
hours
Includes: 16 hours of clinical
experience

N/A

Louisiana

1. La. Admin. Code tit. 48, § 10015 (2012) Total Instruction: 80
hours
Includes: 40 hours of clinical
experience

Dementia training must be included
in nurse aide training but hours are
not specified.

1. 10-144 Me. Code R.110, § 8.C (2014)

Total Instruction: 180
hours
Includes: 70 hours of clinical
experience

12 hours per year in-service training,
which must include some training in
providing services to residents with
cognitive impairment.

Maryland

1. Md. Code Regs. 10.07.02.40 (2014)

Total Instruction: 100
hours
Includes: 40 hours of clinical
experience

N/A

Massachusetts

1. Code of Massachusetts Regulations,
Title 105.156.320.

Total Instruction: 75
hours
Includes: 16 hours of clinical
experience

N/A

Iowa

Maine
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CNA Training by State (Patient Protection and Affordable Care Act, 2010)
Michigan

1. Michigan Department of Community
Health, Bureau of Health Professions,
Nurse Aide Training Curriculum.

Total Instruction: 75
hours
Includes: 16 hours of clinical
experience

N/A

Minnesota

1. Follows Federal Code of Regulations:
CFR Title 42, Vol. 3, 483.

Total Instruction: 75
hours
Includes: 16 hours of clinical
experience

N/A

Mississippi

1. Follows Federal Code of Regulations:
CFR Title 42, Vol. 3, 483.

Total Instruction: 75
hours
Includes: 16 hours of clinical
experience

N/A

Missouri

1. Mo. Rev. Stat. § 198.082
(1988)
2. Mo. Code Regs. Ann. Tit.
19 § 30-84.010 (2014)

Total Instruction: 175
hours
Includes: 100 hours of clinical
experience

Dementia training must be included
in nurse aide training, but hours are
not specified.

Montana

1. Montana Department of Public Health
and Human Services, Quality Assurance
Division, Certification Bureau, State Plan
for the Nurse Aide Training and
Competency Testing Program.

Total Instruction: 75
hours
Includes: 25 hours of clinical
experience

N/A

Nebraska

1. 172 Neb. Admin. Code ch. 108 § 003
(2014)

Total Instruction: 75
hours
Includes: 16 hours of clinical
experience

N/A

Nevada

1.Nev. Admin. Code § 632.758 (1992)

Total Instruction: 75
hours

N/A

New Hampshire

1. New Hampshire Code of
Administrative Rules, Chapter Nur 10,
Section Nur 704.09

Total Instruction: 100
hours
Includes: 60 hours of clinical
experience

N/A

New Jersey

1. N.J. Stat. Ann. § 26:2M-7.2 (2012)

Total Instruction: 90
hours
Includes: 40 hours of clinical
experience

N/A

New Mexico

1. New Mexico Administrative Code,
8.312.2.21

Total Instruction: 75
hours

N/A

New York

1. 10 N.Y. Comp. Codes. R. & Regs. §
415.26 (2010)

Total Instruction: 100
hours
Includes: 30 hours of clinical
experience

Dementia training must be included
in nurse aide training, but hours are
not specified.

North Carolina

1. North Carolina Department of Health
and Human Services, Division of Health
Service Regulation, Center for Aide
Regulation and Education, State Approved
Curriculum for Nurse Aide I Training.

Total Instruction: 75
hours
Includes: 16 hours of clinical
experience

N/A

North Dakota

1. North Dakota Administrative Code,
33.07.06.02.

Total Instruction: 75
hours
Includes: 16 hours of clinical
experience

N/A

1. Ohio Admin. Code 3701-17- 07.1
(2012)

Total Instruction: 75
hours
Includes: 16 hours of clinical
experience

For nurse aides working in specialty
units, 12 hours per year including
dementia-related continue education
is required.

Ohio

Oklahoma

1. Okla. Stat. Ann. tit. 63, § 1-1951 (2013) Total Instruction: 75
2. Okla. Admin. Code § 310:677-11-4
hours
(2009)
Includes: 16 hours of clinical
experience
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N/A

CNA Training by State (Patient Protection and Affordable Care Act, 2010)
Oregon

1. Oregon Administrative Code, 851-0610090.

Total Instruction: 150
hours
Includes: 75 hours of clinical
experience

N/A

Pennsylvania

1. Pennsylvania Department of Education,
Application for Approval of Nurse Aide
Training and Competency Evaluation
Program, June 2012

Total Instruction: 80
hours
Includes: 37.5 hours of clinical
experience

N/A

Rhode Island

1. R.I. Admin. Code 31-5-26 Appendix II
(2012)

Total Instruction: 100
hours
Includes: 20 hours of clinical
experience

Dementia training must be included
in nurse aide training but hours are
not specified.

South Carolina

1. South Carolina Department of Health
and Human Services, Department of
Facility Services, South Carolina Nurse
Aide Training Program Packet,
“Guidelines for Nurse Aide Program
Training Approval.”

Total Instruction: 75
hours
Includes: 16 hours of clinical
experience

N/A

South Dakota

1. Admin. R. S.D. 44:04:18:15 (1995)

Total Instruction: 75
hours
Includes: 16 hours of clinical
experience

Dementia training must be included
in nurse aide training, but hours are
not specified.

1. Tennessee Annotated Code 68-11-209

Total Instruction: 75
hours
Includes: 35 hours of clinical
experience

N/A

Texas

1. Tex. Health & Safety Code Ann. §
250.0035 (2011)
2. 40 Tex. Ad- min. Code § 94.3 (2013)
3. 40 Tex. Ad- min. Code § 94.9 (2013)
4. 40 Tex. Ad- min. Code § 1.1929 (2004)

Total Instruction: 100
hours
Includes: 40 hours of clinical
experience

Nurse aides are required to complete
24 hours in-service education every
two years which includes training in
the care of patients with Alzheimer’
disease.

Utah

1. Utah Administrative Code, Rule R43245.

Total Instruction: 100
hours
Includes: 24 hours of clinical
experience

N/A

Vermont

1. Vermont Board of Nursing,
Administrative Rules, Part 16.12.

Total Instruction: 80
hours
Includes: 30 hours of clinical
experience

N/A

Virginia

1. 18 Va. Ad- min. Code § 90-25-140
(2014)
2. 18 Va. Ad- min. Code § 90-26-40
(2014)

Total Instruction: 120
hours
Includes: 40 hours of clinical
experience

Dementia training must be included
in nurse aide training, but hours are
not specified.

1. Wash. Ad- min. Code § 246-841-100
(2008)
2. Wash. Ad- min. Code § 246-842-100
(1991)

Total Instruction: 85
hours
Includes: 50 hours of clinical
experience

N/A

1. West Virginia Department of Health
and Human Resources, Bureau for Public
Health, Office of Health Facility
Licensure and Certification, Nurse Aide
Educational Program, Criteria and
Guidelines.

Total Instruction: 120
hours
Includes: 55 hours of clinical
experience

N/A

Wisconsin

1. Wis. Admin. Code Trans. § 129.07
(2008)
2. Wis. Admin. Code Trans. § 129.08
(2011)

Total Instruction: 120
hours
Includes: 32 hours of clinical
experience

Dementia training must be included
in nurse aide training, but hours are
not specified.

Wyoming

1. Wyoming State Board of Nursing,
Total Instruction: 75
Administrative Rules and Regulations, Ch. hours
II, Section 5(b)
Includes: 16 hours of clinical
experience

Tennessee

Washington

West Virginia
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N/A

This analysis shows that 31 states along with the District of Columbia are more
than meeting the federal requirements training. This analysis also illustrates that the state
of Kentucky still lacks in terms of consideration of updating nurse aide training. In a
review of other states, most have updated state CNA training regulations in the last 10-15
years to reflect best practices. In Kentucky, the last changes that were implemented to
nurse aide training on a state-wide level were with the provisions that were included in
OBRA-87 in 2006 (Hawes, 2003). It is also important to consider that there have been
numerous changes in terms of our understanding of the impact and nature of AD since
the time that OBRA-87 was implemented. Several states have addressed this by requiring
that nurse aide training to include hours and clinical supervision in providing care for
persons with AD. Other states not only include AD training at the onset of nurse aide
training but also require continuing education each year. It has been shown that better
trained CNAs who are more capable of performing tasks provide better care (Han et al.,
2014). The Institute for Medicine recommended that training hours for CNAs should at a
minimum be 120 hours and that the certified nursing assistant certification exam directly
assesses competence in the care of older people (Institute of Medicine, 2008).
Summary
Alzheimer’s is a devastating disease that affects over 5 million persons in the
United States, and it will continue to increase as the baby boomer generation ages
(Alzheimer’s Association, 2018). It is a disease without a cure or validated ways to slow
down its progression (Alzheimer’s Association, 2018). The challenges faced today in
providing care for persons with AD are very much rooted in the historical
characterizations of the disease. This has affected the care of persons and even the way
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that medications are developed for those facing the disease. CNAs have emerged as the
primary caregivers for persons with AD living in nursing home settings. The education
provided to CNAs, while adequate in understanding the basic nursing care of persons
with AD fails to teach CNAs how to provide compassionate care. This new level of
training is needed in order to give CNAs the tools to overcome the societal stigma that
follows the disease and develop a stronger bond with patients and their workplace.
While this chapter served as an introduction to the challenges of the disease and
furthermore, provided a foundation for understanding its’ unique complexities,
subsequent chapters will focus on building a new approach to providing compassionate
care for persons with AD.

1
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CHAPTER II: LITERATURE REVIEW
This chapter introduces a theoretical framework for conceptualizing AD. It
provides insight into the need for compassionate care and the stress associated with CNA
caregiving. Specifically, theories of disablement and symbolic interactionism are
discussed. The chapter also includes learning theories that were used to inform the
development of the compassionate care curriculum, specifically cognitive learning theory
and social learning theory. Also, Kirkpatrick’s evaluation model is discussed as a
framework for the evaluation of the new curriculum. The chapter concludes with a
conceptual hypothetical model that was used to investigate the effectiveness of the
compassionate care curriculum in reducing the stress levels of persons with AD in
nursing facilities.
It should be noted that the theoretical framework explored does not reflect all the
major paradigms that exist related to AD, the nature of the disease as a disability,
learning about caregiving or the actual process of caregiving. However, the theories that
were selected for inclusion provide a solid foundation for conceptualizing the
complexities of providing compassionate care.
Theoretical Frameworks for Conceptualizing Alzheimer’s disease
AD is both debilitating and disabling for the individual suffering from the disease.
Understanding how persons with AD respond to physical and mental changes and their
new identity becomes an important aspect of any AD-related social research. Hence,
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understanding the perspective of persons with AD, provided the foundation for
developing a compassionate care curriculum that could provide tools and skills to CNAs
to care for persons with AD.
Theories examined included theories of disablement and symbolic interactionism.
These theories were chosen because they conceptualize the complexities that contribute
to the environment of the individual living with AD. Both theories conceptualize AD as a
disability and a loss of the individual’s personhood. Theories of disablement focus
primarily on the process that the individual undergoes from being a functional,
productive member of society to becoming a person with a disability (S. Nagi, 1964,
1991). Symbolic Interactionism (SI) provides a conceptualization of how persons with
AD and those around them interact post-diagnosis of AD (Blumer, 1969; Stryker, 1980).
Theories of disablement
A progressive disease, Alzheimer’s impacts the individual in a way that is
particularly devastating. Persons with AD are not only confronted with the challenges of
the disease but also with the feelings associated with loss of functions. Theories of
disablement provide a framework within the field of disability research to give an
understanding regarding the process of change that occurs as an individual is faced with
their disability.
Saeed Nagi was the first to conceptualize disability as a process (S. Nagi, 1964).
In Nagi’s model, disablement is defined as any chronic or acute condition that has an
impact on the individual’s performance and functioning (S. Nagi, 1964, 1991; S. Z. Nagi,
1976). This framework is based on four interrelated concepts termed active pathology,
impairment, functional impairment, and disability (S. Nagi, 1964, 1991). Active
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pathology is the result of trauma, infection or illness, neurological diseases or any other
etiology. In this case, active pathology includes AD. Impairment is the resulting loss or
the abnormality of the anatomical, physiological, mental or emotional nature. For AD,
this would include many of the symptoms of the disease such as memory loss, confusion,
and disruption of sleep patterns due to the histological abnormalities of AD. Functional
limitations refer to the restrictions in performing basic activities of daily living. This
would include the limitations that are often faced by persons with AD as the disease
progresses. It includes the loss of participating in personal care, shopping, and even
eating. In Nagi’s model, the culminating process of these factors leads to disability (S.
Nagi, 1964, 1991; Saad & Judith, 1980).
Framing the development of AD as a process that leads to disability provides an
understanding of how a person with AD might conceptualize the disease as it progresses.
Faced with the prospect of disability due to AD, the individual processes the change in
status within their world, from an able-bodied person to a person living with a disability.
For the person with AD this can also contribute to a feeling of loss of self, particularly as
the disease progresses (S. Nagi, 1964, 1991). For example, persons with AD may not
have the capacity to complete the activities that once provided them with enjoyment.
Additionally, persons may be viewed by their family as needing increased support and
care. The increased loss of independence can be overwhelming to the person with AD.
Overall, in the early stages of the disease, while the person is still very much aware of
their situation, this can contribute to depression and behaviors associated with this loss of
identity (Hausner, 2004).
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Nagi’s model is limited in several areas that need to be addressed. At the time of
its development, the model did not account for external factors such as environment or
the societal implications of disability. Initially, the model did not focus on the effects that
disablement had on a persons’ health (Jette, 1997). Furthermore, Nagi’s model has not
been specifically applied to AD research, only general forms of disability. The model
also does not focus on any of the precipitating factors that lead to a person’s disability.
However, Nagi’s model provides a foundation for understanding the internal process that
the person with AD undergoes related to their disease. Since its original introduction to
the scholarly work in the field of disability and disablement, it has been modified to
address some of the limitations associated with the model.
One limitation of Nagi’s model was addressed in the 1990’s by scholars
Verbrugge and Jette (Branch, 1996). While the original model provides a foundational
understanding of the disablement process, Verbrugge and Jette expounded upon this by
examining the precipitating factors that lead to a persons’ disability (Verbrugge & Jette,
1994). Through this adaptation, disability or disabling conditions such as AD are
classified as dysfunctions within the human body. However, externalities or internal
crises could either speed up the decline in functioning or stabilize it depending on the
nature of the situation (Verbrugge & Jette, 1994). This provides a foundation for
understanding how persons faced with impending loss of function can manage given their
environment in addition to the actual physical and biological concerns that are brought
upon by the disease (Verbrugge & Jette, 1994).
As an individual with AD faces their eventual prognosis, understanding the
transition to disability becomes important in providing care and support to not only the
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individual but their family as well (Verbrugge & Jette, 1994). In order to understand this
transitional process, theories of disablement provide a foundation for conceptualizing the
imminent disability that one faces (Verbrugge & Jette, 1994). Furthermore, these
frameworks also address the significant stigma that is often associated with cognitive
decline and loss of function within society (Verbrugge & Jette, 1994).
Symbolic interactionism
Theories of disablement provide a foundation for understanding how an
individual undergoes the journey from functioning to disability. However, how the
individual interacts and responds to their situation is also an essential consideration that
must be made when conceptualizing the impact of AD. Symbolic Interactionism (SI)
focuses on how the individual interacts within their own unique system (Blumer, 1969;
Stryker, 1980). AD affects the ability to perform activities of daily living and erases
many memories, which, in turn, can also strip away the sense of identity. Take, for
example, a 68-year old grandmother that has recently been diagnosed with AD. Although
she may have cared for her grandchildren for a number of years, as the disease progresses
she won’t be able to continue in the same way she did in the past. The loss of memory
and ability to function in activities of daily living creates a loss of a sense of self.
Utilization of the theory of SI can provide an understanding of this individual’s journey
and how she attributes meaning to her life and interactions with her family given her
diagnosis (Ariotti, 1999).
To understand the way in which a person interacts with their environment, SI
provides both a foundation and an intricate understanding of the social interaction process
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that humans engage in. SI also provides an understanding of how these interactions can
change over time given the progression of the disease (Blumer, 1969).
First developed by George Herbert Meade and later articulated and expanded
upon by his student, Herbert Blumer, SI was first introduced in the 1920’s (Blumer,
1969). However, its origins reside in the work of renowned sociologist Max Weber
(Segre, 2014). Given its origins in sociological theory, SI, at its core emphasizes the
interactions and their subsequent meanings between individuals. SI has applicability for
many populations and is not solely focused on persons with AD. However, it provides a
deeper understanding of how the individual is involved in their environment. SI is
predicated on the understanding that all persons engage in their environment in some way
(Blumer, 1969; Stryker, 1980).
SI is the process in which persons make meaning of their circumstances through
interactions with the systems that surround them. Underlying SI is the emphasis not
simply on social behavior, but on a deeper level, how the behavior is constructed
(Stryker, 1980). SI provides an in-depth understanding of social interaction (Blumer,
1969; Stryker, 1980). It is not viewed as a byproduct of an individual’s need to attribute
meaning to the world around them (Dennis, 2011). From engagement with others, the
individual develops and attributes meaning to actions, items and even other humans in
their environment (Blumer, 1969; Stryker, 1980).
It is important to consider that the foundations of SI are built upon three separate,
yet interrelated concepts (Blumer, 1969; Stryker, 1980). The first concept is that human
beings act towards items in their environment based on the meanings attributed to these
items (Dennis, 2011). For example, all humans respond accordingly to their mothers or
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fathers since there is meaning associated with these persons within society (Dennis,
2011). The second concept of SI posits that the meaning attributed to humans and objects
is derived from social interaction (Blumer, 1969; Stryker, 1980). The meaning attributed
to these figures (mother and father) arises from the social engagement process. Lastly,
these meanings undergo a process of continuous revision as the individual continues to
engage within their environment (Blumer, 1969; Stryker, 1980).
This brings us back to the example of the recently diagnosed 68-year old with
AD. Through her interactions with her family, she had conceptualized her role as being
that of a caregiver to both her adult children and her grandchildren. These social
interactions gave her purpose and meaning in her life. Hence, when the disease renders
her unable to do these activities any longer, she not only loses these interactions but loses
her role within her family as well. The disease in effect informs the way she will define,
interpret and react to the new situation and make meaning based on her perceptions. This
is an example of how symbolic interactionism can help in understanding the roles or
identity that persons attribute to themselves, and the loss that AD inflicts as it progresses
(Waldrop, Clemency, Lindstrom, & Clemency, 2015).
From this perspective, persons are rational actors that continuously engage with
each other. Given these circumstances, individual’s behavior will be shaped by these
interactions. Furthermore, given this emphasis on interaction, it is assumed that social
actions are representations of the social structures that are prevalent within the societal
system. Hence, these are hidden motivations that contribute to one’s construction or
meaning-making. The process of meaning-making is viewed on a continuous spectrum.
Interactions change over time between actors within the system. Therefore, this alters the

72

meaning that the individual attributes to the circumstance. Meaning making is as much a
contextual phenomenon as it is continuous (Blumer, 1969). Within different interactions
with different actors, persons can take on new roles or gain new perceptions about
oneself (Blumer, 1969).
From the lens of SI, social interaction is a cornerstone of the world in which we
live (Dennis, 2011). Humans engage with each other through verbal and non-verbal
contact. For an individual with AD, this process takes on new meaning. Communication
and ways of self-expression increasingly deteriorate as the disease progresses. Thus, AD
can have a powerful impact on the role of the individual within society as well as how
persons with AD interact and engage with those around them.
Symbolic interactionism and stigma. The concept of stigma was first developed
in depth by Goffman (Erving Goffman, 1986). His work has been applied to many
different conditions including mental illness, AIDS and epilepsy. Goffman posits that
stigma originates when an individual has an undesirable attribute that discredits them
within society (Erving Goffman, 1986). For persons with AD, the disease becomes an
attribute from which they cannot separate and contributes to them experiencing stigma
within society. The stigmatization of persons with AD, as outlined in Chapter 1, is rooted
in the historical conceptions of dementia and the way that person with AD are treated in
society can be described in more depth using symbolic interactionism.
As previously stated, humans engage with each other in a constant loop of
communication where interactions are being perceived in different ways by all parties
that are engaged in the interaction (Blumer, 1969).As the disease progresses, persons
living with AD do not meet the norms of society. They often behave in ways that are
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challenging for others. This impacts the person’s ability to interact with others. For
example, an individual with AD may be unwilling to shower regularly. Norms of our
culture dictate that this is an activity of daily living that is important and is valued. When
others in society encounter the un-showered, perhaps disheveled individual, then they do
not know how to respond. This challenges the way that they believe that person typically
behave.
For caregivers, the stigma associated with the disease is often profound and
results in what Goffman defines as affiliate stigma (Erving Goffman, 1986). Caregivers
derive their role from essentially providing care to the person with Alzheimer’s disease.
This means that the individual, while not directly inflicted with the disease, feels the
stigma associated with providing care to someone with the disease. This can be a
contributing factor to the caregiver’s burnout and their feelings of frustration as they too
feel stigmatization. This, in turn, affects the quality of care that the individual with AD
receives.
Theoretical Frameworks for Understanding Learning Processes
While the previous section explored two theories that provide a theoretical
framework to understand persons living with AD, it is also important to consider how to
implement curriculum and training for working with persons with the disease. CNAs are
charged with providing direct care to persons with AD in nursing home settings.
Understanding how these professionals develop skills disseminated through training is
important. Theories of learning provide a framework for understanding how persons
process information and provide a framework for best practices in disseminating
information that can be retained and utilized (Spring, 2010).
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Learning is a complex process that requires not only obtaining information but
also the transference of the information into tangible, measurable behaviors (Hergenhahn,
1976). Hence, learning should not simply involve passive dissemination of information
from instructor to the learner. Instead, learning is characterized primarily by changes in
behavior (Spring, 2010). Hence, for learning to be successful, the learner must not only
process the information provided but also translate it into observable behaviors. Learning
theories are cogent frameworks consisting of established concepts and ideas that provide
explanations of how people learn (Spring, 2010).
Within educational psychology, there exist several types of theories of learning
that present different perspectives and highlight different components that are viewed as
critical to the learning process. The utilization of contrasting learning theories is useful in
the development of curriculum (Spring, 2010). The following section will highlight two
theories of learning, cognitive and social, how the theory conceptualizes learning, and the
processes involved in learning to be effective. Moreover, these particular theories were
chosen due to their contributions to conceptualizing motivation and learning.
Cognitive Learning Theory
The cornerstone of cognitive-based learning theory rests on the notion that to
change an individual’s behavior; their cognition must first be changed (Bush, 2006).
Therefore, foundations of cognitive learning theory focus primarily on the learner and
their internal processes of learning (Braungart & Braungart, 2003). Since learning is
viewed as an internal process, persons in the learning environment will process the
information provided differently and in their own way due to their own, unique set of
experiences (Bush, 2006). Under cognitive-based learning, transference of learning is

75

achieved through understanding, with an emphasis on the notion of learning to learn
(Braungart & Braungart, 2003). Once this process is changed through a learning
experience, it becomes an inherent process by which the learner begins to implement the
tools or strategies that have previously been disseminated through education or training
(Braungart & Braungart, 2003).
Given the emphasis on the internal processes of the learner, it might be assumed
that individual reward is necessary to reinforce the transition from taking knowledge and
implementing it into practice, however, this is not the case. Instead, it is more important
to consider the learner’s motivation for learning and furthermore, their overall goals as it
relates to the material at hand (Braungart & Braungart, 2003; Bush, 2006). Understanding
this information about the learner requires an understanding of the experiences and
unique skill set that the individual brings to the learning process. Without these insights,
the instructor will not be able to engage with the learner. This has obvious implications
for the utilization of the material disseminated.
Within cognitive based theories, there exist different models to explain how
information is retained and applied by the learner. One model, known as the informationprocessing model of memory functioning, offers a schema of memory organization that
follows a path of linear stages (Leonard, 2002). The first stage, operationalized as
attention, requires that the learner engages in the external stimuli provided in the
educational opportunity. In this stage, the learner should be able to respond to the
instructor with feedback, questions, and overall engage in behaviors that illustrate their
attention to the material (Braungart & Braungart, 2003). If the learner is not engaged in
the attention stage or seemingly receptive to the material, it is suggested that the

76

instructor try again later when the learner is more apt to be attentive to the material. The
second stage of the model is characterized as processing (Braungart & Braungart, 2003).
During this stage, the learner is processing the information using their preferred mode of
learning. Hence, it becomes increasingly important to understand whether the learner
aligns more with audio, visual, or application modes of learning. In the third stage, the
learner moves from processing the information provided to storing information into their
short-term memory, known as memory storage (Braungart & Braungart, 2003). At this
stage, information is ascertained through learning and either disregarded or moved into
long-term memory for utilization. The final stage within this model is the action phase.
This stage is predicated on the previous stage in that learners will either eliminate the
information learned or put it into action (Braungart & Braungart, 2003). However, the
model does not end in the final stage. The learner may find that after some time they have
issues with retrieving the learned material or that they have retrieved the information
incorrectly (Leonard, 2002). This requires part of the process to start over, as the learner
will need to modify the information if this happens and an instructor or another learner
corrects them (Braungart & Braungart, 2003). Understanding this process is useful in the
creation of curriculum since it provides a framework for how the learner processes and
retrieves information and converts this into actions.
Under the cognitive learning framework, it should also be noted that persons are
thought to understand and process the information provided through making meaning and
relating the information to experiences or other portions of information that have already
retained (Leonard, 2002). This becomes helpful in understanding how the individual
retains the information that is provided.
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Cognitive-based learning theories have relevance to this study in that it provides a
framework for understanding the motivation for learning and how learned behaviors
become a continuous, inherent mechanism. Through this framework, it is important to
provide learners with a clear understanding of why the material is important. For CNAs
working with persons with AD, this will be emphasized through the need to provide
compassionate care to the individual. Furthermore, cognitive theories of learning reiterate
the importance of understanding the learner’s motivations, goals, and life experiences.
These have an impact on the way in which the learner not only processes information but
also how information is translated into actions.
Social Learning Theory
In contrast to the internal processes that are emphasized in cognitive-based
learning, theories of social learning postulate that persons learn through their social
environment. First developed by Albert Bandura, the foundations of social learning
theory are built on the understanding that the learner’s environment and interactions with
other learners is most important in building a body of knowledge that can be transferred
into behaviors (Bandura, 1977, 1986). With the emphasis on the learner’s environment,
social learning theory suggests that modeling from others is the most important impetus
to changing behavior (Bandura, 1986). Furthermore, the individual learner does not have
to be reinforced under this framework. Known as vicarious reinforcement, the theory
posits that if a learner witnesses a role model or other learner in their environment
receiving praise or positive attention, then this will reinforce the behavior. Reward,
however, is not always necessary for the learner to adopt the behavior since viewing the
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action will undoubtedly have an impact regardless of whether the role model receives
praise or reinforcement (Bandura, 1977, 1986).
In his seminal work, Bandura outlined a four-step model that delineates the
process of social learning (Bandura, 1977, 1986). Given that it focuses on the internal
processes that an individual learner undergoes to participate in and benefit from social
learning, it is aligned with models under cognitive forms of learning as previously
elucidated. The first step in Bandura’s model is the attentional phase (Bandura, 1977).
This phase is necessary for learning to occur and is the point at which the individual
learner observes a role model engaging in the behavior. The role model is an individual
that the learner views as a competent and reliable leader in the environment (Bandura,
1986). The next step is the retention phase in which the learner observes the role model in
action and then processes the behavior observed. The third step is the reproduction phase.
The learner copies the behaviors that have been observed from the role model.
Reproduction of the behaviors in this phase are strengthened if the learner goes through
the process of mental rehearsal, an immediate reenactment of the behavior, and if the
learner receives corrective feedback from the role model (Bandura, 1977). The final step
is the motivation phase where the learner is motivated to complete the behavior. This
model reflects Bandura’s conception of the learner as being the primary agent in the
social environment by which all the observations and subsequent behaviors are filtered
given the learner’s experiences and motivations (Bandura, 1977, 1986).
For developing a curriculum that CNAs can use effectively, social learning theory
provides an understanding of how persons perceive their environment as a tool of
learning. Persons observe behaviors of others within the environment and depending on
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the feedback of the observable behavior, will implement it. Furthermore, social learning
theory highlights the need for going further than simply disseminating information to
learners. Instead, learners can actively observe behaviors in their environment and then,
implement these behaviors if they seem appropriate.
Kirkpatrick Model of Evaluation
The purpose of this dissertation study is to introduce a CC curriculum that
incorporates the theories of learning and therefore a model for evaluation is needed. The
Kirkpatrick Model of Evaluation was first introduced in the late 1950’s by David
Kirkpatrick as a process of evaluation to determine whether newly adopted models of
training or a new curriculum produces the intended results and objectives (D. L.
Kirkpatrick, 1959a, 1960). The structure of the model allows for understanding how
learners understand and adopt the curriculum to their practice. The model was later
expanded on and refined through a number of scholarly literature by Kirkpatrick and his
son (D. L. Kirkpatrick & Kirkpatrick, 2005; J. Kirkpatrick, 2005). The model is widely
used in evaluation studies (Campbell & Mather, 2018; Farjad, 2012; C. Jones, Fraser, &
Randall, 2018; Praslova, 2010; Simpson & Scheer, 2016). The Kirkpatrick model can be
applied during any stage of evaluation, including before, during or after the
implementation of training (C. Jones et al., 2018).
The Kirkpatrick model denotes 4 levels of evaluation that will be utilized in the
study (D. L. Kirkpatrick, 1960; J. Kirkpatrick, 2005). They are as follows: Level 1Reaction, explores to what degree participants react favorably to the learning event;
Level 2- Learning, explores to what degree participants acquire the intended knowledge,
skills, and attitudes based on their participation in the learning event; Level 3- Behavior,
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explores to what degree participants apply what they learned during the training when
they are back on the job; and, Level 4- Results, explores to what degree outcomes occur
as a result of the learning event and subsequent reinforcement (D. L. Kirkpatrick, 1960; J.
Kirkpatrick, 2005).
The first level, reaction, focuses on the reaction of the learners to the delivered
content (D. L. Kirkpatrick, 1959b). Reaction to the training is important for two primary
reasons. First, it enables the learners to become part of the process. Second, the feedback
solicited from learners can be used in future iterations of the development of the content
(D. L. Kirkpatrick, 1959b; J. Kirkpatrick, 2005). Given the research discussed in the
aforementioned section, empowering CNAs to provide feedback to the content that is
provided in the curriculum will become a valuable asset, particularly during the pilottesting phase.
After determining the learners’ reaction to the training, learning is the second
level of evaluation (D. L. Kirkpatrick, 1959a). It is important to measure how learners
understand the concepts and techniques that were provided in training. This can often be
achieved through a skill-based knowledge test that is taken at the pre- and post-time
intervals (Reio, Rocco, Smith, & Chang, 2017).
In level three of Kirkpatrick’s model, there is a shift in focus from learning to
transfer (J. Kirkpatrick, 2005). The focus of this level is on the job performance of the
learner and how they were able to implement the material that was delivered through the
training (Reio et al., 2017). This level is critical as results cannot be assessed (level 4) if
the learners have not transferred their learning in behavior changes that are measured by
the organization (Reio et al., 2017). This level is considered more time consuming than
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the previous levels since it requires the organization to examine the behaviors of the
learners and assess whether transference of learning has occurred (J. Kirkpatrick, 2005).
Finally, the model culminates with the fourth level- results. In this context, results
mean the assessment of the desired outcomes of the curriculum. (C. Jones et al., 2018).
This can be the most challenging level of the model to assess and measures the actual
organizational change that occurred as a result of the training (Reio et al., 2017). Studies
that utilize all four levels of the model provide comprehensive evaluations (C. Jones et
al., 2018).
Conceptual Hypothetical Model
Utilizing the presented theories as a foundation, a conceptual hypothetical model
was developed. The purpose of this proposed model is to provide an understanding of
how the stress of persons with AD living in nursing facilities can be improved by the
implementation of a compassionate care curriculum for CNAs. Figure 1 shows the
proposed model along with an overview of the variables that are included in the model.
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Figure 1. Conceptual Hypothetical Model

Operationalization of Conceptual Model Variables
The following provides an overview and justification for all variables that were
included in the conceptual hypothetical model.
Control Variables. To focus on the impact of a CC curriculum in how to care
for residents with AD living in nursing facilities, a variety of variables served as control
variables for the study. These variables were divided into those that focused specifically
on CNA characteristics and those that focused specifically on the characteristics of
persons with AD.
CNA characteristics. The following CNA characteristics were controlled for:
Age of CNAs. It is important to control for age of the CNAs that are providing
care to persons with AD. Age-related values exist within helping professions including
CNAs. Persons from younger age cohorts tend to be more open to change, while older
age cohorts report being more set in their current ways of providing care (Caplan & Bull,
1992). Age is also related to job and training experience (Onnismaa, 2008). CNAs that
are older, by virtue, had more experience and therefore, are more likely to respond to
difficult situations in a more positive way (Onnismaa, 2008).
CNA Gender. Gender could influence the way in which the CC curriculum is
implemented, and persons with AD are cared for. The CNA workforce is predominately
comprised of females (United States Department of Health and Human Services Centers
for Disease Control, 2018). Females in helping professions, such as CNAs, tend to
exhibit higher levels of empathy than their male colleagues (Williams, 1989).
Furthermore, this level of empathy displayed can lead to higher rates of emotional fatigue
and exhaustion (Williams, 1989). Females often choose to enter into helping professions,
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such as the CNA profession, for different reasons than men (Byrne, 2008). This could
potentially impact care because females and males could interact differently with the
residents with AD.
CNA Race/Ethnicity. Reports have indicated that while persons of color make up
roughly one-quarter of the total United States workforce across all fields and professions,
within the CNA workforce, African Americans make up over one-third of the workforce
(United States Department of Health and Human Services Centers for Disease Control,
2018). It has also been suggested that factors related to disparities between races can
increase job strain (Chaudhuri, Yeatts, & Cready, 2013; Hurtado, Sabbath, Ertel, Buxton,
& Berkman, 2012). In a study specifically looking at factors of jobs strain, it was found
that there were differences in black CNAs and white CNAs. More specifically, black
CNAs felt they had less control over their work (Hurtado et al., 2012). Furthermore,
black CNAs in the study reported earning $2.58 less per hours than white CNAs (Hurtado
et al., 2012). These factors contributed to higher feelings of job strain that could lead to
differential interactions with residents with AD (Hurtado et al., 2012).
Years of experience working in nursing facilities. For nursing facility staff and
administrators, experience in the field is often correlated to higher scores on the core
quality measures as stipulated by CMS (Krause, 2012). In general, within the nursing
profession, years of experience is correlated to higher feelings of competency in
providing care (Takase, 2013). Hence, overall years of work experience can have an
impact on the care that residents in the facility receive on a daily basis.
Years of experience in specified nursing facility. The number of years that the
CNAs worked in the specified nursing facility was seen as important, particularly
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considering the impact that staffing turnover has on the structure of the facility and the
care received by residents (Castle, Engberg, R., & Men, 2007). This should be
differentiated from the number of years that the individual has worked in the field in total
since turnover and facility changes are common within the CNA profession. Furthermore,
it is assumed that each facility has its own culture, work environment, and expectations.
Becoming a part of this unique culture is important to both workers and the residents they
serve. Studies have shown that the number of years working in a specific nursing home
settings can have a positive impact on nursing facility workers perceived feelings of selfefficacy (Pfister et al., 2013).
Educational attainment. Education attainment included only formal education
received by the CNAs (Griscti & Jacono, 2006). CNAs are required to have a high school
diploma (Montgomery, Holley, Deichert, & Kosloski, 2005), with some being more
qualified. Education attainment impacts the care they provide to persons with AD, with
more education providing a positive effect on the quality of care (Coogle, Parham, &
Rachel, 2011).
Characteristics of residents with Alzheimer’s disease. As with the considerations
to control for variables related to the CNAs, there are important control variables to
consider in relation to the characteristics of residents with AD.
Age of persons with AD. As people age, they are more predisposed to having AD.
Both gender and age are the most significant predictors of developing the disease (Vina
& Lloret, 2010). Thus, the prevalence rate of the disease is much higher for those persons
aged 85 and older than it is for persons 65 and older (Centers for Disease Control and
Prevention, 2017 ). Furthermore, it has been shown that persons with AD who are 85
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years and older are more prone to exhibit the various behavioral symptoms that are often
associated with the disease (Furuta, Mimura, Isono, Sugai, & Kamijima, 2004). Hence,
the older the residents with AD, the more complicated the care can be. Age is also
connected to other chronic conditions that the individual may be predisposed to in
addition to AD, including, cataracts, hearing loss, high blood pressure, or cardiovascular
disease (Salive, 2013). If a person with AD has one or more other chronic conditions, this
will require increased care.
Gender of persons with AD. From the onset of AD research, it was established
that the disease disproportionately affects women (Farrer et al., 1997). This early research
has been expounded upon in subsequent decades, making it clear that while there is a
debate about why more women are diagnosed with AD, the fact remains that there is a
difference between genders (Vina & Lloret, 2010).
Gender has an impact on the interactions between residents in a nursing home and
staff. In a study of interactions between staff and residents, it was noted that female
residents did not initiate interactions with male staff (Lindesay & Skea, 1997). Some
critical feminist gerontological theories suppose that women spend most of their lives
feeling disenfranchised and not valued within society (hooks, 2000). These feelings of
inferiority might transfer into their lives within any long-term care facility (Lindesay &
Skea, 1997).
Race/ethnicity of persons with AD. An individual’s race/ethnicity may have an
impact on their care. Minorities in society are often marginalized and these disparities
extend to the care that they receive in the nursing facility. One study focused on social
engagement showed that while a majority of nursing home residents showed low social
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engagement, there was a difference for racial/ethnic minorities. When compared to white
residents, minority residents were between 30% and 40% less likely to show overall high
social engagement (Y. Li & Cai, 2014).
Cognitive Functioning. Identifying cognitive functioning assists in understanding
where the person with AD is in the trajectory of the disease (Silverberg et al., 2011).
More care is needed for those with higher levels of cognitive decline (Silverberg et al.,
2011). The goal is to ensure that all residents receive the same quality of care, regardless
of their mental acuity.
Predictor Variables. Predictor variables include changes in knowledge of
Alzheimer’s disease; changes in confidence in performing restorative care activities;
changes in caregiver satisfaction; and, changes in affiliate stigma. They are explained in
more detail below.
Changes in knowledge of Alzheimer’s disease. According to the Kirkpatrick
model after the reaction to the curriculum, learning is the second level of evaluation (J.
Kirkpatrick, 2005). It is important to measure how learners understood the concepts and
strategies for providing care that was included in the delivered curriculum. It was
anticipated that an increase in knowledge would have an impact on care. From the
literature, we know that education has a direct positive impact on the quality of care
provided by CNAs (Trinkoff et al., 2017; Yeatts, Cready, Swan, & Shen, 2010).
Changes in confidence in performing restorative care activities. Following
Kirkpatrick’s model, there is a shift in focus from learning to the transference of skills
through behavior (J. Kirkpatrick, 2005). The focus on this variable was to determine if

88

CNAs moved past the learning processes to utilize the information that they were
provided via the curriculum.
From the literature, we know that an increase in education and experience
correlated with higher performance in restorative care activities (Castle et al., 2007).
Based on increased training and more experience with working with the needs of this
population, it was anticipated that CNAs would have more confidence in their abilities to
provide compassionate care.
Changes in confidence in performing restorative care activities are connected to
Bandura’s social cognitive theory (Bandura, 1986). It was posited that self-efficacy is an
important factor for behavioral change to occur. Through the process of feeling more
confident in their abilities, it was assumed that nurse aides would want to use the skills
they developed during their exposure to the curriculum.
Changes in Caregiver Satisfaction. The relationship between the care receiver
and the caregiver can be a special bond, one that the caregiver will cherish long after the
care receiver has passed away. However, in those moments when caregiving is
particularly difficult when the individual with AD is at their lowest moment, caregiving
can be particularly challenging. All of this can have an impact on caregiver satisfaction.
The conceptual model included the impact that caregiver satisfaction from the
perspective of the CNAs would have on the care of residents in the nursing facilities.
Caregiver satisfaction is the alternative to caregiver fatigue (Figley, 1995). Figley
states that caring comes with a cost that can manifest in a negative way that includes
fatigue (Figley, 1995). Therefore, fatigue often is the direct result of trauma and stressrelated exhaustion that occurs in helping professions such as that of CNAs (Sabo, 2006).
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This is particularly true as the caregiver’s life becomes more intertwined with the
individual that they are providing care to and can intensify based on the circumstances.
For example, caregivers can experience secondary trauma based on the individual’s
circumstances (Sabo, 2006). Fatigue can be related to many of the activities that nursing
aides are faced with, including providing care to persons with AD when they are not
adequately educated with tools and techniques to help in this care. This fatigue can
contribute to negative care for persons with AD, particularly if the CNA does not have
the adequate skills to cope with their feelings. Adequate skills, in this context, are those
skills that are needed to provide a truly compassionate approach to caregiving. Thus,
caregiver satisfaction is achieved when the CNA is equipped to deal with the exhaustion
and stress that is accompanied by the process of providing care to persons with AD.
Satisfaction is not limited to the opposite of compassion fatigue. Satisfaction also
includes the feelings of reward that are often accompanied by caregiving. Thus, for
caregivers, there is also this understanding that while caregiving can be burdensome and
difficult, that it also provides a rewarding experience.
Changes in Affiliate Stigma. Stigma is defined as an “attribute, behavior, or
reputation which is socially discrediting in a particular way: it causes an individual to be
mentally classified by others in an undesirable, rejected stereotype rather than in an
accepted, normal one” (Erving Goffman, 1986). Goffman described not only the
stigmatization that persons with disabilities, such as AD suffer, but also the stigma that
extends to persons that associated with stigmatized persons; this is known as affiliate
stigma.
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It has been shown that caregivers and family members experience stigma and both
function and wellness are affected (Kahn, Wishart, Randolph, & Santulli, 2016).It has
also been found that stigma by association related to AD is especially high in the delivery
of services and in the lives of persons with AD (Werner & Heinik, 2008). The purpose of
the compassionate care curriculum was to contribute to a decrease in the affiliate stigma
of the CNAs.
Moderator Variable. The curriculum served as the moderator variable in this
study. The control group continued with their traditional care and the experimental group
engaged with the compassionate care curriculum.
Traditional Curriculum. The control group received no additional training and
continued with care per norm. This included providing residents with AD basic nursing
care. All CNAs went through the mandatory certification program which included 75
hours of basic nursing care and had participated in Hand in Hand training through CMS
(Kentucky Adminstrative Regulations, 2006; Patient Protection and Affordable Care Act,
2010). As it is mandated that basic nursing care is supplemented with 12 hours of training
each year, CNAs at the control facility participated in required training on topic areas
such as lifting, toileting, administering medication, and other areas that would assist them
in providing the task-specific areas of basic nursing care.
Compassionate Care Curriculum. The development of the curriculum followed a
problem-based learning approach (Barrows & Tamblyn, 1980), presented in a format that
allowed for collaborative adult learning to take place (Schapiro, 2003), within the context
of on-the-job learning (Khan, Khan, & Khan, 2011). Problem-based learning has two
fundamental assertions: 1) learning through problem-solving is more effective for

91

creating a body of knowledge usable in the future than traditional memory-based
learning; and 2) health team skills most important for patients are problem-solving skills,
not memory skills (Barrows & Tamblyn, 1980). Adult learning is guided by the
assumptions that for learning to be meaningful and significant, it should be self-directing,
draw on past and present experiences as a resource for learning, address problems, and
situations learners are currently facing, be based in relationship and in community, and be
both a cognitive and an affective experience (Schapiro, 2003). On-the-job learning is
focused on supporting the organization to increase performance and develop workers that
will be satisfied with their jobs and stay in the job for a longer period of time (Khan et
al., 2011).
The content was presented in an online modular format, starting with didactic
overviews, and then followed by case studies to highlight the content. Eight online
modules were developed that focused on three primary areas: 1) the disease and its
impact; 2) compassionate caregiving for persons with Alzheimer’s disease; and 3) caring
for the caregiver. For all CNAs that participated in the study, it took approximately 8
hours spread out across one week for the modules to be completed.
After the completion of the online modules, all CNAs participated in hands-on
learning and support, by participating in compassionate care groups. These groups were
held at the nursing facility where the CNAs were employed in order to receive additional
on-the-job support. Each hour-long group session began with a brief didactic focused on
a set of difficult behaviors the CNAs in the facility decided they needed the most help
with. As part of the brief 15-minute didactic presentation, interventions were discussed
that could be used to address these behaviors. The rest of the hour was used to discuss
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specific residents who were demonstrating these behaviors. Strategies that could work for
the specific residents were explored in the context of group learning where everyone
contributed to the discussion and provided insight. A specific behavior management care
plan for the residents discussed was then written up and shared with all CNAs. During the
first month, these groups were held twice a week at different times to allow for as many
CNAs to participate as possible. The next two months, these groups were held once a
week on different days, again to allow for as many CNAs to participate as possible.
These compassionate care groups allowed for the development of a strong care
community within the nursing home and better collaboration between CNAs in the
coordination of care for persons with AD at the facility.
Outcome Variables. The following are the two outcome variables in the
conceptual model defining the stress of persons with AD.
Stress of Person with AD: Agitation. The model culminates in an examination of
the stress of the person with AD living in the nursing facilities and receiving care from
CNAs. Stress of the person with AD was measured by agitation and levels of salivary
cortisol. When a person with AD is stressed, this can manifest as agitation (Hooker et al.,
2002). Agitation is attributable to the stress a person feels as they begin to decline as a
result of the disease. Personhood is the very embodiment of the individual’s character,
and often with AD, this is stripped away, making it particularly difficult for caregivers to
deal with the AD patient. If a person with AD feels as though their needs are not being
met or if they are challenged to do certain tasks that make them feel uncomfortable, this
could result in anxiety. Take, for example, a resident that no longer prioritizes showering
or bathing. When they were fully functioning, prior to the disease, this was more than
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likely a priority and part of their activities of daily living. However, as the disease
progresses, they might no longer value participation in this activity. Or the act of taking a
shower or bath might be so physically difficult for them that they might fear participation
in this activity. If the individual is pushed to engage in this activity, this could cause
anxiety that results in negative behaviors. Thus, the purpose of the CC curriculum was to
generate a decrease in stress for the resident by introducing a more compassionate
approach rather than forcing the individual to engage in the activity because of technical
and administrative procedural rules.
Stress of Person with AD: Salivary Cortisol. Lastly, levels of salivary cortisol
were measured in the person of AD. Cortisol is an essential hormone in the regulation of
the stress response along the hypothalamic-pituitary-AD renal (HPA) axis, and salivary
cortisol has been used as a measure of free circulating cortisol levels (Maruyama et al.,
2012; Smith & Vale, 2006). Measuring cortisol levels in persons with AD has been
established as a way to better understand the stress that the person is undergoing on a
biological level (Woods et al., 2008). As a biomarker, salivary cortisol is a simple and
non-invasive way of measuring a persons’ level of stress. Salivary cortisol testing has
been a successful way to measure emotional variables in patients with AD (de la Rubia
Orti et al., 2018).
Summary
This chapter provided an overview of the literature that was relevant to the
primary components of this dissertation. Overviews of established theoretical
perspectives were discussed as it pertains to persons with AD, CNAs that are providing
care to persons with AD and theories of learning to assist in the development of the
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project. Furthermore, a hypothetical, theoretical model was developed to conceptualize
the theories and how they will impact stress for persons with AD living in nursing
facilities.
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CHAPTER III: METHODOLOGY
The aim of this study was the implementation and evaluation of a newly
developed CC curriculum for CNAs. This chapter focuses on the methodology of the
study. In order to evaluate the effectiveness of the compassionate care curriculum, the
study was broken down into two parts. The first part of this study focused on the
evaluation of CNA training in nursing facilities, specifically the first three levels of
Kirkpatrick’s model, namely Reaction, Learning, and Behavior. The second part of this
study focused on level four of the Kirkpatrick model, which examined results in the form
of the stress outcomes of residents with AD.
Study #1: Evaluation of the Compassionate Care Curriculum (Kirkpatrick
Levels One, Two, and Three)
Research Design and Hypothesis
Study #1 utilized a quantitative pre-post control group design to examine changes
in CNAs knowledge, self-efficacy, caregiver satisfaction and affiliate stigma over a 12week period. The experimental group was exposed to the newly developed compassionate
care curriculum, with the control group being exposed to the standard curriculum that is
currently used in Kentucky. The following specific aim and research hypothesis guided
study #1:
Aim 1: To determine if the CNA compassionate care curriculum for nursing home
residents with AD is better than the current standard curriculum to increase the following
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attributes of CNAs: knowledge of AD, caregiving self-efficacy, feelings of caregiving
satisfaction, and feelings of affiliate stigma.
Hypothesis 1: After completion of the CNA compassionate care curriculum by the
experimental group, CNAs will show a significantly higher increase in knowledge,
caregiving self-efficacy, caregiving satisfaction and a significantly higher reduction in
feelings of affiliate stigma than the CNAs who completed the current standard curriculum.
Sample
This study included an experimental facility and a control facility in Kentucky,
both part of Signature HealthCARE which is a healthcare and rehabilitation company
with 118 locations in 10 states and over 17,000 employees. Both facilities were urban,
with the experimental facility located in Jefferson County, and the control facility in
Fayette County. Both were small size nursing facilities. According to the CMS quality
measures, both the experimental and control facility scored 4 out of 5 on staffing at
baseline. For quality of resident care, both facilities scored 4 out of 5 at baseline. Neither
facility had any penalties for the past 3 years. All CNAs at these two facilities who took
care of the residents with AD that took part in the study were included in the sample for a
total of 99 CNAs, 48 in the experimental group and 51 in the control group.
Measures
Demographics. The following demographics of CNAs were collected to ensure
equivalency between the CNAs in the experimental and control groups:
Age. The age of the CNA.
Gender. The gender of the CNA.
Race/Ethnicity. The race/ethnicity of the CNA.
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Years of experience working in nursing facilities. The number of years that the
CNA has worked specifically in nursing facilities.
Number of years’ experience in specified nursing facility. The number of years
that the CNA has worked in the current facility that is a part of the study.
Educational attainment. The number in years that the CNAs received formal
educational training.
Learner outcome measures. The following measures were used to examine
CNA learner specific attributes and changes:
Learner Satisfaction. The learner satisfaction survey was administered after the
completion of the curriculum program to determine CNAs satisfaction with the program.
This was only administered to CNA learners that were part of the experimental group.
The learning satisfaction survey consisted of 3 items, rated on a scale ranging from 1 (not
satisfied at all) to 5 (very satisfied).
AD knowledge. AD knowledge was measured using the AD Knowledge Scale
(ADKS). The ADKS is a 30-item, true/false scale and covers the following topic areas:
risk factors, assessments, and diagnosis, symptoms, course, life impact, caregiving,
treatment and management. Reliability for the ADKS has shown that reliability is
acceptable (test-retest correlation = .81; internal consistency reliability = .71) and has
been validated as a tool for assessing knowledge of all types of caregivers and in different
settings (Carpenter, Balsis, Otilingam, Hanson, & Gatz, 2009).
CNA Self-Efficacy. Self-efficacy was measured using the Nursing Assistants’
Self-Efficacy for Restorative Care Activities (NASERC). The NASERC is a measure that
determines nursing assistants’ confidence in performing restorative care activities in
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nursing home settings. This is a 10-item measure that was administered to CNAs after
they have completed the curriculum to determine their confidence in performing tasks in
working with residents with AD. Alpha coefficients for the NASERC ranged from .80 to
.91 (Resnick & Simpson, 2003).
Caregiving Satisfaction. Caregiving satisfaction was measured by the Revised
Caregiving Appraisal scale also known as the RCAS (Lawton, Kleban, Moss, Rovine, &
Glicksman, 1989). It measures the extent to which caregiving is a source of fulfillment
and self-esteem by examining the acceptance of subjective burden, caregiver satisfaction,
and caregiving impact. The reliability of the RCAS is high for the general population
(Cronbach alpha=.90).
Affiliate Stigma. Affiliate stigma was measured using the Affiliate Stigma Scale.
The Affiliate Stigma Scale emanates from Goffman’s understanding of stigma (Erving
Goffman, 1986). Affiliate stigma is defined as self-stigmatization that an individual faces
when they associate or affiliate with a stigmatized population (Mak & Cheung, 2008).
For CNAs, this is the feeling of the stigma that they feel by working with a marginalized
population. The Affiliate Stigma Scale contains three unidimensional domains: cognition
(7 items), affect (7 items) and behavior (8 items), rated on a 4-point Likert scale. A
higher score on the scale indicates a higher level of affiliated stigma. The use of this scale
to determine self-stigma with caregivers has been supported with a Cronbach alpha for
this population ranging between .85 and .94. (Chang, Su, & Lin, 2016).
Data Collection
At baseline, prior to the implementation of the curriculum, and after 12-weeks,
data were collected on the demographics of the CNAs along with their pre-test on AD
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knowledge, self-efficacy, caregiving satisfaction, and affiliate stigma for both the
experimental and control groups. At the 12-week period, after the curriculum and care
community meetings were implemented, data on AD knowledge, self-efficacy,
caregiving satisfaction, and affiliate stigma were collected again for both groups. During
this time, data were also collected on learning satisfaction, only for the CNAs in the
experimental group.
Power Analysis
An a priori power analysis was performed with G*Power (Faul, Erdfelder,
Buchner, & Lang, 2009) with the alpha level for the MANOVA analysis set to .05 and a
correlation of .50 to achieve power of .80 and a medium effect size, which suggested a
total sample size of 76 (38 in the experimental group and 38 in the control group) to
detect a significant model. For this study, we had 48 CNAs that were part of the
experimental group and 51 CNAs that were part of the control group for a total of 99
CNAs in the study. Therefore, we met the power requirement for the study.
Analysis
Analysis of this study used a repeated measures approach. This type of analysis is
appropriate when the same group of people are pre-tested and post-tested on a dependent
variable.
All data collected was examined for missing values, outliers and distribution
form, to determine if it would meet the assumptions of the appropriate tests for the
planned analysis. As this is a study utilizing a control group, it was first important to test
for equivalence between the two groups at baseline. Where appropriate, either Chi-square
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tests or independent samples t-tests were completed on all the demographic and
dependent variables at baseline.
After equivalency was tested, a two-way mixed design MANOVA was utilized to
examine how scores changed for all of the dependent variables after implementation of
the CC curriculum. A two-way mixed design MANOVA is appropriate when there is
both within-subjects and between-subject’s factors. For this study, the focus of the
analysis was to examine whether there was a significant difference over time (withinsubjects), whether there were differences between the control and experimental groups
(between-subjects), and whether there was an interaction effect between time and group,
indicating if the groups change differently over time.
For this study, there were two points of data collection: at baseline and 12 weeks
after the beginning of the curriculum and compassionate care group. There were four
dependent variables: knowledge of AD, self-efficacy of restorative care activities,
caregiving satisfaction, and affiliate stigma.
Study #2: Evaluation of the Compassionate Care Curriculum (Kirkpatrick Level
Four)
Research Design and Hypothesis
The second study examined the final element of the Kirkpatrick model, namely
stress levels of residents with AD. This study was conducted by testing a hybrid
multilevel growth model, as detailed in Chapter 2 Figure 10, with a three-nested level
structure. According to Singer and Willet (2003), a study examining growth over time
must include at least 3 waves of data collection. This study fulfills this requirement as it
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utilized data collected from residents with AD that looked at changes between baseline, 6
weeks and 12 weeks.
The outcome variable used in this model was operationalized as stress
experienced by residents with AD over a 12-week period. Stress was operationalized as
agitation and salivary cortisol levels. Therefore, the model was treated as a hybrid model
where the model was first built with agitation as the outcome variable of interest. After
this model was built, agitation was moved to a predictor and tested in the second model
where salivary cortisol levels became the outcome variable.
Multilevel modeling, many times referred to as hierarchical linear modeling, is an
appropriate statistical technique to analyze data that is clustered. Multilevel modeling
assumes that there is a hierarchical structure in the data set and that units of observation
fall into groups or clusters. For this study, the three clusters or levels were as follows:
level 1 referred to the three measurement occasions for each resident with AD, level 2
referred to the residents with AD, and level 3 referred to the CNAs providing care to the
residents with AD. Figure 13 illustrates the levels of the model. The advantage for using
multilevel modeling in data that is clustered like this is the ability to examine the distinct
effect of the predictors at each level, by allowing for the separation of the variance that is
occurring at each level.
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Figure 2. Data Structure
Traditional multilevel modeling is used to analyze data that is purely hierarchical
in nature meaning that each lower-level unit belongs to a single higher-level unit (Chung
& Beretvas, 2012). However, this approach ignores the fact that often, longitudinal data
is not structured in a pure hierarchical way. Given that within each nursing facility,
residents with AD are cared for by many different CNAs, this is a multiple membership
model (Chung & Beretvas, 2012). In multiple membership models, the lower level units
do not belong to only one higher level unit. Instead, the lower level units are nested
within multiple higher-level units. Thus, the residents with AD were nested within the
CNAs. This specific type of multiple membership model is also referred to as a two-way
cross-classified data structure. It is important to note that in multiple membership models,
data will vary dependent on the degree to which the lower level units belong to the
higher-level units.
In clustered data, it is important to account for dependence or correlation among
responses in the same unit or cluster. Utilizing multilevel modeling allows this
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dependence or correlation to be explicitly modeled. One primary difference between
multilevel modeling and traditional regression analysis is that multilevel modeling allows
random effects such as random intercept and slopes or random coefficient for each unit.
Multilevel modeling can also make use of all available outcomes data in the estimation of
the model parameters because it treats time in a flexible manner (J. D. Singer & Willett,
2003). This is particularly important given the type of study subject, namely persons with
AD at the end of life. It was, therefore, possible to keep data from study participants,
even if circumstances might change and they had to end their participation within the 12week period of the study. However, all study participants were able to remain in the
study.
The study analysis followed a two-step approach. As part of step 1, we identified
an aim 1 that focused only on a two-level multilevel structure where measurement points
over time were identified as level 1 and persons with AD identified as level 2. The only
level 2 predictor that was added in the model was group status. This same analysis could
have been completed as part of a time series mixed ANOVA analysis where time is
treated as the within effect, and the group status is treated as the between effect.
As part of step 2, the researcher identified an aim 2 that focused on a three-level
cross-classified structure where level 1 and level 2 stayed the same as in step 1. However,
in this step, level 3 was added and included the impact of the CNAs on the outcome
variables connected to the residents. This type of analysis can only be completed in a
multilevel model environment. The reason for this two-step approach was to illustrate the
power of multilevel modeling in this type of dataset where data from both residents and
CNAs need to be considered for a complete understanding of change in the outcome
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variable. Not only can the effect of changes in CNA knowledge, self-efficacy, caregiver
satisfaction, and affiliate stigma be evaluated without any variance constraints but also
CNA impact on each individual resident can be weighted according to the time spent with
each resident over the 12-week period.
The following research hypotheses were tested, which captured the multilevel
growth aspects of the CNAs and persons with AD. Aim 1 focused on the two-level
multilevel structure while aim 2 focused on the three-level cross-classified model.
Aim 1: To determine if residents with AD from an experimental nursing facility differ in
their stress levels from residents with AD from a control nursing facility, after the
implementation of a compassionate care curriculum in the experimental nursing facility.
Hypothesis 1a: Residents with AD from the experimental nursing facility will have a
different 12-week agitation change trajectory than the residents with AD from the control
nursing facility.
Hypothesis 1b: Residents with AD from the experimental nursing facility will have a
different 12-week salivary cortisol change trajectory than the residents with AD from the
control nursing facility.
Aim 2: To determine if differences in change in CNAs knowledge of Alzheimer’s
disease, caregiver confidence, caregiver satisfaction, and stigma will have a differential
effect on the 12-week stress trajectories of residents with AD in the experimental and
control nursing facilities. For the hypotheses related to aim 2, the background
characteristics for CNAs and residents with AD were controlled for, when the model
required it.
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Hypothesis 2a: Differences in change in CNAs knowledge, confidence, satisfaction and
affiliate stigma will have a differential effect on the 12-week agitation trajectories of
residents with AD in experimental and control nursing facilities.
Hypothesis 2b: Differences in change in CNAs knowledge, confidence, satisfaction and
stigma and differences in residents with AD agitation will have a differential effect on the
12-week salivary cortisol trajectories of residents with AD in experimental and control
nursing facilities.
Sampling
The CNA sample for study #2 included all the CNAs that took part in study #1.
The resident sample for study #2 was drawn from residents with AD in the two nursing
homes where the CNAs worked. In the experimental facility there was a total of 50
residents with AD, and in the control facility, there was a total of 45 residents with AD.
The sample from each nursing home included a convenience sample of 25 residents from
the experimental group and 27 residents from the control group, for a total of 52 residents
from both nursing homes. The selection of participants was based on their availability
and the willingness of their caregiver or legal authorized representative to consent to their
participation. For the purposes of selecting the sample, Rapid Cognitive Screening (RCS)
was used. As described in the measures section, this screening tool score is between 0
and 10, with 0 indicating severe dementia and 10 indicating normal cognitive
functioning. The original intention of using the RCS was only to include residents that
scored 0-5 (indicating dementia) on the RCS. However, in our control group, there was
one individual that scored a 6. After further discussion with the facility, it was determined
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that this individual would remain a part of the study sample, due to concerning behavior
manifestations.
Power Analysis
In multilevel modeling, there exist sample size requirements for each level of the
model (Snijders, 2005). In terms of power, while higher samples sizes at all levels are
important, the primary concern is the sample size at the highest level. Power for level 1
depends on the number of measurement occasions, while power for level 2 depends on
the number of residents with AD, and power for level 3 depends on the amount of CNAs
that participate (Snijders, 2005).
Statistical power concerns in multilevel modeling are complicated as the power
differs for fixed effects vs. random effects as a function of effect size, intraclass
correlation, and the number of groups and cases per group (J. Cohen, Cohen, West, &
Aiken, 2003). With the significance level set at 0.05, the intra-class correlation at a small
size of 0.05, which is recommended for health and mental health research (Spybrook,
Raudenbush, Liu, Congdon, & Martinez, 2008), the model wanted to detect at least a
medium effect size (0.04) and achieve at least 80% power. At the highest level of the
model, at least 20 units were needed for adequate power (Kreft & De Leeuw, 1998). For
this study, level 3 (CNAs) included 99 CNAs, meeting the main requirement for power.
Level 2 (residents) included 52 residents and level 1 (time) had 156 measurement
occasions.
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Operationalization of variables
The variables included in this study were provided a priori as part of the
development of a conceptual framework that was delineated in Chapter 2. In this chapter,
the variables are operationalized.
Control variables. To focus solely on the impact of enhanced training on the care
of residents with AD living in nursing facilities, a variety of control variables formed part
of the study. These variables were divided into segments that focus specifically on CNA
characteristics and the characteristics of the persons with AD.
Nursing Aide Characteristics. The same CNA demographics that were described
in Study #1 were used as control variables in this study, namely: age, gender,
race/ethnicity, years of experience as a CNA, number of years’ experience in specified
nursing facility and number of years of formal education.
Residents with AD Characteristics. The following characteristics of the residents
with AD were controlled for:
Age. The age of the residents with AD.
Gender. The gender of the residents with AD.
Race/ethnicity. The race/ethnicity of the residents with AD.
Cognitive Functioning. Cognitive functioning was measured by the Rapid
Cognitive Screen (RCS), a brief screening tool consisting of 5 questions that is used in a
variety of settings for the detection of cognitive impairment (Malmstrom et al., 2015).
Scores on the RCS range from 0 -10, with 0 indicating severe dementia and 10 indicating
normal cognitive functioning. A score between 0-5 indicates dementia, a score between
6-7 indicates mild cognitive impairment, and a score between 8-10 indicates normal
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cognitive functioning. The RCS includes 3-items from the St. Louis University Mental
Status (SLUMS) exam, which is a commonly used assessment tool for determining
cognitive decline. Validation studies show that the RCS predicts dementia with a
sensitivity of 0.89 and a specificity of 0.94 (Malmstrom et al., 2015).
Predictor Variables. The following training related CNA variables have been
noted to impact the stress of residents with AD. The CNA predictor variables included
changes in AD knowledge, self-efficacy, caregiving satisfaction, and affiliate stigma. All
these variables were operationalized as part of Study #1.
Moderator Variable. The moderator variable was defined as the following
between the experimental and control groups.
Traditional Curriculum. This included all of the basic nursing care curriculum
and training that CNAs received in the control group.
Compassionate Care (CC) Curriculum. In addition to the basic nursing care
training that all CNAs receive, the CC curriculum focused specifically on AD and
consisted of 8 online modules and participate in the care groups. All the CNAs in the
experimental group participated in the CC curriculum.
Outcome Variables. The following measures were utilized to determine if there
was a reduction of stress for residents with AD.
Agitation. The Cohen-Mansfield Agitation Inventory (CMAI) was used to
measure agitation. This rating inventory was developed in 1986, consisting of 29 agitated
behaviors each on a 7-point scale. The CMAI has been used in nursing home settings
(Cohen- Mansfield, Marx, & Rosenthal, 1989).The CMAI is considered a reliable scale
with a Cronbach’s alpha score of .92 (Zare, Shayeghian, Birashk, & Afkham, 2012).
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Subscales include disruptiveness, aggressive behavior, physically non-aggressive
behavior and verbally non-aggressive behavior (Whall et al., 1999). Each person’s
subscale scores can be combined into a total score (Whall et al., 1999). For the purposes
of this study, a total score was used. On the CMAI, scoring ranges from a 1 indicating
that the behavior has never occurred to a 7 indicating that the behavior occurs several
times an hour.
Salivary cortisol levels. Salivary cortisol has recently emerged as a novel
biomarker for psychosocial stress responsiveness within the sympathetic
adrenomedullary (SAM) system (Maruyama et al., 2012; Smith & Vale, 2006). The
literature supports the use of these tests in that it is relatively inexpensive and noninvasive when compared to other biomarker testing. Salivary cortisol levels were
collected using a testing kit from Peak Biometrics (PeakBiometrics, 2018). The kit
utilized a smartphone and adaptive equipment that quickly analyzed each sample on site.
Data Collection
The same data that were collected from CNAs during study #1 was used for study
#2. For the residents with AD, data were collected at baseline that included the resident
demographics, CMAI scores, and cortisol levels. The demographics of the residents were
collected from the nursing facility administration. As the CMAI is an inventory that uses
a rating scale, CNAs that worked with the residents that were part of the study were
asked to complete the measure based on the resident’s behaviors. The facility
administrator determined which CNA would be the most appropriate person to complete
the inventory. The same CNA was used to complete the CMAI at baseline, six weeks and
12 weeks after the implementation of the curriculum. For the cortisol testing, each

110

resident’s saliva was collected using a salivette that the resident was able to bite onto and
produce a small amount of saliva. The salivette was then placed in a secured Ziplock bag
labeled with the resident’s confidential ID and no other identifying information. After
samples were collected from each resident participating in the study, the samples were
analyzed at the facility. The analysis involved taking the saliva sample and piping it on to
a test strip. The test strip was then placed in a smartphone reader that was connected to an
iPhone with an app designed by Peak Biometrics to read the cortisol levels from the test
strip. After the read-out was produced from the app, the sample was discarded onsite in
one of the facility’s biohazard containers.
Analysis
Initial descriptive analysis of the data was conducted using IBM SPSS Statistics
25. To prepare the data for analysis, the data were organized into three files that included
the following: the CNA data, the resident data and another file that included the weights
for the amount of time each CNA worked with each resident. To correctly fit the CNA
data to the resident data, it was important to track the proportion of time each CNA
worked with each resident. Therefore, each resident with AD had 5 columns (the
maximum number of CNAs working with one resident) reserved containing the
identification codes for each CNA that provided care along with a proportion of time
spent with the resident. These proportions were referred to as weights. The data were
collected from the facility administrators.
The three files were merged into one file and then restructured to a vertical file,
where each resident in the study had multiple cases in the file that represented each
measurement occasion where data were collected. Final model variables in the vertical
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file were inspected for the form by inspecting the distribution of CNA-level and residentlevel variables. The data were then analyzed with MLwiN 3.2, a program designed
specifically for this type of analysis (Rabash, Steele, Browne, & Goldstein, 2009).
Model fit was accomplished with Bayesian modeling. First, Iterative Generalized
Least Squares (IGLS) was used, followed by Markov Chain Monte Carlo (MCMC)
estimation to estimate a baseline (Kreft & De Leeuw, 1998). MLwiN utilizes a
Metropolis Hastings sampling method to sample diffuse preceding distributions. For the
chains to converge to the distribution of interest, a burning period was used. The chains
were then a dependent sample of values from the distribution of interest. In accordance
with using Markov chain Monte Carlo (MCMC) estimation, a burn-in of 500 and a chain
of 20,000 (Chung & Beretvas, 2012) were used. As a result of dependence, a suggested
effective sample size (ESS) of 250 is a statistical convention for model convergence
(Steele, 2008). With the 20,000 chain, the ESS of 250 was met.
After the data was restructured, aim 1 and aim 2 were met by first building a twolevel model (Model 1a and 1b) and then building a three-level model (Model 2a and 2b).
Both these models were developed using a random intercept model. The following steps
were used: a) Fitting the unconditional model which described the level of
agitation/saliva cortisol across all residents (Model 2Aa and 2Ab); b) fitting the
unconditional growth model depicting the extent of agitation/cortisol across all residents
across time (Model 2Ba and Model 2Bb); c) fitting the main effects to explain the
changes in the dependent variables (Model 2Ca and Model 2Cb); and d) fitting the
interaction effects of time with the main effects to explain the change over time (Model
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2Da and Model 2Db); To create a parsimonious model, control variables and predictor
variables that did not contribute to the model were removed.
Human Subjects Protection
The study was approved by the Institutional Review Board at the University of
Louisville, as well as the Signature Healthcare research committee. The approved
informed consent and assents contained detailed information about the study, the possible
risks and benefits and the amount of time it would take to complete the survey. The study
did not involve the use of deception, drugs or devices, covert observation, special
participant populations, induction of mental and/or physical stress, procedures that may
cause physical harm to the participant, issues commonly regarded as socially
unacceptable, or procedures that might be regarded as an invasion of privacy.
At the beginning of the program, at the experimental nursing facility, prior to
starting the implementation of the curriculum, a member of the research team took as
much time as needed to explain the informed consent to the CNAs and then had them
sign the document. A copy of the informed consent was provided to each CNA. The
process was the same for CNAs at the control nursing facility. The exception was that
they did not receive the curriculum and they were only asked to participate in the surveys.
For the residents with AD, an assent was used. The study was explained to the
resident prior to the beginning of the study. Due to the nature of the residents
participating in this study, the study was explained again at the beginning of each session.
When a resident with AD could not verbalize their consent, a member of the research
team contacted the legally authorized representative (LAR). The LAR was a member of
the resident’s family. The LAR was asked to participate in the informed consent
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procedures. The same procedure was used to explain the study to the LAR that was used
to explain the study to the participants. It was explained to all participants that they were
not going to be compensated for their participation. They were also told that they might
withdraw from the study at any time without penalty.
Once data were collected from a participant, a unique identifying number was
assigned to the participant at the time of enrollment in the study, to ensure confidentiality.
Data from this study were not shared outside of the research team.
All methods of data collection were done at the convenience of the participants in
the project. The risks involved in this study were minimal. However, they were
addressed. The term “risk” refers to psychological or physical injury, social, legal, and
financial harm (Dunn & Chadwick, 1999). For the CNA, participation in the curriculum
and care groups could have contributed to emotional discomfort. The expectation was
that the curriculum and participation in care groups would contribute to more quality
care, however, it could have the unintended consequence of making the CNAs more
aware of limitations in their skill set. Furthermore, there was a risk that someone might
have felt uncomfortable answering one or more questions on the surveys that were part of
the study. For the residents with AD, obtaining their saliva for cortisol testing could have
caused discomfort and additional stress, depending on where they were at in the
trajectory of the disease and their behaviors.
Summary
This chapter delineated the methodological approach and analysis plan for the two
studies through a discussion of the research questions, the research design, sampling,
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operationalization of measures, and the methods of analysis. The following chapter will
detail the results of the two separate studies delineated in this chapter.
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CHAPTER IV: RESULTS
The aim of this dissertation study was to examine the impact of the
implementation of a new CC curriculum on the quality of care provided by CNAs to
residents with AD. More specifically, the study used Kirkpatrick’s model of evaluation to
assess the reactions, learning, and behavior change of the CHNs exposed to the
curriculum, and ultimately the impact of the curriculum on the stress levels of residents
with AD.
Findings related to the following research aims are described in this chapter:
Study #1, Aim 1: To determine if the CNA compassionate care curriculum for nursing
home residents with AD is better than the current standard curriculum to increase the
following attributes of CNAs: knowledge of AD, caregiving self-efficacy, feelings of
caregiving satisfaction, and feelings of affiliate stigma; Study #2, Aim 1: To determine if
residents with AD from an experimental nursing facility differ in their stress levels from
residents with AD from a control nursing facility, after the implementation of a
compassionate care curriculum in the experimental nursing facility; Study #2, Aim 2: To
determine if differences in change in CNAs knowledge of Alzheimer’s disease, caregiver
confidence, caregiver satisfaction, and stigma will have a differential effect on the 12week stress trajectories of residents with AD in the experimental and control nursing
facilities. This chapter describes data preparation activities and preliminary analysis,
describes the study sample, details the model building process and presents the results.
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Data Preparation and Preliminary Analyses
Data Screening
Data was screened for missing values and outliers. As MLwin cannot handle
missing data, all data was checked to ensure that there was no missing data from each
file. All data necessary from each research participant (both CNAs and residents) were
collected. Therefore there was no need to take any further actions related to missingness.
No outliers were detected.
Creating one horizontal data file
All data from the study were entered into three separate SPSS files. The first
SPSS horizontal file contained the data from the residents with AD. A horizontal file is
structured in a way where one participant has one row in the file with all the data over
time presented on the one row with different labels indicating the different time periods.
The resident file included the control variables (age, gender, ethnicity, and rapid
cognitive screening scores) along with the outcome variables (agitation and cortisol
levels). The residents with AD data file was used to describe the resident sample.
The second horizontal file contained the CNA specific data and included the
control variables (number of years working in nursing facilities, number of years working
in the specific nursing facility, gender, age, and ethnicity) and the predictor variables
(knowledge, self-efficacy, stigma, and caregiving satisfaction). The CNA file was used to
answer the questions related to Study #1, and also to describe the CNA sample.
The third horizontal file contained the CNA weights. The most CNAs one
resident with AD were exposed to, were five. Therefore, in the CNA file, five variables
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were created, namely, CNA1, CNA2, CNA3, CNA4, and CNA5. The weights
represented the proportion of exposure time each CNA had with each resident.
For the purpose of matching the data, the resident participant ID was used as the
common identifier in all of these horizontal files. Then, the separate data files were
merged through an iterative merging process. First, the resident file was merged with
CNA weights. Then the CNA file was merged with the combined resident CNA weight
file. This last process was a complicated procedure due to the fact that for each resident,
data on the CNA predictor and controls had to be calculated as proportional data based on
the CNA weights.
Creating the vertical data file
After the horizontal file was merged, it was necessary to develop a vertical file
because multilevel modeling requires that data be arranged in a vertical format.
Therefore, the horizontal data file was restructured to a vertical data file with multiple
rows for each measurement occasion. Essentially, this means that the vertical file was
comprised of fewer columns but had more rows than the previous horizontal file.
The vertical data file had five types of variables: 1) level identifiers for
measurement occasion (level 1), residents with AD (level 2), and CNAs (level 3); 2) time
indicator with values from zero to two denoting baseline, 6-week and 12-week data; 3)
control variables for both the residents with AD and the CNAs; 4) CNA predictor
variables that included group status, change scores in knowledge, self-efficacy, stigma
and caregiving satisfaction; and 5) resident outcome variables that included agitation and
salivary cortisol levels. The final file included 156 Level 1 units (measurement
occasions) for 52 Level 2 units (residents) being care for by 99 Level 3 units (CNAs).
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Description of Sample
The following is an overview of the sample that was part of the study. First, the
sample of the CNAs is described after which the sample of residents with AD is
described.
Certified Nursing Assistants
Demographics. In order to test the assumption of equivalency between the
experimental and control groups, the demographic variables were compared to each other
with either an independent sample T-test or a Chi-square test. Table 2 provides an
overview of the two groups in terms of age, race/ethnicity, gender, number of years
working in nursing facilities, number of years working in the current facility, and number
of years of formal education.
Table 2
Comparison of demographic variables (CNAs)
Experimental
Mean (SD)/f
34.66 (7.24)

Control
Mean (SD)/f
31.93 (6.02)

45
3

t/ χ2
2.25

P value
0.01

51
0

3.28

0.11

8
37
3

9
41
1

1.17

0.55

# of years working
in nursing facilities

6.29 (4.56)

4.55 (3.24)

2.20

0.03

# of years working
in current facility

1.97 (1.29)

1.86 (1.46)

0.38

0.70

# of years of formal
education

12.27 (0.67)

12.21 (0.57)

0.44

0.66

Age
Gender
Female
Male
Race/Ethnicity
Black
White
Hispanic

119

From Table 2 it is clear that the control and experimental groups were similar on
most demographic variables except for age and the number of years working in a nursing
facility. The experimental group was older and worked longer in nursing facilities than
the control group. During model testing, specific attention was given to these two
variables to investigate if they significantly contributed to the variability in the outcome
variables.
Outcome Variables (Study #1). Table 3 shows the comparison of the outcome
variables in Study #1 between the two groups at baseline, using independent sample ttests. As previously denoted, these scores were standardized using a z-score to make for
more efficient comparison.
Table 3
Comparison of outcome variables at baseline (CNAs)

AD Knowledge
Self-efficacy
Caregiving
Satisfaction
Affiliate Stigma

Experimental
Mean (SD)/f
19.58 (3.89)
5.71 (1.19)
3.02 (0.68)
2.89 (0.29)

Control
Mean (SD)/f t/ χ2 P value
20.58 (4.08) -1.25
2.14
5.72 (1.20) -0.36
0.97
2.71 (0.62)
2.93 (0.25)

2.35
-0.63

0.21
0.52

There were no significant differences between the control and experimental group
on their AD knowledge, self-efficacy, caregiving satisfaction or affiliate stigma at
baseline.
Residents with AD
Demographic variables. The same equivalency tests were needed to compare the
demographic variables residents with AD in the experimental and control groups, using
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independent samples T-tests and Chi-Square tests. Table 4 provides an overview of the
two groups in terms of age, race/ethnicity, gender, and their rapid cognitive scores.
Table 4
Comparison of demographic variables (Residents with AD)
Experimental
Age
Gender
Female
Male
Race/Ethnicity
Black
White
Rapid Cognition

Control

Mean (SD)/f
78.47 (7.26)

Mean (SD)/f
77.09 (6.01)

t/ χ2
0.74

P
value
0.46

19
8

18
7

0.17

1.00

6
21

3
22

0.95

0.69

2.26 (1.60)

2.76 (1.30)

-1.22

0.22

There were no statistically significant differences between the two groups on any
of the demographic variables.
Outcome Variables (Study #2). Table 5 shows the comparison of the outcome
variables from Study #2 for the residents with AD at baseline, using independent samples
T-tests.
Table 5
Comparison of outcome variables at baseline (Residents with AD)

Agitation
Salivary Cortisol

Experimental
Mean (SD)/f
132.40 (14.67)
0.13 (1.03)

Control
Mean (SD)/f
133.12 (10.44)
-0.14 (.94)

t/ χ2
-0.2
0.98

P value
0.84
0.33

There were no significant differences between the control and experimental group
on the agitation of residents with AD as well as their salivary cortisol levels.
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Description of CNA Workload.
For the CNAs, an overview of the number of residents that were cared for by each
CNA and the proportion of time that was spent with each resident with AD is showed in
Table 6.
Table 6
Total Number of Residents Cared for by CNA

CNA ID
CNA 6
CNA 7
CNA 8
CNA 10
CNA 13
CNA 15
CNA 17
CNA 22
CNA 24
CNA 38
CNA 1
CNA 2
CNA 3
CNA 4
CNA 5
CNA 9
CNA 11
CNA 12
CNA 14
CNA 16
CNA 20
CNA 26
CNA 28
CNA 30
CNA 32
CNA 34
CNA 35
CNA 36
CNA 37
CNA 39
CNA 40
CNA 41
CNA 42
CNA 43
CNA 44
CNA 45

Experimental Group
Total Number of
Patients cared for by
Residents Cared
CNA weighted by
for by CNA
time
3
0.77
3
0.38
3
0.78
3
0.53
3
0.71
3
0.70
3
1.05
3
0.44
3
0.74
3
1.79
2
0.67
2
0.66
2
0.62
2
0.90
2
0.44
2
1.00
2
0.9
2
0.33
2
0.98
2
0.50
2
0.56
2
0.10
2
0.22
2
0.26
2
0.77
2
0.28
2
1.05
2
0.67
2
0.75
2
0.49
2
0.64
2
0.71
2
0.64
2
0.17
2
0.53
2
0.83
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CNA ID
CNA 84
CNA 68
CNA 74
CNA 81
CNA 83
CNA 86
CNA 95
CNA 49
CNA 50
CNA 54
CNA 55
CNA 58
CNA 64
CNA 70
CNA 72
CNA 80
CNA 82
CNA 85
CNA 87
CNA 88
CNA 90
CNA 92
CNA 51
CNA 52
CNA 53
CNA 56
CNA 57
CNA 59
CNA 60
CNA 61
CNA 62
CNA 63
CNA 65
CNA 66
CNA 67
CNA 69

Control Group
Total Number of
Patients cared for by
Residents Cared
CNA weighted by
for by CNA
time
6
3.00
3
0.72
3
0.6
3
0.61
3
1.22
3
1.68
3
1.39
2
0.47
2
0.48
2
0.46
2
0.87
2
0.77
2
0.34
2
0.41
2
0.30
2
0.33
2
0.78
2
0.80
2
0.77
2
0.65
2
0.07
2
0.23
1
0.23
1
0.10
1
0.33
1
0.33
1
0.34
1
0.18
1
0.43
1
0.23
1
0.48
1
0.16
1
0.36
1
0.31
1
0.19
1
0.31

CNA ID
CNA 46
CNA 47
CNA 18
CNA 19
CNA 21
CNA 23
CNA 25
CNA 27
CNA 29
CNA 31
CNA 33
CNA 48

Mean

Experimental Group
Total Number of
Patients cared for by
Residents Cared
CNA weighted by
for by CNA
time
2
0.31
2
0.18
1
0.84
1
0.35
1
0.52
1
0.23
1
0.19
1
0.30
1
0.06
1
0.15
1
0.33
1
0.37

2.00

0.56

CNA ID
CNA 71
CNA 73
CNA 75
CNA 76
CNA 77
CNA 78
CNA 79
CNA 89
CNA 91
CNA 93
CNA 94
CNA 96
CNA 97
CNA 98
CNA 99
Mean

Control Group
Total Number of
Patients cared for by
Residents Cared
CNA weighted by
for by CNA
time
1
0.07
1
0.76
1
0.06
1
0.23
1
0.35
1
0.22
1
0.17
1
0.15
1
0.06
1
0.25
1
0.45
1
0.46
1
0.19
1
0.38
1
0.50
1.63
0.49

The second and fifth columns in Table 6 is the total number of residents that each
CNA worked with and is irrespective of the proportion of each resident’s care that they
provided. The third and sixth column examines the number of residents with AD cared
for by each CNA this time weighted by the proportions of time spent with each resident.
We see that the number of residents cared for by CNA's in the study ranges from 1
resident to 6 residents. The majority of the CNA's provided care to one or two residents
that were in the study. We also see that the number of whole residents with AD by CNAs
range from 0.07 (CNA 71) to 3.00 (CNA 84).
Study #1: Evaluation of the Compassionate Care Curriculum (Kirkpatrick Levels
One, Two, and Three)
Study #1 focused primarily on the differences in the pre and posttest scores of the
experimental and control CNA groups, but also investigated the satisfaction of the CNAs
with the CC curriculum (Level 1 of Kirkpatrick’s model). The hypothesis for study #1
was as follows: After completion of the CNA compassionate care curriculum by the
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experimental group, the CNAs will show a significantly higher increase in knowledge,
caregiving self-efficacy, caregiving satisfaction and a significantly higher reduction in
feelings of affiliate stigma than the CNAs who completed the current standard
curriculum.
Satisfaction of CNAs with the CC curriculum
The satisfaction of the CNAs is shown in Table 7.
Table 7
Satisfaction of CNAs with CC curriculum

Overall, how satisfied were you with the Alzheimer’s disease curriculum?
Has this curriculum met your expectations?
Overall, how satisfied were you with the care groups?
Overall Mean

N
48
48
48
48

Mean
4.29
4.73
4.83
4.62

Overall, learners were generally satisfaction with the curriculum (mean=4.29,
SD=0.65) and the curriculum met their expectations (mean=4.73, SD=0.54). Learners
also reported the highest satisfaction with the care groups (mean=4.83, SD=0.38). The
overall mean across all of the satisfaction questions showed that learners were satisfied
with the compassionate care curriculum (mean=4.62, SD=0.41).
Differences between pre- and posttest
The multivariate test results of the two-way mixed MANOVA is shown in Table
8.
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SD
0.65
0.54
0.38
0.41

Table 8
Multivariate Test Results
Effect

F

Hypothesis df

Error df

Sig.

Partial Eta
Squared

Observed
Power

Between
Subjects

Group Effect

6.22

4

94

0.001

0.21

0.99

Within
Subject

Time Effect
Group*Time

24.48
23.59

4
4

94
94

0.001
0.001

0.51
0.50

1.00
1.00

The results of the two-way mixed MANOVA showed that there was a significant
between subjects group effect between the experimental and control groups, a significant
within subjects time effect between baseline and 12-weeks and a significant interaction
effect between group and time, showing a large effect size. The univariate test results for
the group effect, time effect, and group*time effect are shown in Table 9. Bonferroni
corrections were applied to the univariate effects (alpha level divided by 4 dependent
variables), resulting in adjusted alpha levels for interpretation purposes.
From Table 9 it is clear that all univariate group effects were significant,
indicating that groups were overall different on AD knowledge, self-efficacy, caregiving
satisfaction, and affiliate stigma. The effect size was small for all four variables.
Furthermore, the time effect showed that the sample changed significantly between pre
and post on all four dependent variables. The effect size for AD knowledge was large,
and for the other variables, the effect sizes were medium. The experimental and control
groups changed differently between pre- and posttest on all four dependent variables.
These differences are shown below in Figures 3-6.

125

Table 9
Univariate Test Results for MANOVA Analysis
Effect

Group Effect

Time Effect

Group*Time

Knowledge
Self-Efficacy
Caregiving
Satisfaction
Affiliate
Stigma
Knowledge
Self-Efficacy
Caregiving
Satisfaction
Affiliate
Stigma
AD Knowledge
Self-Efficacy
Caregiving
Satisfaction
Affiliate
Stigma

F

Hypothesis
df

Error Sig. Bonferroni Partial
df
(alpha Correction
Eta
level)
Squared

Observed
Power

3.09
4.21
8.13

1
1
1

97
97
97

0.08
0.04
0.01

0.02
0.01
0.003

0.03
0.04
0.08

0.41
0.53
0.81

4.67

1

97

0.03

0.01

0.05

0.57

45.72
19.48
27.21

1
1
1

97
97
97

0.001
0.001
0.001

0.0003
0.0003
0.0003

0.32
0.17
0.22

1.00
0.99
1.00

16.71

1

97

0.001

0.0003

0.15

0.98

49.09
24.96
1.67

1
1
1

97
97
97

0.001
0.001
0.20

0.0003
0.0003
0.05

0.34
0.21
0.02

1.00
1.00
0.25

25.31

1

97

0.001

0.0003

0.21

1.00

As shown in Figure 3 below, at baseline, the experimental group had slightly less
knowledge than the control group, although the difference was not significant. The AD
knowledge of the experimental group improved between baseline and 12-weeks. The
control group showed similar AD knowledge at the 12-week period than what they had at
baseline. The time*group interaction effect was significant with a large effect size.
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AD Knowledge
25
24
23
22
21
20
19
18
17
16
15

24.00

20.59

20.51

19.58

Baseline

12 Weeks
Experimental

Control

Figure 3. Interaction Effect Between Group and Time for AD Knowledge
10

Self-Efficacy

8
6

6.64
5.67

5.72
5.73

4
2
0
Baseline

12 Weeks
Experimental

Control

Figure 4. Interaction Effect Between Group and Time for Self-Efficacy
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The self-efficacy of the two groups were similar at baseline. The self-efficacy for
the experimental group improved between baseline and 12-weeks but deteriorated
slightly for the control group. The time*group interaction effect was significant with a
medium effect size.
At baseline, caregiver satisfaction was slightly higher for the experimental group
than the control group, although the difference was not significant. For both groups, there
was a slight improvement at 12-weeks in caregiver satisfaction. This improvement was
greater for the experimental group. The time*group interaction effect showed a trend
with a small effect size.
At baseline, the experimental group felt slightly less affiliate stigma than the
control group, although the difference was not significant. The feelings of affiliate stigma
for the experimental group declined between baseline and 12 weeks. For the control
group, it remained similar at the 12-week period than what they felt at baseline. The time
*group effect was significant, with a medium effect size.
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Caregiver Satisfaction
5
4
3.03

3.18
2.81

3
2

2.72

1
0
Baseline

12 Weeks
Experimental

Control

Figure 5. Interaction Effect Between Group and Time for Caregiver Satisfaction

Affiliate Stigma
5
4
3

2.93

2.95
2.76

2.90
2
1
0
Baseline

12 Weeks
Experimental

Control

Figure 6. Interaction Effect Between Group and Time for Affiliate Stigma
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Study #2: Evaluation of the Compassionate Care Curriculum (Kirkpatrick Level
Four)
Study #2 focused primarily on the impact of the compassionate care curriculum on the
stress levels of the residents with AD. The hypotheses for study #2 were as follows:
Hypothesis 1a: Residents with AD from the experimental nursing facility will have a
different 12-week agitation change trajectory than the residents with AD from the control
nursing facility; Hypothesis 1b: Residents with AD from the experimental nursing facility
will have a different 12-week salivary cortisol change trajectory than the residents with
AD from the control nursing facility; Hypothesis 2a: Differences in change in CNAs
knowledge, confidence, satisfaction, and affiliate stigma will have a differential effect on
the 12-week agitation trajectories of residents with AD in experimental and control nursing
facilities; Hypothesis 2b: Differences in change in CNAs knowledge, confidence,
satisfaction and stigma and differences in residents with AD agitation will have a
differential effect on the 12-week salivary cortisol trajectories of residents with AD in
experimental and control nursing facilities.
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Model Building
Both agitation and salivary cortisol levels were standardized for this analysis with
a mean of 0 and a standard deviation of 1, using the z-score formula. Standardizing
scores was to ensure ease of interpretation of the results and is a standard procedure in
MLWin.
Assessing the need for the multilevel model. An efficient way to initially assess
patterns of change in a study is to graph actual group trajectories for a sample of cases
and visually inspect them. For this sample, the whole sample was first graphed
collectively and compared between the experimental and control groups in terms of
trajectories for changes in agitation (Figures 7-8) and cortisol levels (Figure 9-10). (J. D.
Singer & Willett, 2003)

Figure 7. Collected growth trajectories for experimental group on agitation
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Figure 8. Collected growth trajectories for control groups on agitation
By looking at these collected growth trajectories, it visually appears that residents
with AD in the experimental facility where the compassionate care curriculum was
implemented reduced their agitation levels. However, the residents with AD in the
control facility showed agitation levels that were similar between pre and post
assessment, with slightly higher agitation levels at 6 weeks.
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Figure 9. Collected growth trajectories for experimental group on saliva cortisol levels

Figure 10. Collected growth trajectories for control group on saliva cortisol levels
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By looking at these collected growth trajectories it visually appears that residents
with AD in the experimental facility where the compassionate care curriculum were
implemented slightly reduced their salivary cortisol levels, peaking at the 6-week
assessment. Residents in the control facility showed a slight increase in their salivary
cortisol levels, also peaking at the 6-week assessment.
These growth trajectories were also individually plotted and visually inspected for
a random sample of 8 from each group. For agitation levels, experimental resident 2 and
experimental resident 3 started slightly higher than the control resident 2 and control
resident 3. Control resident 2-4 had a slightly flat trajectory compared to some of the
residents in the experimental group. Experimental residents 6-8 all started high and by the
6-week time period had agitation levels that decreased and then remained lower at the 12week time period. Control resident 6 is notable because their agitation levels increased
slightly from baseline to 12 weeks. For cortisol levels, experimental residents 15, 18 and
21 showed a sharp decline from baseline to 6-weeks and then showed a continued decline
at the 12-week time period. Experimental residents 16 and 17 remained slightly flat
across the baseline, 6 week and 12-week time periods. Control residents 15, 19, 20 all
showed a slight increase in cortisol levels. Control residents 16, 18 and 22 all showed a
slight decline in cortisol levels.
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Figure 11. Empirical growth plots for a sample of the study population
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Hypothesis 1a: Agitation. Hypothesis 1a focuses on the trajectories of residents
with AD in terms of agitation compared to the control group of residents with
Alzheimer’s disease, without taking into effect the impact the different nurses had on the
residents.
Unconditional Model. The first model (Model 1Aa) that was fitted was the
unconditional model which described the mean agitation score across all residents
irrespective of time. The following equation was used to fit this model.
ZAgitationij~N (XB, Ω)
ZAgitationij = β0ijCONSTANT
β0ij= β0 + u0j + e0ij

[u0j] ~N(0, Ωu) : Ωu = [σ2u0]
[e0ij] ~N(0, Ωe) : Ωe = [σ2e0]
Table 10 reveals the estimated intercept, variance components and model fit for
the two-level unconditional model using residents with AD at level 2, and measurement
points at level 1. There were 52 level 2 units, and 156 level 1 units.
Based on the intercept value, it is estimated that the mean resident with AD is
predicted a Z agitation score of 0.004. This estimate does not differ significantly from
zero and is expected as the response variable is approximately standardized and therefore
has a mean of approximately zero. The between resident variance is estimated at 0.39
(level 2), and the within resident variance is estimated at 0.63 (level 1).
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Table 10
Model 1Aa
Model 1Aa

Parameter
Fixed Effects
ZAgitation
CONSTANT

0.004 (0.11)

Random parameters
Level: Level 2 Resident
Var (CONSTANT)
Level: Level 1 Time
Var (CONSTANT)
DIC:
pD:
Note: Standard errors are in parentheses.
***p < 0.001; **p < 0.01; *p < 0.05; ~p<0.10

0.39 (0.13)
0.63 (0.09)
404.54
34.81

The intraclass correlation was calculated using the following formula:
BCC =
=
=

G
DEF
G
G
DEF
+ DHF

F.JK
F.JKLF.MJ

0.38

Based on the calculation the ICC is 0.38, suggesting that 38% of the variance in
agitation levels was between residents with AD. This supports the need for a multilevel
model which accounts for variance both between and within subjects.
The Defiance Information Criterion (DIC) is a likelihood-based measure for
comparing models. The DIC combines goodness of fit with model complexity (the
number of parameters), to allow for DIC values from different models to be compared
directly. The model with the lowest DIC is seen as the best model. If the DIC value
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decreases by approximately 10 points, the smaller value is considered to be a significant
improvement (Browne, 2009). The DIC for the unconditional model is estimated at
404.54. It is expected that with more variables added to the model, the between and
within variances will decrease, and the fit statistic will improve.
Unconditional Growth Model. The unconditional growth model (Model 1Ba) is
the unconditional model with the time variable added. It depicts the average agitation
scores over time across individuals. The formula used to fit this model, is shown below:
ZAgitationij~N (XB, Ω)
ZAgitationij = β0ijCONSTANT + β1Timeij
β0ij= β0 + u0j + e0ij

[u0j] ~N(0, Ωu) : Ωu = [σ2u0]
[e0ij] ~N(0, Ωe) : Ωe = [σ2e0]
In Table 11, Model 1Ba is added for comparison with Model 1Aa.
Table 11
Comparison of Model 1Aa and 1Ba
Parameter
ZAgitation
CONSTANT
Time

Model 1Aa
Fixed Effects
0.00 (0.11)

Random parameters
Level: Level 2 Resident
Var(CONSTANT)
0.39 (0.13)
Level: Level 1 Time
Var(CONSTANT)
0.63 (0.09)
DIC:
404.54
pD:
34.81
Note: Standard errors are in parentheses.
***p < 0.001; **p < 0.01; *p < 0.05; ~p<0.10
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Model 1Ba

0.46 (0.13)***
-0.45 (0.06)***

0.48 (0.13)
0.42 (0.06)
348.23
41.8

Adding time to the model resulted in an improved model fit (DIC = 404.54 for the
unconditional model versus DIC = 348.23 for the unconditional growth model). Model fit
was not possible with time as a random effect and had to be added as a fixed effect. With
time added to the model, the variance within individuals was reduced from 0.63 to 0.42,
but the variance between individuals increased 0.39 to 0.48, showing the need to explain
the differences between residents with AD with additional predictors, specifically the
intervention that is assumed to have a differential effect on the two groups in the sample.
Time was a significant predictor in this model.
Conditional Growth Model. The conditional growth model (Model 1Ca) added
group status as a predictor, using the following formula:
ZAgitationij~N (XB, Ω)
ZAgitationij = β0ijCONSTANT + β1Timeij + β2Experimentalj
β0ij= β0 + u0j + e0ij

[u0j] ~N(0, Ωu) : Ωu = [σ2u0]
[e0ij] ~N(0, Ωe) : Ωe = [σ2e0]
Table 12 compares the unconditional model with the unconditional growth model
and the conditional growth model.
Adding group status to the model resulted in an improved model fit (DIC =
348.23 for the unconditional growth model versus DIC = 328.94 for the conditional
growth model). For this model the within person variance stayed the same, but the
between person variance was almost all explained by group status. The model also shows
that group status was a significant predictor, with the experimental group having
significantly less agitation than the control group across time periods.
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Table 12
Comparison of Mode1 1Aa, Model 1Ba and Model 1Ca
Parameter

Model 1Aa
Model 1Ba
Fixed Effects

ZAgitation
CONSTANT
Time
Experimental

0.00 (0.11)

0.46 (0.13)***
-0.45 (0.06)***

Model 1Ca

1.09 (0.11)***
-0.45 (0.06)***
-1.23 (0.13)***

Random parameters
Level: Level 2 Resident
Var(CONSTANT)
0.39 (0.13)
0.48 (0.13)
Level: Level 1
Time
Var(CONSTANT)
0.63 (0.09)
0.42 (0.06)
DIC:
404.54
348.23
pD:
34.81
41.8
Note: Standard errors are in parentheses.
***p < 0.001; **p < 0.01; *p < 0.05; ~p<0.10

0.06 (0.05)

0.43 (0.06)
328.94
19.05

Conditional growth model with Interaction Effects. This final model (Model
1Da) added the interaction effects between group and time as a final way to account for
the intervention as the groups were hypothesized to change differently over time. The
following formula was used for this model:
ZAgitationij~N (XB, Ω)
ZAgitationij = β0ijCONSTANT + β1Timeij + β2Experimentalj + β3Experimental.Timeij
β0ij= β0 + u0j + e0ij

[u0j] ~N(0, Ωu) : Ωu = [σ2u0]
[e0ij] ~N(0, Ωe) : Ωe = [σ2e0]
Table 13 compares all models.
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Table 13
Comparison of all models
Parameter

Model 1Aa

ZAgitation
CONSTANT
Time
Experimental
Experimental.Time

Model 1Ba
Fixed Effects

0.00 (0.11)

0.46 (0.13)***
-0.45 (0.06)***

Model 1Ca

Model 1Da

1.09 (0.11)***
-0.45 (0.06)***
-1.23 (0.13)***

0.60 (0.11)***
0.04 (0.06)~
-0.28 (0.15)~
-0.95 (0.08)***

0.06 (0.05)

0.15 (0.05)

0.43 (0.06)
328.94
19.05

0.19 (0.03)
221.25
39.94

Random parameters
Level: Level 2
Resident
Var (CONSTANT)
0.39 (0.13)
0.48 (0.13)
Level: Level 1 Time
Var (CONSTANT)
0.63 (0.09)
0.42 (0.06)
DIC:
404.54
348.23
pD:
34.81
41.8
Note: Standard errors are in parentheses.
***p < 0.001; **p < 0.01; *p < 0.05; ~p<0.10

Adding the interaction effect of group status with time, significantly improved the
model fit (DIC=404.54 for the unconditional model, 348.23 for the unconditional growth
model, 328.94 for the conditional growth model, and 221.25 for the conditional growth
model with main and interaction effects). For this model, the within person variance
greatly reduced and the between person variance increased slightly from the previous
model. The interaction effect between group status and time was the only significant
variable driving this model.
Figure 12 shows the trajectory of agitation over time between the two groups.

144

Model 1A: Agitation
1.00
0.60

0.64

0.68
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12 week
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0.32

0.00
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-0.50

-0.59
-1.00
-1.50
-1.51
-2.00
Experimental

Control

Figure 12. Trajectory of agitation over time between the two groups
ICC was calculated on the final model using the same formula as used with the
null model:
G
DEF
BCC = G
G
DEF + DHF

=
=

F.WX
F.WXLF.WK

0.44

This shows that after adding only the group status and time changes to the model,
the between residents with AD variance increased. Model 1A was able to demonstrate
that residents with AD in the experimental group had a significantly different agitation
growth trajectory than the residents with AD in the control group. However, there were
differences between the residents with AD that could not be explained simply by being in
the experimental or control group. It is hypothesized that the reason for these differences
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lie with the CNA’s taking care of the residents. Not only was the CNA’s influenced
differently by the curriculum, but there were also differences in resident characteristics
that could have provided a barrier to CNA’s to provide compassionate care and rate
agitation of the patients in a more favorable manner. Model 2A will investigate these
influences on agitation.
Hypothesis 1b: Salivary Cortisol. Hypothesis 1b focuses on the trajectories of
residents with AD in terms of salivary cortisol compared to the control group of residents
with Alzheimer’s disease, without taking into effect the impact the different CNAs had
on the residents.
Unconditional Model. The first model (Model 1Ab) that was fitted was the
unconditional model which described the mean salivary cortisol levels across all residents
irrespective of time. Table 14 reveals the estimated intercept, variance components, and
model fit for the two-level unconditional model.
Table 14
Model 1Ab
Model 1Ab

Parameter
Fixed Effects
ZSalivary Cortisol
CONSTANT

0.007 (0.13)

Random parameters
Level: Level 2 Resident
Var (CONSTANT)
Level: Level 1 Time
Var (CONSTANT)
DIC:
pD:
Note: Standard errors are in parentheses.
***p < 0.001; **p < 0.01; *p < 0.05; ~p<0.10
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0.73 (0.18)
0.29 (0.04)
292.55
46.53

Based on the intercept value, it is estimated that the mean resident with AD is
predicted a Z cortisol level of 0.007. This estimate does not differ significantly from zero
and is expected as the response variable is approximately standardized and therefore has
a mean of approximately zero. The between resident variance is estimated at 0.73 (level
2), and the within resident variance is estimated at 0.29 (level 1). The intraclass
correlation was calculated using the following formula:
BCC =
=
=

G
DEF
G
G
DEF
+ DHF
F.ZJ
F.ZJLF.GK

0.72

Based on the calculation the ICC is 0.72, suggesting that 72% of the variance in
cortisol levels was between residents with AD. This supports the need for a multilevel
model which accounts for variance both between and within subjects.
The DIC for the unconditional model is estimated at 292.55. It is expected that
with more variables added to the model, the between and within variances will decrease,
and the fit statistic will improve.
Unconditional Growth Model. The unconditional growth model (Model 1Bb) is
the unconditional model with the time variable added. It depicts the average salivary
cortisol levels over time across individuals. For this model, time was allowed to have a
random intercept and slope on level 2, resulting in a better fit. The model was not able to
fit with a random slope on level 1. The formula used to fit this model, is shown below:
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ZCortisolLevels_` ~N(ab, Ω)
ZCortisolLevels_` = βF_` CONSTANT + βW` Time_`
βF_` = βF + cF` + dF_`
βW` = βW + cW`
cF`
DG DG
ec f ~N(0, ΩE ): ΩE = g EF EW h
W`
DEFW
G ]
idF_` j ~N(0, ΩE ): ΩE = [DHF

In Table 15, Model 1Bb is added for comparison with Model 1Ab.
Table 15
Comparison of Model 1Ab and Model 1B
Parameter

Model 1 Ab
Fixed Effects

ZSalivary Cortisol
CONSTANT
Time

0.007 (0.13)

Model 1 Bb

0.01 (0.14)
0.003 (0.06)

Random parameters
Level: Level 2 Resident
Var(CONSTANT)
0.73 (0.18)
Var(Time)
Level: Level 1 Time
Var(CONSTANT)
0.29 (0.04)
DIC:
292.55
pD:
46.53
Note: Standard errors are in parentheses.
***p < 0.001; **p < 0.01; *p < 0.05; ~p<0.10
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0.85 (.21)
0.11 (0.04)
0.19 (0.04)
252.95
75.87

Adding time to the model resulted in an improved model fit (DIC = 292.55 for the
unconditional model versus DIC = 252.95 for the unconditional growth model). With
time added to this model, the variance within the individuals was reduced from 0.29 to
0.19; however, the variance between persons with AD increased from 0.73 to 0.85. This
shows the need to explain the differences between persons with AD with additional
predictors, specifically the intervention that is assumed to have a differential effect on the
two groups in the sample.
Conditional Growth Model. The conditional growth model (Model 1Cb) added
group status as a predictor, using the following formula:
ZCortisolLevels_` ~N(ab, Ω)
ZCortisolLevels_` = βF_` CONSTANT + βW` Time_` + βG Experimental`
βF_` = βF + cF` + dF_`
βW` = βW + cW`
cF`
DG DG
ec f ~N(0, ΩE ): ΩE = g EF EW h
W`
DEFW
G ]
idF_` j ~N(0, ΩE ): ΩE = [DHF

Table 16 compares the unconditional model with the unconditional growth model
and the conditional growth model.
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Table 16
Comparison of Model 1Ab, Model 1Bb and Model 1Cb
Parameter
ZSalivary Cortisol
CONSTANT
Time
Experimental

Model 1 Ab
Fixed Effects

Model 1 Bb

0.007 (0.13)

Model 1 Cb

0.01 (0.14)
0.003 (0.06)

0.10 (0.19)
0.003 (0.06)
-0.19 (0.30)

0.85 (.21)
0.11 (0.04)

0.90 (0.23)
0.11 (0.04)

0.187 (0.04)
252.95
75.87

0.19 (0.04)
253.98
75.63

Random parameters
Level: Level 2 Resident
Var(CONSTANT)
0.73 (0.18)
Var(Time)
Level: Level 1 Time
Var(CONSTANT)
0.29 (0.04)
DIC:
292.55
pD:
46.53
Note: Standard errors are in parentheses.
***p < 0.001; **p < 0.01; *p < 0.05; ~p<0.10

Adding group status to the model did not result in an improved model fit (DIC =
252.95 for the unconditional growth model versus DIC = 253.98 for the conditional
growth model). For this model, the within person variance stayed the same, but the
between person variance increased from 0.85 to 0.90. Group status was not a significant
predictor.
Conditional growth model with Interaction Effects. This final model (Model
1Db) added the interaction effects between group and time as a final way to account for
the intervention as the groups were hypothesized to change differently over time. The
following formula was used for this model:
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ZCortisolLevels_` ~N(ab, Ω)
ZCortisolLevels_`
= βF_` CONSTANT + βW` Time_` +. βG Experimental`
+ βJ Experimental. Time_`
βF_` = βF + cF` + dF_`
βW` = βW + cW`
cF`
DG DG
ec f ~N(0, ΩE ): ΩE = g EF EW h
W`
DEFW
G ]
idF_` j ~N(0, ΩE ): ΩE = [DHF

Table 17 compares all models.
Table 17
Comparison of All Models
Parameter
ZSalivary Cortisol
CONSTANT
Time
Experimental
Experimental.Time

Model 1 Ab Model 1 Bb
Fixed Effects

Model 1 Cb

Model 1Db

0.007 (0.13)

0.10 (0.19)
0.003 (0.06)
-0.19 (0.30)

-0.16 (0.19)
0.26 (0.07)***
0.30 (0.27)
-0.51 (0.10)***

0.01 (0.14)
0.003 (0.06)

Random parameters
Level: Level 2 Resident
Var(CONSTANT)
Var(Time)
Level: Level 1 Time
Var(CONSTANT)

0.73 (0.18)

0.85 (.21)
0.11 (0.04)

0.90 (0.23)
0.11 (0.04)

0.84 (0.20)
0.05 (0.03)

0.29 (0.04)

0.19 (0.04)

0.19 (0.04)

0.19 (0.03)

252.95
75.87

253.98
75.63

243.95
66.881

DIC:
292.55
pD:
46.53
Note: Standard errors are in parentheses.
***p < 0.001; **p < 0.01; *p < 0.05; ~p<0.10
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Adding the interaction effect of group status with time, significantly improved the
model fit (DIC=292.55 for the unconditional model, 252.95 for the unconditional growth
model, 253.98 for the conditional growth model, and 243.95 for the conditional growth
model with main and interaction effects). For this model, the within person variance
stayed the same from the previous model and the between person variance decreased
slightly. Time was a significant variable in this model along with the interaction effect
between group status and time.
Figure 13 shows the trajectory of salivary cortisol over time between the two
groups.

Model 1B: Salivary Cortisol Levels
1.00
0.39

0.50

0.00

0.12
0.15
-0.11
6 week

Baseline
-0.16

12 week
-0.36

-0.50

-1.00

-1.50

-2.00
Experimental

Control

Figure 13. Trajectory of salivary cortisol levels over time between the two groups
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ICC was calculated on the final model using the same formula as used with the
null model:
G
DEF
BCC = G
G
DEF + DHF

=

F.kl
F.klLF.WK

=

0.48

This shows that after adding only the group status and time changes to the model,
the between residents with AD variance decreased over time. Model 1b was able to
demonstrate that persons with AD in the experimental group had a significantly different
salivary cortisol growth trajectory than the persons with AD in the control group. The
experimental group showed a decrease in cortisol levels over 12 weeks, with the control
group showing an increase in cortisol levels.
Hypothesis 2a: Agitation. Hypothesis 2a focuses on the trajectories of persons
with AD in terms of agitation compared to the control group, while taking into effect the
impact of the different CNAs on the persons with AD.
Unconditional Unclassified Null Model. The first model (Model 2Aa) that was
fitted was the unconditional unclassified model. This model only fits the effect of the
CNA that had the highest weighted time with a specific resident. The reason for building
this model first was to investigate if a classified model where the effect of all CNA’s
working with a specific resident was modeled, would be a better fitted model. If not, only
the effect of one CNA needed to be modelled, resulting in a less complicated model. The
following equation was used to fit this model:
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ZAgitation_`m ~ N(ab, Ω)
ZAgitation_`m = nF_`m CONSTANT
nF_`m = nF + νFm + cp`m + dF_`m
G
[νFm ] ~ q (0, Ωr ): Ωr = [DrF
]
G
iuF`m j ~ q (0, ΩE ): ΩE = [DEF
]
G
ieF`m j ~ q (0, ΩH ): ΩH = [DHF
]

Table 18 shows the estimated intercept, variance components, and model fit for
the three-level unconditional unclassified model using CNAs at level 3, persons with AD
at level 2, and measurement points at level 1. There were 50 level 3 units, 52 level 2
units, and 156 level 1 units.
Table 18
Model 2Aa
Parameter
ZAgitation
CONSTANT

Model 2Aa
Fixed Effects
-0.004(0.11)

Random parameters
Level: Level 3 CNA
Var(CONSTANT)
0.23 (0.19)
Level: Level 2 Resident
Var(CONSTANT)
0.19 (0.19)
Level: Level 1 Time
Var(CONSTANT)
0.63 (0.09)
Var(Time)
DIC:
403.89
pD:
34.90
Note: Standard errors are in parentheses.
***p < 0.001; **p < 0.01; *p < 0.05; ~p<0.10
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Based on the intercept value, it is estimated that the mean resident with AD is
predicted a Z agitation score of -0.004. This estimate does not differ significantly from
zero and is expected as the response variable is approximately standardized and therefore
has a mean of approximately zero. The between CNA variance is estimated at 0.23 (level
3), the resident with AD variance is estimated at 0.19 (level 2), and the within resident
variance is estimated at 0.63 (level 1). The DIC for the unconditional model is estimated
at 403.89.
Classified Unconditional Model. The next model that was built was the
classified unconditional model. Unlike the unclassified unconditional model, this model
took into consideration that one resident received care from multiple CNAs. The
following formula was used for this model:
ZAgitationij~N (XB, Ω)
ZAgitationij = β0ijCONSTANT
(J) (J)

(G)

nF_ = nF + Σ`tuvwW(_) x_,` cF` + cF,yz{zyG|}(_) + dF_
(J)

(J)

(J)

(J)

icF,uvwW(_) j ~q~0, ΩE : ΩE = [ΩEF,F ]
(G)

(G)

(G)

(G)

icF,yz{zyG|}(_) j ~q~0, ΩE : ΩE = [ΩEF,F ]
[dF_ ] ~N(0, ΩH ): ΩH = [ΩHF,F ]
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Using a classified model resulted in an improved model fit (DIC = 403.89 for the
unclassified unconditional model versus DIC = 395.79 for the classified unconditional
model). Given that this model produced a better fit, it was better to build a classified
model instead of an unclassified model.
Based on the intercept value, it is estimated that the mean resident with AD is
predicted a Z agitation level of 0.002. This estimate does not differ significantly from
zero and is expected as the response variable is approximately standardized and therefore
has a mean of approximately zero. The between CNA variance is estimated at 0.93 (level
3), the between resident variance is estimated at 0.04 (level 2), and the within resident
variance is estimated at 0.61 (level 1). Table 19 shows the classified unconditional model
compared to the unclassified unconditional model.
Table 19
Comparison of Model 2Aa (i) and Model 2Aa (ii)
Parameter
ZAgitation
CONSTANT

Model 2Aa (i)
Fixed Effects

Model 2Aa (ii)

-0.004(0.11)
Random parameters

Level: Level 3 CNA
Var(CONSTANT)
0.23 (0.19)
Level: Level 2
Resident
Var(CONSTANT)
0.19 (0.19)
Level: Level 1 Time
Var(CONSTANT)
0.63 (0.09)
Var(Time)
DIC:
403.895
pD:
34.90
Note: Standard errors are in parentheses.
***p < 0.001; **p < 0.01; *p < 0.05; ~p<0.10
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0.002 (0.13)

0.93 (0.35)

0.04 (0.05)
0.61 (0.08)
395.79
31.91

The intraclass correlation for level 3 was calculated using the following formula:
(J)

BCC =

ΩEF,F
(J)

(G)

ΩEF,F + ΩEF,F + ΩHF,F
=
=

F.KJ
F.KJLF.FlLF.MW

0.59

The intraclass correlation for level 2 was calculated using the following formula:

(G)

BCC =

ΩEF,F
(J)

(G)

ΩEF,F + ΩEF,F + ΩHF,F
=
=

F.Fl
F.KJLF.FlLF.MW

0.03

Based on the calculation the ICC for level 3 is 0.59, suggesting that 59% of the
variance in agitation was between CNAs, with the ICC for level 2 showing that there was
very little variance between residents left to explain. The reason for this may lie in the
fact that the CNAs were responsible for rating the agitation levels of the residents, and
that the ratings were more a result of their view on agitation than “true agitation levels”
for the residents. The ICC supports the need for a multilevel model which accounts for
variance not only between and within residents, but also between CNAs providing care.
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The DIC for the unconditional model is estimated at 395.79. It is expected that
with more variables added to the model, the between and within variances will decrease,
and the fit statistic will improve.
Classified Unconditional Growth Model. The unconditional growth model
(Model 2Ca) is the unconditional model with the time variable added. It depicts the
average agitation scores over time across individuals. The formula used to fit this model
is shown below:
ZAgitationij ~N (XB, Ω)
ZAgitationij = β0ijCONSTANT+ β1iTimei
(J) (J)

(G)

nF_ = nF + Σ`tuvwW(_) x_,` cF` + cF,yz{zyG|}(_) + dF_
β1i= β1 + e1i
(J)

(J)

(J)

(J)

icF,uvwW(_) j ~q~0, ΩE : ΩE = [ΩEF,F ]
(G)

(G)

(G)

(G)

icF,yz{zyG|}(_) j ~q~0, ΩE : ΩE = [ΩEF,F ]

Table 20 shows the classified unconditional model (Model 2Aa) compared to the
classified unconditional growth model (Model 2Ba).
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Table 20
Comparison of Model 2Aa (ii) and Model 2Ba
Parameter
ZAgitation
CONSTANT
Time

Model 2Aa (ii)
Fixed Effects

Model 2Ba

0.002 (0.13)

0.01 (0.18)
-0.21 (0.04)***

Random parameters
Level: Level 3
CNA
Var(CONSTANT)
0.93 (0.35)
2.40 (0.54)
Level: Level 2 Resident
Var(CONSTANT)
0.04 (0.05)
0.03 (0.04)
Level: Level 1
Time
Var(CONSTANT)
0.61 (0.08)
0.75 (0.06)
Covar (Time/CONSTANT
-0.55 (0.06)
Var(Time)
0.38 (0.04)
DIC:
395.79
136.01
pD:
31.91
364.14
Note: Standard errors are in parentheses.
***p < 0.001; **p < 0.01; *p < 0.05; ~p<0.10
Adding time to the model resulted in an improved model fit (DIC = 136.01 for the
unconditional growth model versus DIC = 395.79 for the unconditional model).
compared to the unconditional model. Time was added as a random effect on level 1. For
this model, the between CNA variance increased from 0.93 to 2.40, the between resident
variance stayed the same, and the within person variance increased from 0.61 to 0.77.
This model showed that time was a significant variable.
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Classified Conditional Growth Model with CNA Predictors. A model was built
where both the CNA and resident control variables were added to the unconditional
growth model. However, this model showed a worst fit than the unconditional growth
model, and none of the control variables were significant. Therefore, this model was not
included. The next model built was the conditional growth model with the CNA
predictors. Only the predictors that showed significance were included. The following
formula was used to build this model:
ZAgitationij ~N (XB, Ω)
ZAgitationij = β0ijCONSTANT+ β1iTimei + β2ZSelfEfficacyi +
Β3ZKnowledgei
(J) (J)

(G)

nF_ = nF + Σ`tuvwW(_) x_,` cF` + cF,yz{zyG|}(_) + dF_
β1i= β1 + e1i
(J)

(J)

(J)

(J)

icF,uvwW(_) j ~q~0, ΩE : ΩE = [ΩEF,F ]
(G)

(G)

(G)

(G)

icF,yz{zyG|}(_) j ~q~0, ΩE : ΩE = [ΩEF,F ]

Table 21 shows the comparison of the conditional growth model with predictors added in
(Model 2Ca) to the previous models.
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Table 21
Comparison of Model 2Aa (ii), Model 2Ba, and Model 2Ca
Parameter
ZAgitation
CONSTANT
Time
ZKnowledge
ZSelfEfficacy

Model 2Aa (ii) Model 2Ba
Fixed Effects
0.002 (0.13)

0.01 (0.18)
-0.21 (0.04)***

Model 2Ca

-0.05 (0.13)
-0.18 (0.04)***
-0.54 (0.17)***
-0.47 (0.19)***

Random parameters
Level: Level 3 CNA
Var(CONSTANT)
0.93 (0.35)
2.40 (0.54)
Level: Level 2 Resident
Var(CONSTANT)
0.04 (0.05)
0.03 (0.04)
Level: Level 1 Time
Var(CONSTANT)
0.61 (0.08)
0.75 (0.06)
Covar (Time/CONSTANT
-0.55 (0.06)
Var(Time)
0.38 (0.04)
DIC:
395.79
136.01
pD:
31.91
34.14
Note: Standard errors are in parentheses.
***p < 0.001; **p < 0.01; *p < 0.05; ~p<0.10

1.02 (0.70)
0.20 (0.20)
1.29 (0.09)
-0.96 (0.06)
0.65 (0.04)
111.33
31.58

Adding in the predictor variables of the change scores of knowledge and selfefficacy to the model resulted in an improved model fit (DIC =111.33 compared to the
previous model where DIC=136.01). For this model, the between CNA variance
decreased from 2.40 to 1.02, the between resident variance increased from 0.03 to 0.20,
and the within person variance increased from 0.75 to 1.29. This model showed that time,
and knowledge change scores and self-efficacy change scores were significant variables.
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Classified Conditional Growth Model with CNA Predictors and Interactions.
The final model included the predictor variables in the previous model but added in the
interaction effects with time. The following formula was used for this model:
ZAgitationij ~N (XB, Ω)
ZAgitationij = β0ijCONSTANT+ β1iTimei + β2ZSelfEfficacyi + Β3ZKnowledgei +
β4ZSelfEfficacy.Timei + Β5ZKnowledge.Timei

(J) (J)

(G)

nF_ = nF + Σ`tuvwW(_) x_,` cF` + cF,yz{zyG|}(_) + dF_
β1i= β1 + e1i
(J)

(J)

(J)

(J)

icF,uvwW(_) j ~q~0, ΩE : ΩE = [ΩEF,F ]
(G)

(G)

(G)

(G)

icF,yz{zyG|}(_) j ~q~0, ΩE : ΩE = [ΩEF,F ]

Table 22 compares the final model (Model 2Da) to the previous models.
Adding in the main effects in addition to the interaction effects significantly
reduced the DIC for an overall better fit (DIC of 93.57 compared to a DIC of 111.33 for
Model 2Ca). For this model, the between CNA variance slightly decreased from 1.02 to
0.99, the between resident variance stayed the same, and the within person variance
decreased from 1.29 to 1.18. This model showed that time, knowledge, along with the
interaction effect of self-efficacy with time were all significant. The interaction effect of
knowledge change with time showed a trend.
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Table 22
Comparison of all models
Parameter

Model 2Aa (ii)

Model 2Ba

Model 2Ca

Model 2Da

Fixed Effects
ZAgitation
CONSTANT

0.002 (0.13)

0.01 (0.18)

-0.05 (0.13)

-0.03 (0.14)

-0.21 (0.04)***

-0.18 (0.04)***

-0.18 (0.04)***

ZKnowledge

-0.54 (0.17)***

-0.44 (0.19)***

ZSelfEfficacy

-0.47 (0.19)***

-0.27 (0.21)

Time

ZKnowledge.Time

-0.08 (0.05)~

ZSelfEfficacy.Time

-0.14 (0.05)***
Random parameters

Level: Level 3 CNA
Var(CONSTANT)

0.93 (0.35)

2.40 (0.54)

1.02 (0.70)

0.99 (0.71)

0.04 (0.05)

0.03 (0.04)

0.20 (0.20)

0.20 (0.20)

0.61 (0.08)

0.75 (0.06)

1.29 (0.09)

1.18 (0.06)

-0.55 (0.06)

-0.87 (0.04)

0.38 (0.04)

0.65 (0.04)

0.58 (0.03)

395.79

136.01

111.33

93.57

pD:
31.91
Note: Standard errors are in parentheses.

34.14

31.58

32.11

Level: Level 2 Resident
Var(CONSTANT)
Level: Level 1 Time
Var(CONSTANT)
Covar (Time/CONSTANT
Var(Time)
DIC:

***p < 0.001; **p < 0.01; *p < 0.05; ~p<0.10

Figure 14 shows the knowledge change scores over time for those with change at
the 10th and 90th percentile.
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Model 2a: Knowledge 10th percentile
1.00
0.50

0.23

0.11

-0.02

0.00
Baseline

Six Months

Twelve Months

-0.50
-1.00
-1.50

Model 2a: Knowledge 90th percentile
1.00
0.50
0.00
Baseline
-0.50

Six Months

Twelve Months

-0.65
-0.95

-1.00

-1.25

-1.50

Figure 14. The effect of knowledge change scores and time on agitation
Figure 14 shows even for the CNAs where their change in knowledge was the
smallest, agitation levels of residents decreased as a result of this knowledge change.
Because these were standardized values, it can be concluded that for CNAs at the 10th
percentile of knowledge increase, there was a 0.25 standard deviation decrease in
agitation levels. For those where the knowledge change was the highest, agitation levels
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of residents decreased more from -0.65 to -1.25, therefore a 0.60 standard deviation
decrease in agitation levels. This differential change in agitation levels showed a trend.
Figure 15 shows the self-efficacy change scores over time for those with change
at the 10th and 90th percentile.

Model 2a: Self-Efficacy 10th percentile
1.00
0.50
0.14

0.04

0.00
Baseline

Six Months

-0.05
Twelve Months

-0.50
-1.00
-1.50

Model 2a: Self-Efficacy 90th percentile
1.00
0.50
0.00

-0.34
Baseline

Six Months

Twelve Months

-0.67

-0.50

-1.01

-1.00
-1.50

Figure 15. The effect of self-efficacy change scores and time on agitation
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Figure 15 shows for the CNAs where their change in self-efficacy were the
smallest, agitation levels of residents decreased slightly, from 0.14 to -005 as a result of
this self-efficacy change. This change equals a 0.19 standard deviation decrease from
baseline to twelve months in agitation levels. For those where the self-efficacy change
was the highest, agitation levels of residents decreased more from -0.34 to -1.01 for a
standard deviation decrease of 0.67. This differential change in agitation levels was
significant.
Hypothesis 1 already showed that CNAs in the experimental groups showed a
significantly higher increase in knowledge and self-efficacy over time than the CNAs in
the control group who showed almost no change in knowledge and self-efficacy over
time. Also, model 1a showed the experimental group had a significant decrease in
agitation levels, with the agitation levels for the control group staying the same. From
Model 2a it was possible to conclude that the compassionate care curriculum was able to
change the knowledge and self-efficacy of CNAs resulting in a decrease in agitation
levels for residents with AD.
ICC for level 3 was calculated on the final model using the same formula as used
with the null model:

(J)

BCC =

ΩEF,F
(J)

(G)

ΩEF,F + ΩEF,F + ΩHF,F
=
=
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F.KK
F.KKLF.GFLW.Wk

0.42

ICC for level 2 was calculated on the final model as well:
(G)

BCC =

ΩEF,F
(J)

(G)

ΩEF,F + ΩEF,F + ΩHF,F
=

F.GF
F.KKLF.GFLW.Wk

=

0.08

This shows that after adding the CNA predictors to the model, the between CNA
variance was reduced from 0.59 (null model) to 0.42. The between resident variance
slightly increased from 0.03 (null model) to 0.08. However, this between resident
variance is much less than the variance that still existed after Model 1a was completed. It
is clear that the between resident variance was a product of the characteristics of the
CNAs taking care of the residents. The CNAs were influenced differently by the
curriculum or lack of exposure to the curriculum. Once these differences were accounted
for in the model, the between resident variance decreased.
Hypothesis 2b: Salivary Cortisol Levels. Hypothesis 2b focuses on the
trajectories of persons with AD in terms of salivary cortisol compared to the control
group, while taking into effect the impact of the different CNAs on the persons with AD.
Unconditional Unclassified Null Model. The first model (Model 2Ab (i)) that
was fitted was the unconditional unclassified model. This model only fits the effect of the
CNA that had the highest weighted time with a specific resident. The reason for building
this model first was to investigate if a classified model where the effect of all CNA’s
working with a specific resident was modeled, would be a better fitted model. If not, only
the effect of one CNA needed to be modeled, resulting in a less complicated model. The
following equation was used to fit this model:
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ZSalivaryCortisolLevels_`m ~ N(ab, Ω)
ZSalivaryCortisolLevels_`m = nF_`m CONSTANT
nF_`m = nF + νFm + cp`m + dF_`m
G
[νFm ] ~ q (0, Ωr ): Ωr = [DrF
]
G
iuF`m j ~ q (0, ΩE ): ΩE = [DEF
]
G
ieF_`m j ~ q (0, ΩH ): ΩH = [DHF
]

Table 23 shows the estimated intercept, variance components and, model fit for
the three-level unconditional unclassified model using CNAs at level 3, persons with AD
at level 2, and measurement points at level 1. There were 50 level 3 units, 52 level 2
units, and 156 level 1 units.
Table 23
Model 2Ab
Parameter

Model 2Ab (i)
Fixed Effects
ZSalivary Cortisol
CONSTANT
-0.002 (0.13)
Random Parameters
Level: Level 3 CNA
Var(CONSTANT)
0.04 (0.07)
Level: Level 2 Resident
Var(CONSTANT)
0.70 (0.17)
Level: Level 1 Time
Var(CONSTANT)
0.29 (0.04)
DIC:
292.61
pD:
46.67
Note: Standard errors are in parentheses.
***p < 0.001; **p < 0.01; *p < 0.05; ~p<0.10
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Based on the intercept value, it is estimated that the mean resident with AD is
predicted a Z salivary cortisol levels score of -0.002. This estimate does not differ
significantly from zero and is expected as the response variable is approximately
standardized and therefore has a mean of approximately zero. The between CNA
variance is estimated at 0.04 (level 3), the resident with AD variance is estimated at 0.70
(level 2), and the within resident variance is estimated at 0.29 (level 1). The DIC for the
unconditional model is estimated at 292.61.
Classified Unconditional Model. The next model that was built was the
classified unconditional model. Unlike the unclassified unconditional model, this model
took into consideration that one resident received care from multiple CNAs. The
following formula was used for this model:
ZSalivaryCortisolLevelsij~N (XB, Ω)
ZSalivaryCortisolLevelsij = β0ijCONSTANT
(J) (J)

(G)

nF_ = nF + Σ`tuvwW(_) x_,` cF` + cF,yz{zyG|}(_) + dF_
(J)
(J)
(J)
ecF,uvwW(_)
f ~qâ0, Ω(J)
E ä: ΩE = [ΩEF,F ]

(G)

(G)

(G)

(G)
f ~qâ0, ΩE ä: ΩE = [ΩEF,F ]
ecF,yz{zyG|}(_)

[dF_ ] ~N(0, ΩH ): ΩH = [ΩHF,F ]

Table 24 shows the classified unconditional model (Model 2Ab (ii)) compared to
the unclassified unconditional model (Model 2Ab (i)).
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Table 24
Comparison of Model 2Ab(i) and Model 2Ab(ii)
Parameter
ZSalivary Cortisol
CONSTANT

Model 2Ab (i)
Fixed Effects

Model 2Ab (ii)

-0.002 (0.13)
Random Parameters

-0.004 (0.13)

Level: Level 3 CNA
Var(CONSTANT)
0.04 (0.07)
Level: Level 2 Resident
Var(CONSTANT)
0.70 (0.17)
Level: Level 1 Time
Var(CONSTANT)
0.29 (0.04)
DIC:
292.61
pD:
46.67
Note: Standard errors are in parentheses.
***p < 0.001; **p < 0.01; *p < 0.05; ~p<0.10

0.17 (0.29)
0.67 (0.18)
0.29 (0.04)
292.48
46.64

Using a classified model did not result in an improved fit (DIC = 292.61 for the
unclassified unconditional model versus DIC = 292.48 for the classified unconditional
model). Given that the unclassified unconditional model produced a better fit, it was
better to build a simpler unclassified model instead of a classified model.
For the unclassified, unconditional model, the intraclass correlation for level 3
was calculated using the following formula:
(J)

BCC =

ΩEF,F
(J)

(G)

ΩEF,F + ΩEF,F + ΩHF,F
=
=
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F.Fl
F.FlLF.ZFLF.GK

0.04

The intraclass correlation for level 2 was calculated using the following formula:
(G)

BCC =

ΩEF,F
(J)

(G)

ΩEF,F + ΩEF,F + ΩHF,F
=
=

F.ZF
F.FlLF.ZFLF.GK

0.68

Based on the calculation the ICC for level 3 was 0.04, suggesting that 4% of the
variance in salivary cortisol levels was between CNAs, while the ICC for level 2 was
0.68, suggesting that 68% of the variance was explained by the residents with AD. The
reason for this may be attributed to the fact that salivary cortisol is a biomarker, unlike
the agitation scores which were measured on a rating scale by the CNAs, and therefore
much more subject to CNA influences.
The DIC for the unconditional model was estimated at 292.61. It was expected
that with more variables added to the model, the between and within variances would
decrease, and the fit statistic would improve.
Unclassified Unconditional Growth Model. The unconditional growth model
(Model 2Bb) is the unconditional model with the time variable added. It depicts the
average salivary cortisol levels over time across individuals.
The formula used to fit this model is shown below:

171

ZSalivaryCortisolLevels_`m ~ N(ab, Ω)
ZSalivaryCortisolLevels_`m = nF_`m CONSTANT + nW_ Time_`m
nF_`m = nF + νFm + cp`m + dF_`m
nW_ = nW + dW_`m
G
[νFm ] ~ q (0, Ωr ): Ωr = [DrF
]
G ]
iuF`m j ~ q (0, ΩE ): ΩE = [DEF

eF_`m
DG
ee f ~ q (0, ΩH ): ΩH = å GHF
W_`m
DHFW

G
DHW

ç

Table 25 shows the classified unconditional model (Model 2Ab (i)) compared to
the classified unconditional growth model (Model 2Bb).
Table 25
Comparison of Model 2Ab (i) and Model 2Bb
Parameter
ZSalivary Cortisol
CONSTANT
Time

Model 2Ab (i)
Fixed Effects
-0.002 (0.13)

Model 2Bb

-0.01 (0.15)
0.001 (0.06)

Random Parameters
Level: Level 3 CNA
Var(CONSTANT)
Level: Level 2 Resident
Var(CONSTANT)
Level: Level 1 Time
Var(CONSTANT)
Covar(Time/CONSTANT)
Var(Time)
DIC:

0.04 (0.07)

0.04 (0.07)

0.70 (0.17)

0.77 (0.19)

0.29 (0.04)

292.61

0.46 (0.11)
-0.26 (0.11)
0.22 (0.09)
269.43

46.67

44.89

pD:
Note: Standard errors are in parentheses.
***p < 0.001; **p < 0.01; *p < 0.05; ~p<0.10

172

Adding time to the model resulted in an improved model fit (DIC = 269.43 for the
unconditional growth model versus DIC = 292.61 for the unconditional model). Time
was added as a random effect on level 1. For this model, the between CNA variance
stayed the same, the between resident variance increased from 0.70 to 0.77, and the
within person variance increased from 0.29 to 0.46. Time was not a significant variable.
Unclassified Conditional Growth Model with CNA Predictors. A model was
built where both the CNA and resident control variables were added to the unconditional
growth model. None of the control variables were significant, so this model is not shown.
The next model built was Model 2Cb, where CNA predictor variables were added. None
of the predictors were significant, but the change in knowledge was kept, as the
interaction between knowledge and time was significant in later models. The following
formula was used to build this model:
ZSalivaryCortisolLevels_`m ~ N(ab, Ω)
ZSalivaryCortisolLevels_`m
= nF_`m CONSTANT + nW_ Time_`m + nG Knowledge`m
nF_`m = nF + νFm + cp`m + dF_`m
nW_ = nW + dW_`m
G
[νFm ] ~ q (0, Ωr ): Ωr = [DrF
]
G ]
iuF`m j ~ q (0, ΩE ): ΩE = [DEF

eF_`m
DG
ee f ~ q (0, ΩH ): ΩH = å GHF
W_`m
DHFW

G
DHW

ç

Table 26 shows the comparison of the conditional growth model with CNA
predictors added in (Model 2Cb) to the previous models.
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Table 26
Comparison of Model 2Ab (i), Model 2Bb, and Model 2Cb
Parameter
ZSalivary Cortisol
CONSTANT
Time
ZKnowledge

Model 2Ab (i)
Model 2Bb
Fixed Effects
-0.002 (0.13)

Model 2Cb

-0.01 (0.15)
0.001 (0.06)

-0.01 (0.15)
0.001 (0.06)
-0.20 (0.16)

0.04 (0.07)

0.04 (0.6)

0.77 (0.19)

0.77 (0.19)

0.46 (0.11)
-0.26 (0.11)
0.22 (0.09)
269.43
44.89

0.50 (0.10)
-0.29 (0.09)
0.24 (0.09)
268.88
45.48

Random Parameters
Level: Level 3 CNA
Var(CONSTANT)
0.04 (0.07)
Level: Level 2 Resident
Var(CONSTANT)
0.70 (0.17)
Level: Level 1 Time
Var(CONSTANT)
0.29 (0.04)
Covar(Time/CONSTANT)
Var(Time)
DIC:
292.61
pD:
46.67
Note: Standard errors are in parentheses.
***p < 0.001; **p < 0.01; *p < 0.05; ~p<0.10

Adding the knowledge change score CNA predictor variable to the model did not
result in an improved model fit (DIC =268.88 compared to the previous model where
DIC=269.43). For this model, the variance components stayed the same.
Unclassified Conditional Growth Model with CNA Predictors and Agitation.
The next model included knowledge from the previous model with the addition of the
outcome variable agitation. The following formula was used to create this model:
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ZSalivaryCortisolLevels_`m ~ N(ab, Ω)
ZSalivaryCortisolLevels_`m
= nF_`m CONSTANT + nW_ Time_`m + nG Knowledge`m
+ nJ Agitation_`m
nF_`m = nF + νFm + cp`m + dF_`m
nW_ = nW + dW_`m
nJ` = nJ + cJ`m
G
[νFm ] ~ q (0, Ωr ): Ωr = [DrF
]
G
uF`m
DEF
eu f ~ q (0, ΩE ): ΩE = å
G ç
J`m
DEFJ DEJ

eF_`m
DG
ee f ~ q (0, ΩH ): ΩH = å GHF
W_`m
DHFW

G
DHW

ç

Table 27 compares the model (Model 2Db) to the previous models.
Adding agitation to the model produced a significantly better overall model fit
(DIC= 268.88 for Model 2Cb compared to 252.32 for Model 2Db). Agitation produced a
better fit when it was allowed to vary between residents (Level 2). For this model, the
between CNA variance stayed the same, the between resident variance decreased from
0.77 to 0.74 and the within resident variance decreased from 0.50 to 0.31. This model
showed that time and agitation were both significant.
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Table 27
Comparison of Model 2Ab (i), Model 2Bb, Model 2Cb, and Model 2Db
Parameter
ZSalivary Cortisol
CONSTANT
Time
ZKnowledge
ZAgitation

Model 2Ab (i) Model 2Bb
Fixed Effects
-0.002 (0.13)

-0.01 (0.15)
0.001 (0.06)

Model 2Cb

Model 2Db

-0.01 (0.15)
0.00 (0.06)
-0.20 (0.16)

-0.15 (0.15)
0.15 (0.06)**
-0.03 (0.17)
0.34 (0.08)***

0.04 (0.07)

0.04 (0.6)

0.04 (0.07)

0.77 (0.19)

0.77 (0.19)

0.74 (0.18)
0.06 (0.06)
0.03 (0.02)

0.46 (0.11)
-0.26 (0.11)
0.22 (0.09)
269.43
44.89

0.5 (0.10)
-0.29 (0.09)
0.24 (0.09)
268.88
45.48

0.31 (0.09)
-0.02 (0.09)
-0.01 (0.09)
252.32
50.33

Random Parameters
Level: Level 3 CNA
Var(CONSTANT)
0.04 (0.07)
Level: Level 2 Resident
Var(CONSTANT)
0.70 (0.17)
Covar(ZAgitation/CONSTANT)
Var(ZAgitation)
Level: Level 1 Time
Var(CONSTANT)
0.29 (0.04)
Covar(Time/CONSTANT)
Var(Time)
DIC:
292.61
pD:
46.67
Note: Standard errors are in parentheses.
***p < 0.001; **p < 0.01; *p < 0.05; ~p<0.10

Unclassified Conditional Growth Model with CNA Predictors and Interactions. The
final model included the predictor variables in the previous model but added the
interaction effect between knowledge change and time. The following formula was used
to build this model:
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ZSalivaryCortisolLevels_`m ~ N(ab, Ω)
ZSalivaryCortisolLevels_`m
= nF_`m CONSTANT + nW_ Time_`m + nG_ ZKnowledge`m
+ nJ` ZAgitation_`m + nl ZKnowledge. Time_`m
nF_`m = nF + νFm + cp`m + dF_`m
nW_ = nW + dW_`m
nJ` = nJ + cJ`m
G
[νFm ] ~ q (0, Ωr ): Ωr = [DrF
]
G
uF`m
DEF
eu f ~ q (0, ΩE ): ΩE = å
G ç
J`m
DEFJ DEJ

eF_`m
DG
ee f ~ q (0, ΩH ): ΩH = å HF G ç
W_`m
DHFW DHW
Adding in the interaction between knowledge change and time significantly
reduced the DIC for an overall better fit (DIC of 244.23 compared to a DIC of 252.43 for
Model 2Db). For this model, the between CNA variance stayed the same, the between
resident variance stayed the same, and the within person variance increased slightly from
0.31 to 0.34. This model showed that agitation, along with the interaction effect of
knowledge with time were significant. Time as a variable showed a trend towards
significance. Table 28 compared Model 2Eb to previous models.

177

Table 28
Comparison of All Models
Parameter
ZSalivary Cortisol
CONSTANT
Time
ZKnowledge
ZAgitation
ZKnowledge.Time

Model 2Ab (i)

-0.002 (0.13)

Model 2Bb Model 2Cb
Fixed Effects

Model 2Db

Model 2Eb

-0.01 (0.15)
0.001 (0.06)

-0.15 (0.15)
0.15 (0.06)**
-0.03 (0.17)
0.34 (0.08)***

-.08 (0.15)
0.10 (0.06)~
0.15 (0.18)
0.22 (0.09)*
-0.19 (0.07)**

0.04 (0.6)

0.04 (0.07)

0.04 (0.07)

0.77 (0.19)

0.74 (0.18)
0.06 (0.06)
0.03 (0.02)

0.74 (0.18)
0.06 (0.05)
0.03 (0.02)

0.5 (0.10)
-0.29 (0.09)
0.24 (0.09)
268.88
45.48

0.31 (0.09)
-0.02 (0.09)
-0.01 (0.09)
252.32
50.33

0.34 (0.12)
-0.09 (0.12)
0.04 (0.09)
244.23
51.56

-0.01 (0.15)
0.00 (0.06)
-0.20 (0.16)

Random Parameters
Level: Level 3
CNA
Var(CONSTANT)
0.04 (0.07)
0.04 (0.07)
Level: Level 2
Resident
Var(CONSTANT)
0.70 (0.17)
0.77 (0.19)
Covar(ZAgitation/CONSTANT)
Var(ZAgitation)
Level: Level 1
Time
Var(CONSTANT)
0.29 (0.04)
0.46 (0.11)
Covar(Time/CONSTANT)
-0.26 (0.11)
Var(Time)
0.22 (0.09)
DIC:
292.61
269.43
pD:
46.67
44.89
Note: Standard errors are in
parentheses.
***p < 0.001; **p < 0.01; *p < 0.05; ~p<0.10

Figure 16 shows the knowledge change scores over time for those with change at
the 10th and 90th percentile.
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Model 2b: Knowledge 10th percentile
1.00

0.50

0.00

0.24
0.03

-0.18
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Six Months

Twelve Months

-0.50

-1.00

-1.50

Model 2b: Knowledge 90th percentile
1.00

0.50

0.00

0.14
Baseline

Six Months
-0.04

Twelve Months
-0.22

-0.50

-1.00

-1.50

Figure 16. The effect of knowledge change scores and time on salivary cortisol levels
Figure 16 shows that for the CNAs where their change in knowledge was the
smallest (10th percentile), salivary cortisol levels of residents increased. Because these
were standardized values, it can be concluded that for CNAs at the 10th percentile of
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knowledge increase, there was a 0.42 standard deviation increase in salivary cortisol
levels. For those where the knowledge change was the highest, salivary cortisol levels of
residents decreased from 0.14 at baseline to -0.22 at 12 weeks, therefore a 0.36 standard
deviation decrease in agitation levels. This shows the importance of understanding AD
disease and increased knowledge of CNAs in reducing the stress of AD residents.
Figure 17 shows the agitation scores over time for those with agitation at the 10th
and 90th percentile.

Agitation
0.4
0.3

0.258

0.2
0.1
0
-0.1

Agitation 10th percentile

-0.2
-0.3

-0.276

-0.4

Figure 17. The effect of agitation on saliva cortisol levels

180

Agitation 90th percentile

Figure 17 shows that for persons with agitation levels in the 10th percentile, their
salivary cortisol levels were lower. For those where agitation levels were the highest (90th
percentile), salivary cortisol levels were higher.
Hypothesis 1 already showed that CNAs in the experimental groups showed a
significantly higher increase in knowledge than the CNAs in the control group who
showed almost no change in knowledge over time. Also, model 1b showed the
experimental group had a significant decrease in salivary cortisol levels, with the salivary
cortisol levels increasing for the control group. From Model 2b it is possible to conclude
that the CC curriculum was able to change the knowledge of CNAs resulting in a
decrease in agitation levels, and subsequently a decrease in saliva cortisol levels for
residents with AD.
ICC for level 3 was calculated on the final model using the same formula as used
with the null model:
(J)

BCC =

ΩEF,F
(J)

(G)

ΩEF,F + ΩEF,F + ΩHF,F
=
=

F.Fl
F.FlLF.ZlLF.Jl

0.03

ICC for level 2 was calculated on the final model as well:
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(G)

BCC =

ΩEF,F
(J)

(G)

ΩEF,F + ΩEF,F + ΩHF,F
=

F.Zl
F.FlLF.ZlLF.Jl

=

0.66

This shows that after adding the CNA predictors to the model, the between CNA
variance reduced slightly from 0.04 (null model) to 0.03. The between resident variance
also reduced slightly from 0.68 (null model) to 0.66. However, the between resident
variance left with Model 2b was higher than what was left after Model 1b was completed
(0.48 for Model 1b compared to 0.66 for Model 2b). More analysis will be needed with
additional potential predictors than what was measured with this study to investigate what
other predictors could potentially explain these differences between salivary cortisol
levels of AD residents. What is, however, clear is that positive changes in knowledge led
to significant reductions in agitation, that in turn resulted in reduced salivary cortisol
levels. These results showed the value of the CC curriculum to improve the abilities of
the CNAs to better care for residents with AD.
Summary
This study utilized the Kirkpatrick model to evaluate the effectiveness of the
compassionate care curriculum. The first half of this chapter focused on the first three
levels of the Kirkpatrick model of evaluation, namely, reaction, learning, and behavior.
To understand the impact of the compassionate care curriculum on the CNAs, we
examined changes in their knowledge of AD, self-efficacy, caregiver satisfaction and
affiliate stigma at baseline and then after completing the 12-week compassionate care
curriculum and participating in the care groups. For AD knowledge, a significant increase
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was seen in scores from baseline to 12 weeks for the experimental group while the
control group remained the same over the 12-week period. Self-efficacy for the
experimental group improved between baseline and 12-weeks but deteriorated slightly for
the control group. Caregiver satisfaction showed a slight improvement at 12-weeks for
both groups, yet the experimental group showed a trend of greater improvement than the
control group. For the experimental group, feelings of affiliate stigma declined between
baseline and 12- weeks, while the control group remained similar at the 12-week period.
From the Kirkpatrick model, level 4 examined outcomes. For this study, the focus
was on the stress outcomes of the residents with AD, specifically as it relates to agitation
and salivary cortisol levels. Two models were built that were able to show that the
residents with AD in the experimental group improved in terms of their agitation and
salivary cortisol levels after 12 weeks. These two models did not include the impact of
the CNAs. This helped us establish that there were changes between the two groups
(experimental and control) as a result of the curriculum they were exposed to. The final 2
models were then built that showed the role of the CNAs and how they had an impact on
the two groups. We saw that knowledge changes and self-efficacy changes had an impact
on the agitation levels of residents with AD. For salivary cortisol levels, it was
knowledge changes and agitation scores that had an impact.
Chapter 5 discusses the implications of this study in greater detail. Furthermore,
the strengths and limitations, as well as ideas for future research, are described.
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CHAPTER V: DISCUSSION
Using the Kirkpatrick model of evaluation and a multilevel modeling
methodology, this study examined the use of a CC curriculum with CNA support groups
and its’ impact on persons with AD living in an experimental and a control nursing
facility. The control facility CNAs provided care to persons with AD as usual with no
additional training other than the state mandated CNA training program. The
experimental nursing facility allowed their CNAs to participate in the CC curriculum.
After 12-weeks, this study demonstrated that differences existed between the
experimental and control nursing facilities as a result of the introduction of the CC
curriculum.
At baseline, before the curriculum was introduced to the experimental facility,
analysis was completed to determine if there were differences between the control and
experimental groups. For the CNAs in the study, we looked at age, race/ethnicity, gender,
number of years working in nursing facilities, number of years working in the current
facility, and number of years of formal education. Analysis showed that the control and
experimental groups were similar on most demographic variables except that the
experimental group was older and worked longer in nursing facilities than the control
group. Between the two groups, there were no significant differences between the control
and experimental group on their AD knowledge, self-efficacy, caregiving satisfaction or
affiliate stigma at baseline.
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For the residents with AD, there were no differences in the demographics of the
control and experimental group, namely in terms of their age, gender, race/ethnicity, and
rapid cognitive screening scores. Furthermore, in terms of the outcome variables at
baseline, there were no significant differences between the control and experimental
group on the agitation of residents with AD as well as their salivary cortisol levels.
In looking first at the CNAs change scores from baseline to 12 weeks, we saw a
significant change in terms of AD knowledge, self-efficacy, caregiver satisfaction and
affiliate stigma for those working in the experimental facility compared to those that were
at the control facility and not participating in the CC curriculum.
Multilevel models were first built by examining the outcome measures, agitation,
and salivary cortisol, without including the impact of the CNAs. By building the models
independent of the CNA measures, we were able to demonstrate that the persons with AD
in the experimental group showed improvements in terms of their agitation and salivary
cortisol levels over the 12 weeks the study took place.
Additional models were constructed to show that the CNAs contributed to this
difference between the experimental and control facilities. No control CNA or resident
with AD variables were controlled for in the model, as they did not show to have any
significant impact on the final outcome. In terms of agitation, analysis showed that
knowledge and self-efficacy were the strongest CNA predictors of a decrease in the
resident’s agitation over time.
In the final salivary cortisol model, we were able to show that knowledge and
agitation were the strongest predictors of a decrease in salivary cortisol levels.
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Implications for CNA Training in Kentucky
This study has the potential to impact the way we conceptualize the care provided
by CNAs. Our current structure of training is rather limiting to the CNAs in that they are
not provided with any skill development related to understanding persons with AD and
the disease. As a result, we marginalize CNAs in that we do not fully allow them to
explore all that the profession can offer. By incorporating the CC curriculum, we can
change the conceptualization of care that currently exists within the profession and affect
the way persons with AD are cared for.
Changing the Conceptualization of Care
As previously elucidated in Chapters 1 and 2, the way we conceptualization care
in the United States in nursing facilities has been largely basic nursing care. We have
ignored the relationship between the CNA and the person with AD. Even the movement
towards more person-centered care is more focused on the journey of the person and
leaves no room for the relationship between these two persons. This mode of thinking
ignores the bond that is formed between the CNA and the person with AD. Part of the
intent of the CC curriculum is to acknowledge that there is a bond between the CNA and
the person with AD and to focus on how to help turn that bond into better care.
We know that conceptualizing care solely as basic nursing care is not working, as
evidenced by the current state of long-term care in Kentucky. In terms of long-term care
measures, Kentucky is ranked 50th in the nation (AARP, 2017). Unlike other states, such
as California and Minnesota, Kentucky does not offer additional training for CNAs
working with persons with AD (AARP, 2017). This study demonstrates that with more
training and support, the care that CNAs provide can positively affect persons with AD
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living in nursing facilities. In particular, this study has policy implications for training
regulations for CNAs in Kentucky. As previously stated, the current CNA training in
Kentucky follows the minimum training regulations set for by OBRA in 1987 (Code of
Federal Regulations, 2012; Hawes, 2003). This training is predicated on basic nursing
care, meaning that CNAs are charged with providing care that meets the needs of the
persons with AD in terms of their ADLs.
It is also important to note that the purpose of the CC curriculum is not to replace
the current trainings that are required for CNAs. Basic nursing care is a necessary
component of care. The purpose of this study was to show how care can be enhanced to
include compassionate care and the impact that this can have on persons with AD living
in nursing facilities. This training adds further content to the CNA training structure.
Adding more hours to the certification requirements would be an important step in
assisting CNAs with developing the skills that they need to work with persons with AD.
Therefore, in addition to advocating for more training for CNAs, we hope to advocate at
a state level that the incorporation of more compassionate care, in addition to the current
training that is received, would be important for CNAs and the people they care for.
Currently, there is no legislative agenda in Kentucky that includes a focus on the amount
of training or type of training that CNAs receive.
Future Research
The original research design proposed using eight experimental and eight control
facilities for a larger sample. However, due to a number of factors, namely, funding and
time limitations we had to reduce the sample size. Furthermore, the original proposal
included a sample strategy that focused on exploring the impact of the profit status and
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the size of the facility on the outcomes. The outcomes of this study have opened up
several areas of future research that will be explored, using the original proposal as a
guideline for examining different types of nursing facilities. Therefore, moving forward,
it will be important to establish facilities of different sizes and profit status. For this
study, we only used facilities that were part of the same health care system and were both
considered medium in size. However, to understand further applications of this program,
it will be beneficial to compare groups based on profit status and size and to expand the
program to other healthcare systems.
In addition to expanding this to nursing facilities in other health care systems, we
want to use this information to build a certificate program for compassionate care
curriculum designed specifically for CNAs caring for persons with AD. We have
explored opportunities on how to offer this with a local technical and community college;
therefore, future research of the impact of the curriculum could be tied to this particular
set of courses that CNAs from multiple healthcare systems would attend. The premise of
this expansion would be to use a micro-credentialing approach to learning care and
strategies for working with persons with AD. Micro-credentialing is a competency-based
approach to skill development where learners participate in mini or short modules and
then demonstrate competency in an area (Berry & Cator, 2016).
Expansion of this project will also include a Project Echo focused on the
compassionate care of persons with AD. Project Echo is a telementoring program where
professionals interested in learning more about a particular area such as AD can join via a
teleconferencing program Zoom (University New Mexico School of Medicine, 2018).
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This will allow for the dissemination of the compassionate care curriculum to a wider
audience.
Understanding the long-term impact of the compassionate curriculum and the
establishment of care groups is also an important area of research that was not addressed
in this study. For the purposes of this dissertation, data collection stopped after 12-weeks.
Conducting further data collection on the persons from this study will be useful in
determining if the introduction of the compassionate care curriculum and the care groups
were, in fact, a way to provide better care to persons with AD. Adding this data to the
current study will provide a greater understanding of how the CNAs were able to transfer
the curriculum into behaviors and the impact that it has on persons with AD.
a include this measure and moreover, examine if CNA stress has an impact on the
outcomes of the persons with AD. Given the effective use of salivary cortisol testing for
persons with AD in this study, it will be interesting to also examine CNA stress by
measuring the cortisol levels of the CNAs that participated in the study.
Conclusion
Strengths of the Study
This study contributes to the research focused on training of CNAs in their work
with persons with AD in several critical ways. This study shows that basic nursing care
training as mandated by state agencies is only one aspect of the training that CNAs need
to for their work at nursing facilities. The results of this study indicate that enhancing
mandatory training with a compassionate care curriculum creates a deeper connection
between CNA and persons with AD. This connection can improve care delivery and the
stress of persons with AD.
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Using a control/experimental group design was also a strength in this study. This
design allowed a clear understanding of the effect of the intervention and thereby
increasing the reliability of the study.
At the beginning of this study, there were concerns that retention would be an
issue for the CNAs in the study. However, for this study, we did not have the retention
problems that are problematic for many studies involving CNAs.
This study was also strengthened by the collaboration with the healthcare system
that we partnered with for the project. From the beginning of the project, the
administrators were as accommodating to the project needs as possible. Data were
collected without resistance from the administrators. We believe that this allowed us to
have a complete set of data without any missingness for both the CNA sample and the
persons with AD sample.
Limitations of the Study
While this study contributes to an understanding of the significance of including
compassionate care into the training of CNAs working with persons with AD, there are
limitations that must be addressed. First, due to time and setting restrictions, we were
only able to include two facilities in this study. While we were able to meet the power
requirements for our research design, including more facilities in the study will
strengthen our findings.
Second, after CNAs at the experimental site were enrolled to participate in this
program, we had to close the participation after a certain point despite a desire from more
CNA participants to join in the study. While this will be rectified moving forward by the
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introduction of a new session of the program at the experimental facility identified in this
study, it did limit participation from some CNAs that enrolled in the program late.
Third, the care groups for CNAs were limited in both size and the times they were
offered. Arrangements had to be made for the CNAs to come to the sessions and this
required coordination with the nursing facility to provide coverage for those attending as
it was assumed that this would be part of their shifts at the nursing facility. This meant
that not every CNA in the study was available to attend every session.
Summary
The results of this study showed that integrating compassionate care into the work
that CNAs do with persons with AD can lead to positive outcomes for CNAs in terms of
improved AD knowledge, caregiver self-efficacy, caregiving satisfaction and affiliate
stigma. The implementation of compassionate care also greatly impacts the agitation and
cortisol levels of persons with AD. This has implications for the way we conceptualize
the type of care that is provided by CNAs to persons with AD. Traditional basic nursing
care focuses primarily on the basic needs of the person such as attending to activities of
daily living. CNAs are trained to only provide this care and other areas are considered
outside of their scope. While traditional basic nursing care is important, it should be
supplemented with compassionate care for persons with AD. Compassionate care (CC)
emphasizes the bond between the caregiver (the CNA) and the care receiver (the person
with AD) and their journey together. CC can also provide CNAs with skills to respond to
the changes that the person with AD undergoes as they decline.
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Subject Informed Consent Document and Research Authorization
FOSTERING COMPASSIONATE CARE FOR INDIVIDUALS WITH
ALZHEIMER’S DISEASE
Investigator(s) name & address: Anna C. Faul, PhD & Samantha Cotton, MSSW, 300 E
Market St, Suite 200, Louisville KY 40222.
Site(s) where study is to be conducted: Institute for Sustainable Health & Optimal Aging
Phone number for subjects to call for questions: 502-852-5629
Introduction and Background Information
You are invited to participate in a research study that focuses on compassionate care in
nursing home settings, specifically focusing on residents with Alzheimer’s disease. The
purpose of this study is to evaluate a curriculum designed for nurse aides working with
residents with Alzheimer’s disease. The study is being conducted by Dr. Anna C. Faul,
PhD and Sam Cotton, MSSW, ABD. The study will take place at eight different nursing
facilities in Kentucky.
Approximately 300 subjects will be invited to participate.
Purpose
The purpose of this study is to evaluate a training curriculum delivered to state registered
nurse aides (SNRA’s) in nursing homes.
Procedures
In this study, you will be asked to participate in eight online modules that will provide
you with a foundation about Alzheimer’s disease; these modules will focus on three
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primary areas: 1.) the disease and its impact, 2.) Compassionate caregiving for
individuals with Alzheimer’s disease and 3.) Caring for the caregiver. After the
completion of these eight modules, you will have the opportunity to participate in handson learning and support, known as care groups, within the nursing home where you work.
As part of this study, you will complete pre and post-test surveys about your experience
with curriculum, your knowledge of Alzheimer’s disease and related dementias, and your
confidence in performing activities with residents with Alzheimer’s disease.
Potential Risks
There are no foreseeable risks other than possible discomfort in answering personal
questions. There may be unforeseen risks.
Benefits
Nurse aides may increase their understanding of working with residents with Alzheimer’s
disease, which could contribute to a transformation within the nursing home towards
more compassionate care. The information collected may not benefit you directly. The
information learned in this study may be helpful to others.
Payment
You will not be compensated for your time, inconvenience, or expenses while you are in
this study.
Revocation of Research Authorization
You may cancel the permission you have given to use and share your protected health
information at any time. This means you can tell us to stop using and sharing your
protected health information. If you cancel your permission:
•
•
•

We will stop collecting information about you.
You may not withdraw information that we had before you told us to stop.
o We may already have used it or shared it.
o We may need it to complete the research.
Staff may ask your permission to follow-up with you if there is a medical reason
to do so.

To cancel your permission, you will be requested to complete a written “Revocation of
Research Authorization” form located at the end of this document. You may also obtain
a copy from your study doctor, designated personnel or from the Human Subjects
Protections Program Office website (http://louisville.edu/research/humansubjects/linksto-forms).
Confidentiality

221

Total privacy cannot be guaranteed. We will protect your privacy to the extent permitted
by law. If the results from this study are published, your name will not be made public.
Once your information leaves our institution, we cannot promise that others will keep it
private.
Your information may be shared with the following:
•
Organizations that provide funding at any time for the conduct of the
research.
•
The University of Louisville Institutional Review Board, Human Subjects
Protection Program Office, Privacy Office, others involved in research
administration and compliance at the University, and others contracted by
the University for ensuring human subjects safety or research compliance
•
The local research team
•
Researchers at other sites participating in the study (if applicable)
•
People who are responsible for research, compliance and HIPAA
oversight at the institutions where the research is conducted
•
People responsible for billing, sending and receiving payments related to
your participation in the study
•
Government agencies, such as:
o Office for Human Research Protections
o Office of Civil Rights
Security
Your information will be kept private. Any data collected will be stored at the Institute
for Sustainable Health & Optimal Aging in secure area in a locked file cabinet.
Voluntary Participation
Taking part in this study is voluntary. You may choose not to take part at all. If you
decide to be in this study, you may stop taking part at any time. If you decide not to be in
this study or if you stop taking part at any time, you will not lose any benefits for which
you may qualify.
You will be told about any changes that may affect your decision to continue in the study.
Contact Persons
If you have any questions, concerns, or complaints about the research study, please contact
Samantha Cotton at 502-852-5629.
Research Subject’s Rights
If you have any questions about your rights as a research subject, you may call the
Human Subjects Protection Program Office at (502) 852-5188. You may discuss any
questions about your rights as a research subject, in private, with a member of the
Institutional Review Board (IRB). You may also call this number if you have other
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questions about the research, and you cannot reach the study doctor, or want to talk to
someone else. The IRB is an independent committee made up of people from the
University community, staff of the institutions, as well as people from the community not
connected with these institutions. The IRB has approved the participation of human
subjects in this research study.

Concerns and Complaints
If you have concerns or complaints about the research or research staff and you do not
wish to give your name, you may call the toll-free number 1-877-852-1167. This is a 24hour hot line answered by people who do not work at the University of Louisville.

Acknowledgment and Signatures
This informed consent document is not a contract. This document tells you what will
happen during the study if you choose to take part. Your signature indicates that this
study has been explained to you, that your questions have been answered, and that you
agree to take part in the study. You are not giving up any legal rights to which you are
entitled by signing this informed consent document. You will be given a copy of this
consent form to keep for your records.

________________________________________________________________________
______
Subject Name (Please Print)

Signature of Subject

Date Signed

______________________________
______________________________
__
Printed Name of Legally

Signature of Legally
Date Signed Authorized Representative (if
Authorized Representative

applicable)

__________________________________________________
Authority of Legally Authorized Representative to act on behalf of Subject
*Authority to act on behalf of another includes, but is not limited to parent, guardian, or durable power of
attorney for health care.
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____________________________________________________________________________________
Printed Name of Person Explaining Consent Form Signature of Person Explaining Date Signed
Consent Form (if other than the Investigator)

Printed Name of Investigator

Signature of Investigator

List of Investigators:
Anna Faul, PhD
Sam Cotton, MSSW

Phone Numbers:
502-852-1981
502-852-5629
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Date Signed

REVOCATION OF AUTHORIZATION FOR USE AND DISCLOSURE OF
YOUR HEALTH INFORMATION FOR RESEARCH
Return To:

Institutional Review Board

PI Address: 300 E Market St. Suite 200

OR MedCenter One, Suite 200

Louisville KY 40222

501 E. Broadway

PI Phone: 502-852-5629

Louisville, KY 40202

Do not sign this letter unless you are withdrawing from this research. You will be
sent confirmation that this notice was received.
To Whom It May Concern:
I would like to discontinue my participation in the research study noted above. I understand
that health information already collected will continue to be used as discussed in the
Authorization I signed when joining the study.
Your options are (choose one):

□

Withdraw from Study & Discontinue Authorization:
Discontinue my authorization for the future use and disclosure of protected health
information. In some instances, the research team may need to use your information even
after you discontinue your authorization, for example, to notify you or government agencies
of any health or safety concerns that were identified as part of your study participation.

□

Withdraw from Study, but Continue Authorization:
Allow the research team to continue collecting information from me and my personal health
information. This would be done only as needed to support the goals of the study and would
not be used for purposes other than those already described in the research authorization.

______________________________________________________________________________
__
Printed Name and Signature of Subject
Date Signed
______________________________________________________________________________
_
Signature of Subject’s Legal Representative (if subject is unable to sign)
Date Signed
Printed Name of Subject’s Legal Representative
Optional:
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I am ending my participation in this study because:
_______________________________________
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CNA Baseline Survey (Experimental Group)
Participant ID: __________________

Part I: Demographics
Please answer the following questions about yourself.

1.) Date of Birth: ____ /_____ /____
2.) Gender:
3.) Do you consider yourself Hispanic? Yes____ No_____
4.) Do you consider yourself primarily:
Black
American Indian/Native American
Asian
White
Other

5.) Number of years working in nursing facilities: __________
6.) Number of years working in this specific facility: _______
7.) Number of years of formal educational training: _______
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Part II: Alzheimer’s Disease Knowledge Scale (ADKS)
Please answer each question by indicating whether the statement is true or false.

1. People with Alzheimer’s disease are particularly prone to depression.
a. True
b. False
2. It has been scientifically proven that mental exercise can prevent a person from
getting Alzheimer’s disease.
a. True
b. False
3. After symptoms of Alzheimer’s disease appear, the average life expectancy is 6 to
12 years.
a. True
b. False
4. When a person with Alzheimer’s disease becomes agitated, a medical
examination might reveal other health problems that caused the agitation.
a. True
b. False
5. People with Alzheimer’s disease do best with simple instructions given one step
at a time.
a. True
b. False
6. When people with Alzheimer’s disease begin to have difficulty taking care of
themselves, caregivers should take over right away.
a. True
b. False
7. If a person with Alzheimer’s disease becomes alert and agitated at night, a good
strategy is to try to make sure that the person gets plenty of physical activity
during the day.
a. True
b. False
8. In rare cases, people have recovered from Alzheimer’s disease.
a. True
b. False
9. People whose Alzheimer’s disease is not yet severe can benefit from
psychotherapy for depression and anxiety.
a. True
b. False
10. If trouble with memory and confused thinking appears suddenly, it is likely due to
Alzheimer’s disease.
a. True
b. False
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11. Most people with Alzheimer’s disease live in nursing homes.
a. True
b. False
12. Poor nutrition can make the symptoms of Alzheimer’s disease worse.
a. True
b. False
13. People in their 30’s can have Alzheimer’s disease.
a. True
b. False
14. A person with Alzheimer’s disease becomes increasingly likely to fall down as
the disease gets worse.
a. True
b. False
15. When people with Alzheimer’s disease repeat the same question or story several
times, it is helpful to remind them that they are repeating themselves.
a. True
b. False
16. Once people have Alzheimer’s disease, they are no longer capable of making
informed decisions about their own care.
a. True
b. False
17. Eventually, a person with Alzheimer’s disease will need 24-hours supervision.
a. True
b. False
18. Having high cholesterol may increase a person’s risk of developing Alzheimer’s
disease.
a. True
b. False
19. Tremor or shaking of the hands or arms is a common symptom in people with
Alzheimer’s disease.
a. True
b. False
20. Symptoms of severe depression can be mistaken for symptoms of Alzheimer’s
disease.
a. True
b. False
21. Alzheimer’s disease is one type of dementia.
a. True
b. False
22. Trouble handling money or paying bills is a common early symptom of
Alzheimer’s disease.
a. True
b. False
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23. One symptom that can occur with Alzheimer’s disease is believing that other
people are stealing one’s things.
a. True
b. False
24. When a person has Alzheimer’s disease, using reminder notes is a crutch that can
contribute to decline.
a. True
b. False
25. Prescription drugs that prevent Alzheimer’s disease are available.
a. True
b. False
26. Having high blood pressure may increase a person’s risk of developing
Alzheimer’s disease.
a. True
b. False
27. Genes can only partially account for the development of Alzheimer’s disease.
a. True
b. False
28. It is safe for people with Alzheimer’s disease to drive, as long as they have a
companion in the care at all times.
a. True
b. False
29. Alzheimer’s disease cannot be cured.
a. True
b. False
30. Most people with Alzheimer’s disease remember recent events better than things
that happened in the past.
a. True
b. False
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Part III: Self-Efficacy for Restorative Care Activities
These questions are about your confidence in your ability to provide restorative care at
this present time. For each question, there is a scale from 1 to 10, with 1 representing no
confidence and 10 representing total confidence. Please circle the number that best
represents your feelings.
I feel confident that I can provide restorative care activities related to:
1= No confidence
Having residents participate in bathing.
Having residents participate in dressing.
Having residents participate in eating.
Having residents participate in a walking
program.
Having residents participate in a specific
exercise program.
Having residents participate in toileting
activities.
Episodes when the resident refuses to
participate in specific activities.
Days when I am assigned more residents than
usual because of staffing issues.
When the residents are anxious to get ready
for an appointment or a visit from someone.
When the family wants me to provide total
care.

10= Total Confidence
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8
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8
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8
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8
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8
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8
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Part IV: CaRegiving Appraisal

Your health has suffered because of the care
you must give to the nursing home residents
with Alzheimer’s disease.
You are isolated and alone as a result of
your caring for the nursing home residents
with Alzheimer’s disease.
You will be unable to take care of the
nursing home residents with Alzheimer’s
disease much longer.
You are very tired as a result of your caring
for the nursing home residents with
Alzheimer’s disease.
Taking care of the nursing home residents
with Alzheimer’s disease gives you a
trapped feeling.
Your social life has suffered because you
care for nursing home residents with
Alzheimer’s disease.
Because of the time you spend with the
nursing home residents with Alzheimer’s
disease, you don’t have enough time for
yourself.
You really enjoy being with the nursing
home residents with Alzheimer’s disease.
The nursing home residents with
Alzheimer’s disease pleasure over some
little things gives you pleasure.
Helping the nursing home residents with
Alzheimer’s disease has made you feel
closer to them.
Taking responsibility for the nursing home
residents with Alzheimer’s disease. Gives
your self-esteem a boost.
You get a sense of satisfaction from caring
for the nursing home residents with
Alzheimer’s disease.
Caring for the nursing home residents with
Alzheimer’s disease gives more meaning to
your life.
You feel about to handle most problems in
the care of the nursing home residents with
Alzheimer’s disease.
You are pretty good at figuring out what to
do about the nursing home residents with
Alzheimer’s disease.

1

2

3

4

5

Not at all

A little

Moderately

Quite a bit

A great deal

1

2

3

4

5

1

2

3

4

5

1
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3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5
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2

3

4

5
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Part II: Alzheimer’s Disease Knowledge Scale (ADKS)
Please answer each question by indicating whether the statement is true or false.

1. People with Alzheimer’s disease are particularly prone to depression.
a. True
b. False
2. It has been scientifically proven that mental exercise can prevent a person from
getting Alzheimer’s disease.
a. True
b. False
3. After symptoms of Alzheimer’s disease appear, the average life expectancy is 6 to
12 years.
a. True
b. False
4. When a person with Alzheimer’s disease becomes agitated, a medical
examination might reveal other health problems that caused the agitation.
a. True
b. False
5. People with Alzheimer’s disease do best with simple instructions given one step
at a time.
a. True
b. False
6. When people with Alzheimer’s disease begin to have difficulty taking care of
themselves, caregivers should take over right away.
a. True
b. False
7. If a person with Alzheimer’s disease becomes alert and agitated at night, a good
strategy is to try to make sure that the person gets plenty of physical activity
during the day.
a. True
b. False
8. In rare cases, people have recovered from Alzheimer’s disease.
a. True
b. False
9. People whose Alzheimer’s disease is not yet severe can benefit from
psychotherapy for depression and anxiety.
a. True
b. False
10. If trouble with memory and confused thinking appears suddenly, it is likely due to
Alzheimer’s disease.
a. True
b. False
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11. Most people with Alzheimer’s disease live in nursing homes.
a. True
b. False
12. Poor nutrition can make the symptoms of Alzheimer’s disease worse.
a. True
b. False
13. People in their 30’s can have Alzheimer’s disease.
a. True
b. False
14. A person with Alzheimer’s disease becomes increasingly likely to fall down as
the disease gets worse.
a. True
b. False
15. When people with Alzheimer’s disease repeat the same question or story several
times, it is helpful to remind them that they are repeating themselves.
a. True
b. False
16. Once people have Alzheimer’s disease, they are no longer capable of making
informed decisions about their own care.
a. True
b. False
17. Eventually, a person with Alzheimer’s disease will need 24-hours supervision.
a. True
b. False
18. Having high cholesterol may increase a person’s risk of developing Alzheimer’s
disease.
a. True
b. False
19. Tremor or shaking of the hands or arms is a common symptom in people with
Alzheimer’s disease.
a. True
b. False
20. Symptoms of severe depression can be mistaken for symptoms of Alzheimer’s
disease.
a. True
b. False
21. Alzheimer’s disease is one type of dementia.
a. True
b. False
22. Trouble handling money or paying bills is a common early symptom of
Alzheimer’s disease.
a. True
b. False
23. One symptom that can occur with Alzheimer’s disease is believing that other
people are stealing one’s things.
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a. True
b. False

24. When a person has Alzheimer’s disease, using reminder notes is a crutch that can
contribute to decline.
a. True
b. False
25. Prescription drugs that prevent Alzheimer’s disease are available.
a. True
b. False
26. Having high blood pressure may increase a person’s risk of developing
Alzheimer’s disease.
a. True
b. False
27. Genes can only partially account for the development of Alzheimer’s disease.
a. True
b. False
28. It is safe for people with Alzheimer’s disease to drive, as long as they have a
companion in the care at all times.
a. True
b. False
29. Alzheimer’s disease cannot be cured.
a. True
b. False
30. Most people with Alzheimer’s disease remember recent events better than things
that happened in the past.
a. True
b. False
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Part III: Self-Efficacy for Restorative Care Activities
These questions are about your confidence in your ability to provide restorative care at
this present time. For each question, there is a scale from 1 to 10, with 1 representing no
confidence and 10 representing total confidence. Please circle the number that best
represents your feelings.
I feel confident that I can provide restorative care activities related to:
1= No confidence

10= Total

Confidence
Having residents participate in bathing.
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8

9
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Having residents participate in dressing.
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Having residents participate in eating.

1

2

3

4

5

6

7

8

9

10

1

2

3

4

5

6

7

8
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Having residents participate in a walking
program.
Having residents participate in a specific
exercise program.
Having residents participate in toileting
activities.
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Episodes when the resident refuses to
1
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8
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participate in specific activities.
Days when I am assigned more residents
than usual because of staffing issues.
When the residents are anxious to get ready
for an appointment or a visit from someone.
When the family wants me to provide total
care.

Part IV: Caregiving Appraisal
These questions are about how you feel about the caregiving situation. Please indicate
your amount of agreement with each statement.

5
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2

3

4

Not at all

A little

Moderately

Quite a bit

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

Your health has suffered because of the
care you must give to the nursing home
residents with Alzheimer’s disease.
You are isolated and alone as a result of
your caring for the nursing home
residents with Alzheimer’s disease.
You will be unable to take care of the
nursing home residents with Alzheimer’s
disease much longer.
You are very tired as a result of your
caring for the nursing home residents
with Alzheimer’s disease.
Taking care of the the nursing home
residents with Alzheimer’s disease gives
you a trapped feeling.
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A great
deal
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Not at all

A little
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Quite a bit
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Your social life has suffered because you
care for nursing home residents with
Alzheimer’s disease.
Because of the time you spend with the
nursing home residents with Alzheimer’s
disease, you don’t have enough time for
yourself.
You really enjoy being with the nursing
home residents with Alzheimer’s disease.
The nursing home residents with
Alzheimer’s disease pleasure over some
little things gives you pleasure.
Helping the nursing home residents with
Alzheimer’s disease has made you feel
closer to them.
Taking responsibility for the nursing
home residents with Alzheimer’s disease.
Gives your self-esteem a boost.
You get a sense of satisfaction from
caring for the nursing home residents
with Alzheimer’s disease.
Caring for the nursing home residents
with Alzheimer’s disease gives more
meaning to your life.
You feel about to handle most problems
in the care of the nursing home residents
with Alzheimer’s disease.
You feel reassured about what to do
about the nursing home residents with
Alzheimer’s disease.
You feel uncertain about what to do
about the nursing home residents with
Alzheimer’s disease.
You feel that you should be doing more.
You feel that you could do a better job in
caring for the nursing home residents
with Alzheimer’s disease.
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A great
deal

Part V: Affiliate Stigma Scale
These questions are about how you feel about the working with persons with Alzheimer’s
disease. Please indicate your amount of agreement with each statement.

Other people would discriminate against me if I
am with nursing home residents with
Alzheimer’s disease.
My reputation is damaged because I work with
nursing home residents with Alzheimer’s
disease.
People’s attitude towards me sour when I am
with nursing home residents with Alzheimer’s
disease.
Working with nursing home residents with
Alzheimer’s disease negatively affects me.
Working with nursing home residents with
Alzheimer’s disease makes me think that I am
incompetent compared to others.
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1
Not at all

2
A little

3
Moderately

4
Quite a
bit

1

2

3

4

1

2

3

4

2

3

4

1

2

3

4

1

2

3

4

1

1
Not at all

2
A little

3
Moderately

4
Quite a
bit

1

2

3

4

1

2

3

4

1

2

3

4

1

2

3

4

1

2

3

4

I feel helpless because I work with nursing
home residents with Alzheimer’s disease.

1

2

3

4

I feel sad because I work with nursing home
residents with Alzheimer’s disease.

1

2

3

4

1

2

3

4

1

2

3

4

I avoid communicating with nursing home
residents with Alzheimer’s disease.

1

2

3

4

I dare not tell others that I work with nursing
home residents with Alzheimer’s disease.

1

2

3

4

I have cut down on taking nursing home
residents with Alzheimer’s disease on outings.

1

2

3

4

1

2

3

4

1

2

3

4

1

2

3

4

Working with nursing home residents with
Alzheimer’s disease makes me think that I am
lesser than others.
Working with nursing home residents with
Alzheimer’s disease makes me lose face.
I feel inferior because I work with individuals
with Alzheimer’s disease.
I feel emotionally disturbed because I work with
individuals with Alzheimer’s disease.
The behavior of residents with Alzheimer’s
disease makes me feel embarrassed.

I worry if other would know that I work with
nursing home residents with Alzheimer’s
disease.
I am under great stress as I work with nursing
home residents with Alzheimer’s disease.

Because of my work with nursing home
residents with Alzheimer’s disease, I have
reduced my contacts with friends and relatives.
When I am with the residents with Alzheimer’s
disease, I keep an especially low profile.
I have reduced my contacts with the nursing
home residents with Alzheimer’s disease.
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I dare not participate in activities related to
Alzheimer’s disease lest others suspect that I
work with persons that have the disease.
Because of my work with nursing home
residents with Alzheimer’s disease, I have
reduced my contacts with my neighbors.
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1
Not at all

2
A little

3
Moderately

4
Quite a
bit

1

2

3

4

1

2

3

4

APPENDIX B: INFORMED CONSENTS AND SURVEYS FOR CNAS CONTROL
GROUP
Subject Informed Consent Document and Research Authorization
FOSTERING COMPASSIONATE CARE FOR INDIVIDUALS WITH
ALZHEIMER’S DISEASE
Investigator(s) name & address: Anna C. Faul, PhD & Samantha Cotton, MSSW, 300 E
Market St, Suite 200, Louisville KY 40222.
Site(s) where study is to be conducted: Institute for Sustainable Health & Optimal Aging
Phone number for subjects to call for questions: 502-852-5629
Introduction and Background Information
You are invited to participate in a research study that focuses on compassionate care in
nursing home settings, specifically focusing on residents with Alzheimer’s disease. The
purpose of this study is to evaluate a curriculum designed for nurse aides working with
residents with Alzheimer’s disease. The study is being conducted by Dr. Anna C. Faul,
PhD and Sam Cotton, MSSW, ABD. The study will take place at eight different nursing
facilities in Kentucky.
Approximately 300 subjects will be invited to participate.
Purpose
The purpose of this study is to evaluate a training curriculum delivered to state registered
nurse aides (SNRA’s) in nursing homes.
Procedures
As part of this study, you will complete pre and post-test surveys about your experience
with the curriculum, your knowledge of Alzheimer’s disease and related dementias, and
your confidence in performing activities with residents with Alzheimer’s disease.
Potential Risks
There are no foreseeable risks other than possible discomfort in answering personal
questions. There may be unforeseen risks.
Benefits
Nurse aides may increase their understanding of working with residents with Alzheimer’s
disease, which could contribute to a transformation within the nursing home towards
more compassionate care. The information collected may not benefit you directly. The
information learned in this study may be helpful to others.
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Payment
You will not be compensated for your time, inconvenience, or expenses while you are in
this study.
Revocation of Research Authorization
You may cancel the permission you have given to use and share your protected health
information at any time. This means you can tell us to stop using and sharing your
protected health information. If you cancel your permission:
• We will stop collecting information about you.
• You may not withdraw information that we had before you told us to stop.
o We may already have used it or shared it.
o We may need it to complete the research.
• Staff may ask your permission to follow-up with you if there is a medical reason
to do so.
To cancel your permission, you will be requested to complete a written “Revocation of
Research Authorization” form located at the end of this document. You may also obtain
a copy from your study doctor, designated personnel or from the Human Subjects
Protections Program Office website (http://louisville.edu/research/humansubjects/linksto-forms).
Confidentiality
Total privacy cannot be guaranteed. We will protect your privacy to the extent permitted
by law. If the results from this study are published, your name will not be made public.
Once your information leaves our institution, we cannot promise that others will keep it
private.
Your information may be shared with the following:
• Organizations that provide funding at any time for the conduct of the research.
• The University of Louisville Institutional Review Board, Human Subjects
Protection Program Office, Privacy Office, others involved in research
administration and compliance at the University, and others contracted by the
University for ensuring human subjects safety or research compliance
• The local research team
• Researchers at other sites participating in the study (if applicable)
• People who are responsible for research, compliance and HIPAA oversight at
the institutions where the research is conducted
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• People responsible for billing, sending and receiving payments related to your
participation in the study
• Government agencies, such as:
o Office for Human Research Protections
o Office of Civil Rights
Security
Your information will be kept private. Any data collected will be stored at the Institute
for Sustainable Health & Optimal Aging in secure area in a locked file cabinet.
Voluntary Participation
Taking part in this study is voluntary. You may choose not to take part at all. If you
decide to be in this study, you may stop taking part at any time. If you decide not to be in
this study or if you stop taking part at any time, you will not lose any benefits for which
you may qualify.
You will be told about any changes that may affect your decision to continue in the study.
Contact Persons
If you have any questions, concerns, or complaints about the research study, please
contact Samantha Cotton at 502-852-5629.
Research Subject’s Rights
If you have any questions about your rights as a research subject, you may call the
Human Subjects Protection Program Office at (502) 852-5188. You may discuss any
questions about your rights as a research subject, in private, with a member of the
Institutional Review Board (IRB). You may also call this number if you have other
questions about the research, and you cannot reach the study doctor, or want to talk to
someone else. The IRB is an independent committee made up of people from the
University community, staff of the institutions, as well as people from the community not
connected with these institutions. The IRB has approved the participation of human
subjects in this research study.
Concerns and Complaints
If you have concerns or complaints about the research or research staff and you do not
wish to give your name, you may call the toll free number 1-877-852-1167. This is a 24hour hot line answered by people who do not work at the University of Louisville.
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Acknowledgment and Signatures
This informed consent document is not a contract. This document tells you what will
happen during the study if you choose to take part. Your signature indicates that this
study has been explained to you, that your questions have been answered, and that you
agree to take part in the study. You are not giving up any legal rights to which you are
entitled by signing this informed consent document. You will be given a copy of this
consent form to keep for your records.
________________________________________________________________________
Subject Name (Please Print)

Signature of Subject

Printed Name of Legally

Signature of Legally Authorized Rep

Date Signed

Date Signed

Authorized Representative
________________________________________________________________________
Authority of Legally Authorized Representative to act on behalf of Subject

Printed Name of Person

Explaining Consent Form

Signature of Person Explaining

Date Signed

*Authority to act on behalf of another includes, but is not limited to parent, guardian, or
durable power of attorney for health care.

Printed Name of Person

Explaining Consent Form

Printed Name of Investigator Signed

Signature of Person Explaining

Signature of Investigator

List of Investigators:

Phone Numbers:

Anna Faul, PhD

502-852-1981

Sam Cotton, MSSW

502-852-5629
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Date Signed

Date Signed

REVOCATION OF AUTHORIZATION FOR USE AND DISCLOSURE OF YOUR
HEALTH INFORMATION FOR RESEARCH
Return To:

PI Address: 300 E Market St. Suite 200

Institutional Review Board
OR

MedCenter One, Suite 200

Louisville KY 40222
501 E. Broadway
PI Phone: 502-852-5629
Louisville,
KY 40202
Do not sign this letter unless you are withdrawing from this
research.
You will be

sent confirmation that this notice was received.

To Whom It May Concern:
I would like to discontinue my participation in the research study noted above. I
understand that health information already collected will continue to be used as
discussed in the Authorization I signed when joining the study.
Your options are (choose one):

□

Withdraw from Study & Discontinue Authorization:
Discontinue my authorization for the future use and disclosure of protected health
information. In some instances, the research team may need to use your information
even after you discontinue your authorization, for example, to notify you or
government agencies of any health or safety concerns that were identified as part of
your study participation.

□

Withdraw from Study, but Continue Authorization:
Allow the research team to continue collecting information from me and my personal
health information. This would be done only as needed to support the goals of the
study and would not be used for purposes other than those already described in the
research authorization.

____________________
Printed Name and Signature of Subject
Signed

___

_____
Date

____________________
___
_____
________
Signature of Subject’s Legal Representative (if subject is unable to sign)
Signed
___________________
________

_
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_____

Date

Printed Name of Subject’s Legal Representative
Subject

Birthdate of

_________________________________________________
Relationship of Legal Representative to Subject
____________________
Subject’s Address

_____
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____________
Subject’s Phone Numbe

CNA Baseline and 12 Survey (Control Group)
Participant ID: __________________
Part I: Demographics

Please answer the following questions about yourself.

1.) Date of Birth: ____ /_____ /____
2.) Gender:
3.) Do you consider yourself Hispanic? Yes____ No_____
4.) Do you consider yourself primarily:
Black
American Indian/Native American
Asian
White
Other

5.) Number of years working in nursing facilities: __________
6.) Number of years working in this specific facility: _______
7.) Number of years of formal educational training: _______
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Part II: Alzheimer’s Disease Knowledge Scale (ADKS)
Please answer each question by indicating whether the statement is true or false.

1. People with Alzheimer’s disease are particularly prone to depression.
a. True
b. False
2. It has been scientifically proven that mental exercise can prevent a person from
getting Alzheimer’s disease.
a. True
b. False
3. After symptoms of Alzheimer’s disease appear, the average life expectancy is 6 to
12 years.
a. True
b. False
4. When a person with Alzheimer’s disease becomes agitated, a medical
examination might reveal other health problems that caused the agitation.
a. True
b. False
5. People with Alzheimer’s disease do best with simple instructions given one step
at a time.
a. True
b. False
6. When people with Alzheimer’s disease begin to have difficulty taking care of
themselves, caregivers should take over right away.
a. True
b. False
7. If a person with Alzheimer’s disease becomes alert and agitated at night, a good
strategy is to try to make sure that the person gets plenty of physical activity
during the day.
a. True
b. False
8. In rare cases, people have recovered from Alzheimer’s disease.
a. True
b. False
9. People whose Alzheimer’s disease is not yet severe can benefit from
psychotherapy for depression and anxiety.
a. True
b. False
10. If trouble with memory and confused thinking appears suddenly, it is likely due to
Alzheimer’s disease.
a. True
b. False
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11. Most people with Alzheimer’s disease live in nursing homes.
a. True
b. False
12. Poor nutrition can make the symptoms of Alzheimer’s disease worse.
a. True
b. False
13. People in their 30’s can have Alzheimer’s disease.
a. True
b. False
14. A person with Alzheimer’s disease becomes increasingly likely to fall down as
the disease gets worse.
a. True
b. False
15. When people with Alzheimer’s disease repeat the same question or story several
times, it is helpful to remind them that they are repeating themselves.
a. True
b. False
16. Once people have Alzheimer’s disease, they are no longer capable of making
informed decisions about their own care.
a. True
b. False
17. Eventually, a person with Alzheimer’s disease will need 24-hours supervision.
a. True
b. False
18. Having high cholesterol may increase a person’s risk of developing Alzheimer’s
disease.
a. True
b. False
19. Tremor or shaking of the hands or arms is a common symptom in people with
Alzheimer’s disease.
a. True
b. False
20. Symptoms of severe depression can be mistaken for symptoms of Alzheimer’s
disease.
a. True
b. False
21. Alzheimer’s disease is one type of dementia.
a. True
b. False
22. Trouble handling money or paying bills is a common early symptom of
Alzheimer’s disease.
a. True
b. False
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23. One symptom that can occur with Alzheimer’s disease is believing that other
people are stealing one’s things.
a. True
b. False
24. When a person has Alzheimer’s disease, using reminder notes is a crutch that can
contribute to decline.
a. True
b. False
25. Prescription drugs that prevent Alzheimer’s disease are available.
a. True
b. False
26. Having high blood pressure may increase a person’s risk of developing
Alzheimer’s disease.
a. True
b. False
27. Genes can only partially account for the development of Alzheimer’s disease.
a. True
b. False
28. It is safe for people with Alzheimer’s disease to drive, as long as they have a
companion in the care at all times.
a. True
b. False
29. Alzheimer’s disease cannot be cured.
a. True
b. False
30. Most people with Alzheimer’s disease remember recent events better than things
that happened in the past.
a. True
b. False

254

Part III: Self-Efficacy for Restorative Care Activities
These questions are about your confidence in your ability to provide restorative care at
this present time. For each question, there is a scale from 1 to 10, with 1 representing no
confidence and 10 representing total confidence. Please circle the number that best
represents your feelings.

I feel confident that I can provide restorative care activities related to:
1= No confidence

10= Total Confidence

Having residents participate in bathing.

1

2

3

4

5

6

7

8

9

10

Having residents participate in dressing.

1

2

3

4

5

6

7

8

9

10

Having residents participate in eating.

1

2

3

4

5

6

7

8

9

10

Having residents participate in a walking program.

1

2

3

4

5

6

7

8

9

10

1

2

3

4

5

6

7

8

9

10

1

2

3

4

5

6

7

8

9

10

1

2

3

4

5

6

7

8

9

10

1

2

3

4

5

6

7

8

9

10

1

2

3

4

5

6

7

8

9

10

1

2

3

4

5

6

7

8

9

10

Having residents participate in a specific exercise
program.
Having residents participate in toileting activities.
Episodes when the resident refuses to participate in
specific activities.
Days when I am assigned more residents than usual
because of staffing issues.
When the residents are anxious to get ready for an
appointment or a visit from someone.
When the family wants me to provide total care.
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Part IV: Caregiving Appraisal
These questions are about how you feel about the caregiving situation. Please indicate
your amount of agreement with each statement.

Your health has suffered because of the care
you must give to the nursing home residents
with Alzheimer’s disease.
You are isolated and alone as a result of your
caring for the nursing home residents with
Alzheimer’s disease.
You will be unable to take care of the nursing
home residents with Alzheimer’s disease
much longer.
You are very tired as a result of your caring
for the nursing home residents with
Alzheimer’s disease.
Taking care of the nursing home residents
with Alzheimer’s disease gives you a trapped
feeling.
Your social life has suffered because you care
for nursing home residents with Alzheimer’s
disease.
Because of the time you spend with the
nursing home residents with Alzheimer’s
disease, you don’t have enough time for
yourself.
You really enjoy being with the nursing home
residents with Alzheimer’s disease.
The nursing home residents with Alzheimer’s
disease pleasure over some little things gives
you pleasure.
Helping the nursing home residents with
Alzheimer’s disease has made you feel closer
to them.
Taking responsibility for the nursing home
residents with Alzheimer’s disease. Gives
your self-esteem a boost.
You get a sense of satisfaction from caring for
the nursing home residents with Alzheimer’s
disease.
Caring for the nursing home residents with
Alzheimer’s disease gives more meaning to
your life.
You feel reassured about what to do about the
nursing home residents with Alzheimer’s
disease.

1
Not at all

2
A little

3
Moderately

4
Quite a bit

5
A great
deal

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5
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You feel uncertain about what to do about the
nursing home residents with Alzheimer’s
disease.
You feel that you should be doing more.
You feel that you could do a better job in
caring for the nursing home residents with
Alzheimer’s disease.

1
Not at all

2
A little

3
Moderately

4
Quite a bit

5
A great
deal

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5
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Part V: Affiliate Stigma Scale
These questions are about how you feel about the working with persons with Alzheimer’s
disease. Please indicate your amount of agreement with each statement.
1
Not at all

2
A little

3
Moderately

4
Quite a bit

1

2

3

4

1

2

3

4

2

3

4

1

2

3

4

1

2

3

4

1

2

3

4

1

2

3

4

1

2

3

4

1

2

3

4

1

2

3

4

I feel helpless because I work with nursing
home residents with Alzheimer’s disease.

1

2

3

4

I feel sad because I work with nursing home
residents with Alzheimer’s disease.

1

2

3

4

1

2

3

4

Other people would discriminate against me if I
am with nursing home residents with
Alzheimer’s disease.
My reputation is damaged because I work with
nursing home residents with Alzheimer’s
disease.
People’s attitude towards me sour when I am
with nursing home residents with Alzheimer’s
disease.
Working with nursing home residents with
Alzheimer’s disease negatively affects me.
Working with nursing home residents with
Alzheimer’s disease makes me think that I am
incompetent compared to others.
Working with nursing home residents with
Alzheimer’s disease makes me think that I am
lesser than others.
Working with nursing home residents with
Alzheimer’s disease makes me lose face.
I feel inferior because I work with individuals
with Alzheimer’s disease.
I feel emotionally disturbed because I work with
individuals with Alzheimer’s disease.
The behavior of residents with Alzheimer’s
disease makes me feel embarrassed.

I worry if other would know that I work with
nursing home residents with Alzheimer’s
disease.
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1

1
Not at all

2
A little

3
Moderately

4
Quite a bit

I am under great stress as I work with nursing
home residents with Alzheimer’s disease.

1

2

3

4

I avoid communicating with nursing home
residents with Alzheimer’s disease.

1

2

3

4

I dare not tell others that I work with nursing
home residents with Alzheimer’s disease.

1

2

3

4

I have cut down on taking nursing home
residents with Alzheimer’s disease on outings.

1

2

3

4

1

2

3

4

1

2

3

4

1

2

3

4

1

2

3

4

1

2

3

4

Because of my work with nursing home
residents with Alzheimer’s disease, I have
reduced my contacts with friends and relatives.
When I am with the residents with Alzheimer’s
disease, I keep an especially low profile.
I have reduced my contacts with the nursing
home residents with Alzheimer’s disease.
I dare not participate in activities related to
Alzheimer’s disease lest others suspect that I
work with persons that have the disease.
Because of my work with nursing home
residents with Alzheimer’s disease, I have
reduced my contacts with my neighbors.
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APPENDIX C: RESIDENT WITH ALZHEIMER’S DISEASE ASSENT AND
SURVEYS
SUBJECT ASSENT
I am invited to be in a research study being done Dr. Anna Faul, PhD, and Sam Cotton,
MSSW, ABD. When a person is in a research study, they are called a “subject”. I am
invited because I have been diagnosed with Alzheimer’s disease and I live in a nursing
home.
This means that myself or my caregivers at the nursing home will be asked questions
about me including questions about my demographics, my quality of life, and questions
about when I get upset or agitated. As a subject in this study, I will have my salvia taken
3 times during the study so that the research team can look at my stress levels. There may
be some risks with this study. These risks are having your saliva taken and answering
questions which may cause discomfort. This study will last 8 months. The benefit to me
for participating in this study is that the data we collect will be used to help inform your
care and the care of others at the nursing home where you live.
My family, the researchers, and the workers at the nursing home I live at will know that
I’m in the study. If anyone else is given information about me, they will not know my
name. A number or initials will be used instead of my name.
I have been told about this study and know why it is being done and what I have to do.
My family has agreed to let me be in the study. If I have any questions I can ask Dr. Faul
or Sam Cotton. They will answer my questions. If I do not want to be in this study or I
want to quit after I am already in this study, I can tell the researcher and they will discuss
this with my family.
Printed Name of Subject

Signature of Subject

Date Signed

Printed Name of Legal Representative

Printed Name of Investigator

Signature of Investigator

260

Date Signed

Resident Survey Baseline, 6 weeks and 12 weeks

Participant ID: __________________
Part I: Basic Demographics

Please answer the following questions about the resident.

1.) Date of Birth: ____ /_____ /____
2.) Gender:
3.) Do you consider yourself Hispanic? Yes____ No_____
4.) Do you consider yourself primarily:
Black
American Indian/Native American
Asian
White
Other

261

Part II: Rapid Cognitive Screen (For Demographic purposes only)

1.) Please remember these five objects. I will ask you what they are later. [Read
each object to patient using approximately 1 second intervals.]
Apple

Pen

Tie

House

Car

Please repeat the objects for me. [If patient does not repeat all 5 objects correctly, repeat
until all objects are recalled correctly or up to a maximum of 2 times.]

2.) [Give patient pencil and blank sheet with clock face.]
This is a clock face. Please put in the hour markers and the time at ten
minutes to eleven o’clock.

____/ 2 (points) Hour markers are okay
____/2 (points) Time correct

3.) What were the five objects I asked you to remember?
____/ 1 (point) Apple
____/ 1 (point) Pen
____/ 1 (point) Tie
____/ 1 (point) House
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____/ 1 (point) Car

4.) I’m going to tell you a story. Please listen carefully because afterwards, I’m going
to ask you about it.
Jill was a very successful stockbroker. She made a lot of money on the stock market.
She then met Jack, a devastatingly handsome man. She married him and had three
children. They lived in Chicago. She then stopped work and stayed at home to bring
up her children. When they were teenagers, she went back to work. She and Jack
lived happily ever after.
What state did she live in?
____/ 1 (point) Illinois

[Do not repeat the story but do make sure that the patient is listening the first time
you read it to them. Do not prompt or give hints. The answer of “Chicago” as the
state that she lives in gets no credit but you may prompt them once by repeating the
question when “Chicago” is given as the answer.]
_______Total Score [0-10 points]

Scoring
8-10……Normal
6-7………Mild Cognitive Impairment
0-5……..Dementia
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For RCS Clock Question
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Part III: The Cohen-Mansfield Agitation Inventory
Please read each of the 29 agitated behaviors, and circle how often (from 1-7) each was
manifested by the resident during the last 2 weeks:
1
Never

2
Less than
once a week

3
Once or
twice a
week

4
Several
times a
week

5
Once or
twice a day

6
Several
times a
day

7
Several
times an
hour

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

Kicking

1

2

3

4

5

6

7

Grabbing onto people

1

2

3

4

5

6

7

Pushing

1

2

3

4

5

6

7

Throwing things

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

Biting

1

2

3

4

5

6

7

Scratching

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

Pace, aimlessly wandering
Inappropriate dress or
disrobing
Spitting (including at meals)
Cursing or verbal aggression
Constant unwarranted
request for attention or help
Repetitive sentences or
questions
Hitting (including self)

Strange noises (weird
laughter or crying)
Screaming

Trying to get to a different
place (e.g., out of the room,
building)
Intentional falling
Complaining
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Negativism
Eating/drinking
inappropriate substances
Hurt self or others (cigarette,
hot water, etc.)
Handling things
inappropriately
Hiding things
Hoarding things
Tearing things or destroying
property
Performing repetitious
mannerisms
Making verbal sexual
advances
Making physical sexual
advances
General restlessness

1
Never

2
Less than
once a week

3
Once or
twice a
week

4
Several
times a
week

5
Once or
twice a day

6
Several
times a
day

7
Several
times an
hour

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7
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